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Abstract
THE IMPACT OF OBJECTIVE QUALITY RATINGS ON PATIENT SELECTION OF COMMUNITY
PHARMACIES: A DISCRETE CHOICE EXPERIMENT AND LATENT CLASS ANALYSIS
By Julie A. Patterson, BS, PharmD/PhD Candidate
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2017
Advisor: David A. Holdford, R.Ph., M.S., Ph.D., FAPhA
Professor, Department of Pharmacotherapy and Outcomes Science
Background: Pharmacy-related performance measures have gained significant attention
in the transition to value-based healthcare. Pharmacy-level quality measures, including
those developed by the Pharmacy Quality Alliance, are not yet publicly accessible.
However, the publication of report cards for individual pharmacies has been discussed as a
way to help direct patients towards high-quality pharmacies. This study aimed to measure
the relative strength of patient preferences for community pharmacy attributes, including
pharmacy quality. Additionally, this study aimed to identify and describe community
pharmacy market segments based on patient preferences for pharmacy attributes.

Methods: This study elicited patient preferences for community pharmacy attributes using
a discrete choice experiment (DCE) among a sample of 773 adults aged 18 years and older.
Six attributes were selected based on published literature, expert opinion, and pilot testing
feedback. The attributes included hours of operation, staff friendliness/courtesy,
pharmacist communication, pharmacist willingness to establish a personal relationship,
overall quality, and a drug-drug interaction specific quality metric. Participants responded

xii

to a block of ten random choice tasks assigned by Sawtooth v9.2 and two fixed tasks,
including a dominant and a hold-out scenario. The data were analyzed using conditional
logit and latent class regression models, and Hierarchical Bayes estimates of individuallevel utilities were used to compare preferences across demographic subgroups.
Results: Among the 773 respondents who began the survey, 741 (95.9%) completed the
DCE and demographic questionnaire. Overall, study participants expressed the strongest
preferences for quality-related pharmacy attributes. The attribute importance values
(AIVs) were highest for the specific, drug-drug interaction (DDI) quality measure,
presented as, “The pharmacy ensured there were no patients who were dispensed two
medications that can cause harm when taken together,” (40.3%) and the overall pharmacy
quality measure (31.3%). The utility values for 5-star DDI and overall quality ratings were
higher among women (83.0 and 103.8, respectively) than men (76.2 and 94.5,
respectively), and patients with inadequate health literacy ascribed higher utility to
pharmacist efforts to get to know their patients (26.0) than their higher literacy
counterparts (16.3). The best model from the latent class analysis contained three classes,
coined the Quality Class (67.6% of participants), the Relationship Class (28.3%), and the
Convenience Class (4.2%).
Conclusions: The participants in this discrete choice experiment exhibited strong
preferences for pharmacies with higher quality ratings. This finding may reflect patient
expectations of community pharmacists, namely that pharmacists ensure that patients are
not harmed by the medications filled at their pharmacies. Latent class analysis revealed
underlying heterogeneity in patient preferences for community pharmacy attributes.

xiii

Chapter 1: Introduction
1.1 Introduction
The amount of publicly available healthcare quality data has proliferated in recent
decades. Patients may now access a variety of quality information compiled through
governmental (e.g. HEDIS), for-profit (e.g. HealthGrades), and not-for-profit (e.g. LeapFrog)
outlets. A substantial body of literature has debated the impact of these metrics on patient
selection of healthcare providers and facilities. While pharmacy-level quality metrics are
not yet publicly accessible, the publication of report cards for individual pharmacies has
been discussed as a way to help direct patients towards high-quality pharmacies.1
The effort to quantify and promote pharmacy quality has been led by the Pharmacy Quality
Alliance (PQA), a non-profit, multi-stakeholder organization founded in 2006.2 PQA aims to
collaboratively and strategically establish meaningful performance measures at the
pharmacy and pharmacist-level.2 Furthermore, health-plan level PQA measures are
included in the Health Insurance Marketplace plan rating system3 and Medicare Part D Plan
star ratings, which impact payments from the Centers for Medicare and Medicaid (CMS).4
Most studies examining how American patients choose pharmacies have focused on
patient decisions to select mail order pharmacies5–7 or were conducted over twenty years
ago. Older studies on patient selection of community pharmacies reported that patients
consider location,8,9 pharmacist friendliness and professionalism,10,11 price,10 and
pharmacist services10 to be important factors when selecting a pharmacy. More recently, a
survey asked patients to indicate the importance, on a scale of one to five, of 26 attributes
when choosing a pharmacy. The survey also assessed the degree to which respondents
perceived those attributes to differ between pharmacies.12 Survey participants expressed
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strong preferences for pharmacies with competent, knowledgeable, and friendly
pharmacists and staff. Furthermore, these attributes were perceived as the most
differentiating factors between competing pharmacies.12 Location, prescription prices, and
hours of operation were important to most patients but were not seen as differentiating.12
In another study, participants commonly cited relationships with staff (43.6%),
convenience (28.2%), and local pharmacy ownership (15.4%) as important factors when
choosing a pharmacy.13 Themes surrounding relationships with staff and owners were also
prevalent in a series of focus groups conducted by Shiyanbola and Mort.14
A limited number of qualitative studies have explored the potential impact of quality
metrics on the pharmacy selection process. While many participants in one series of focus
groups indicated a willingness to use publicly available quality measures when choosing a
pharmacy, rural patients often expressed a reluctance to use outside metrics given their
relationships with their pharmacy’s owner(s).14 Others stated that the measures would be
useful for pharmacy selection only in specific scenarios, including in the aftermath of a
negative experience or error or if they were moving to a new area.15 The relative
importance of pharmacy structures, processes, and quality-related outcomes of care has
not yet been fully examined, particularly among modern patients with increasing access to
quality and satisfaction information. This research study adds to body of knowledge on the
potential impact of publicly available pharmacy quality metrics by quantitatively assessing
the relative strengths of patient preferences when selecting a community pharmacy.
A discrete choice experiment among a sample of 500 adults (≥18 years) was
conducted for this study. An initial list of sixteen potential attributes for the DCE
experiment was formed based on expert opinion and published literature on how patients
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select healthcare providers. The attribute selection process was guided by the Donabedian
Model for healthcare quality and the SERVQUAL framework for service quality. Pilot testing
feedback was used to reduce the number of attributes to six: hours of operation, staff
friendliness/courtesy, pharmacist communication, pharmacist willingness to establish a
personal relationship, overall quality, and a specific quality metric related to drug-drug
interactions. Participants responded to a block of ten random choice tasks and two fixed
tasks, including a dominant and a hold-out scenario. A conditional logit analysis was used
to quantified the importance of quality information to patients when choosing a
community pharmacy relative to the importance placed on pharmacy characteristics
reflecting structures and processes of care. Additionally, a latent class analysis was used to
identify and describe segments in the community pharmacy market based on patient
preferences.
The study rationale, specific aims, and study significance are provided in the latter
half of Chapter 1. Background information and a systematic review of the literature are
provided in Chapter 2. The methods and results for this study are presented in Chapters 3
and 4, respectively. In chapter 5, a discussion of the study results, study limitations,
suggestions for future research, and study conclusions are presented.
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1.2 Study Rationale and Specific Aims
1.2.1 Study Rationale
Patients select healthcare providers and facilities based on a complex array of
factors. Insights into patient understanding and use of quality information are increasingly
pertinent to community pharmacy given the recent development of pharmacy quality
metrics16 and growing emphasis on pharmacy differentiation.2 Focus group participants
have demonstrated varying degrees of comprehension of and willingness to use pharmacy
quality measures.14,15 At the same time, pharmacy attributes like staff friendliness and
convenience are well understood and consistently ascribed importance by pharmacy
patrons.12–15 A clearer understanding of patients’ priorities during pharmacy selection and
the relative perceived importance of quality metrics can inform pharmacy organizations of
the extent to which publicly available pharmacy quality ratings may drive patients to high
quality community pharmacies. The results may also help to ascertain future needs for
marketing efforts promoting the impact of pharmacists on the quality of medication
management. Additionally, the identification of market segments based on patient
preferences for pharmacy attributes may help pharmacies to provide more effective
patient-centered care by targeting and personalizing services.
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1.2.2 Specific Aims
This study aims to explore the relative importance of pharmacy attributes during
the community pharmacy selection process and to identify market segments based on
patient preferences for pharmacy characteristics. I propose the following specific aims:

Specific Aim 1
To measure the relative strength of patient preferences for community pharmacy
attributes, including quality metrics, during pharmacy selection

Specific Aim 2
A) To describe the associations between patient sociodemographic characteristics
and preferences for pharmacy attributes during pharmacy selection
B) To describe the associations between patient health status, literacy, and
confidence and preferences for pharmacy attributes during pharmacy selection

Specific Aim 3
A) To describe community pharmacy market segments based on patient preferences
for pharmacy attributes
B) To describe the sociodemographic and health characteristics of patients in each
of the identified community pharmacy market segments
C) To compare the sociodemographic and health characteristics of patients in each
of the identified community pharmacy market segments to those of patients in other
segments
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Chapter 2: Background and Literature Review
2.1 The History of Quality Metrics in American Healthcare
The movement to improve healthcare quality in the United States encompasses
diverse stakeholders and approaches. In the last twenty years, governmental agencies and
initiatives, including the Agency for Healthcare Research and Quality (AHRQ) and the
Institute of Medicine’s (IOM) Health Care Quality Initiative, were established to focus and
prioritize research efforts on the evaluation and improvement of healthcare quality. AHRQ
works within the U.S. Department of Health and Human Services to produce evidence that
improves the safety, quality, and accessibility of health care.17 The Agency developed AHRQ
Quality Indicators (QIs), standardized quality measures derived from hospital inpatient
administrative data. The QIs are used both by health systems for internal quality
improvement initiatives and by external agencies for quality-based purchasing and
coverage decisions. The IOM, established in 1996, has published a number of seminal
reports on the quality of healthcare in America, including Crossing the Quality Chasm: A
New Health System for the 21st Century, and To Err is Human: Building a Safer Health System.
To Err is Human has been credited with increasing awareness of medical errors and
establishing the goal of reducing errors by 50 percent over five years. The organization also
published reports making recommendations for the measurement and reporting of
performance data, stating, “public reporting is integral to improving performance.”18
Non-profit organizations have also played a critical role in the rise of healthcare
quality metrics in the United States. The Joint Commission on Accreditation of Healthcare
Organizations (JCAHO), the National Committee for Quality Assurance (NCQA), and the
National Quality Forum (NQF) emerged over the last 40 years to measure the performance

6

of healthcare facilities, practitioners, and health plans. In addition to offering accreditations
and certifications, these multidisciplinary organizations have dedicated considerable
resources to the development of standardized performance metrics for the risk-adjusted
evaluation of healthcare organizations.19
The Centers for Medicare and Medicaid Services (CMS) is increasingly utilizing
healthcare quality metrics in reimbursement decisions and incentive programs. For
example, the AHRQ QIs are used by CMS in its Hospital Value-Based Purchasing Initiative,
the Accountable Care Organizations (ACO) program, and the Meaningful Use Incentive
program. Quality metrics are also commonly made publicly available to inform consumer
decision-making. The Healthcare Effectiveness Data and Information Set (HEDIS),
maintained by NCQA, contains over 80 measures of health plan quality relating to
effectiveness of care, access/availability of care, experience of care, utilization, and relative
resource use.20 The Consumer Assessment of Healthcare Providers and Systems (CAHPS)
family of surveys, also maintained by NCQA, publicly report on patient experiences with a
variety of healthcare facilities. The NCQA combines HEDIS, CAHPS, and accreditation
standards scores into a single rating, on a scale of 1-5, for public and private health
insurance plans. Furthermore, the 2009 Affordable Care and Patient Protection Act
enhanced federal funding for a number of quality-related initiatives, including the Center
for Medicare and Medicaid Innovation, the Medicaid Incentives for Prevention for Chronic
Diseases program, and the Testing Experience and Functional Assessment Tools (TEFT)
grant program.21
The Hospital Quality Alliance, a public-private collaboration established in 2002 to
promote and inform hospital quality of care,22 publicly released hospital performance data
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on ten process of care measures though the Hospital Compare website in 2005.19 Since that
time, similarly formatted sites hosted by Medicare.gov have been generated to provide
consumers with quality metrics for nursing homes, physicians, home health agencies, and
dialysis facilities; an analogous site publicly reporting pharmacy quality has not yet been
developed.

2.2 The Development and Emergence of Pharmacy Quality Metrics
2.2.1 Pharmacy Quality Alliance Quality Metrics
A formal, concerted effort to develop pharmacy-related quality metrics began in
2006 with the establishment of the non-profit, multi-stakeholder Pharmacy Quality
Alliance (PQA). Through a consensus-based process, PQA defines and endorses
performance measures that focus on the appropriate use of medications and pharmacy
services.2 The process by which PQA performance measures are endorsed is lengthy and
includes concept identification, evaluation and refinement. In the first step, PQA staff,
members, and a Measure Advisement Group review national priorities and create lists of
potential measure concepts to meet clinical needs and fill measure gaps.23 Based on a list of
measure concepts prioritized by the Measure Advisement Group, Measure Development
Teams (MDTs), which consist of experts in specific medication use systems or therapeutic
areas, each focus on the development of a single draft measure.
PQA member organizations are invited to comment on draft measures, and the
feedback received is used to edit and refine the measures. Experts in quality and
performance measures then test each draft measure for feasibility, usability, and validity.
Based on the results of these tests, a Strategic Advisory Panel decides whether to
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recommend the measure for endorsement. If a measure is recommended, member
comments are elicited via the PQA website, mail, and a conference call for member
organizations. Following these comments, member organizations vote on whether to
endorse a measure.24
PQA measures are defined by precise measure specifications and must be used
according to specific criteria in order to allow for the evaluation of rates across
comparators. As of February 20, 2017, PQA maintains 18 endorsed quality metrics, each of
which are reviewed annually. Adherence features prominently in the quality metrics, which
include the proportion of days covered (PDC) for each of ten chronic medications and nonwarfarin oral anticoagulants. A measure of primary medication non-adherence has also
been endorsed. Other quality metrics reflect the therapeutic appropriateness of medication
therapy. These metrics include diabetes medication dosing; statin use in persons with
diabetes and coronary artery disease; medication therapy for persons with asthma; use of
high risk medications in the elderly; and opioid and antipsychotic use in high risk
populations. The prevalence of drug-drug interactions and the proportion of
comprehensive medication reviews (CMRs) completed are also captured by PQA-endorsed
pharmacy quality metrics. In December 2016, PQA endorsed two new measures reflecting
the concurrent use of opioids and benzodiazepines and adherence to non-infused disease
modifying agents to treat multiple sclerosis.25
PQA quality measures are used in a number of official capacities. Beginning in 2017,
Qualified Health Plans (QHPs) in the Health Insurance Marketplace are required to report
three PQA metrics to the Quality Rating System (QRS). These measures include the PDCs
from the 2016 coverage year for renin angiotensin system antagonists (RASA), oral
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diabetes medications, and statins.26 PQA quality metrics also play a role in Medicare Part D
Plan Star Ratings. Specifically, five PQA measures are included in in the “Drug Pricing &
Patient Safety” domain of the star ratings. These measures are the PDCs for renin
angiotensin system antagonists (RASA), oral diabetes medications, and statins as well as
the use of high-risk medications in the elderly and the CMR completion rate. The PQA
adherence and high risk medication measures are heavily weighted in the calculation of the
overall plan ratings and are weighted twice as highly as, for example, the criteria “getting
needed prescription drugs”, “appeals upheld”, and “members choosing to leave the plan.”
Furthermore, CMS publicly reports “display measures” for Part D plans on a patient safety
website. The PQA measures for drug-drug interactions, oral diabetes medication dosing,
and statin use in persons with diabetes are included as display measures. In conclusion, the
Pharmacy Quality Alliance has pioneered the development and validation of pharmacy
quality metrics that are now used in a number of governmental capacities related to health
plan ratings.

2.2.2 Patient Perceptions of Pharmacy Quality
Although pharmacy quality experts have endorsed pharmacy quality metrics
through a consensus-driven process, little consensus exists among patients regarding the
components and definition of pharmacy quality. In a series of focus groups guided by the
Donabedian Framework, British patients and pharmacists discussed attributes of a “good”
community pharmacy.27 Patients felt that high quality pharmacies have structures in place
to manage their workload and provide reliable and individualized care. They also
maintained that high quality pharmacies educate their patients about their medications
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and how to take them.27 Shiyanbola et al. also used the Donabedian Framework to inform
their study on older adults’ perceptions of what constitutes a high-quality pharmacy. 28 The
focus group participants in that study most commonly perceived a quality pharmacy to be
one focused on the processes of care. That is, when asked to describe the “kinds of things
that make a pharmacy good,” focus group participants often responded with attributes
focused on the relational aspects of community pharmacy, including the friendliness and
helpfulness of staff and pharmacist availability to communicate directly with patients.28
Therefore, though the body of literature on patient perceptions of pharmacy quality is
limited, patients have consistently opined that pharmacy quality primarily reflects
processes, rather than outcomes, of care.

2.3 The Impact of Publicly Reported Quality Metrics in the United States
The impact of published quality metrics in the United States has been widely
discussed by both proponents and opponents of public performance data. Advocates for
publicly available quality measures assert that the data allow patients to make more
informed decisions about their care and spurs providers to focus on quality improvement
efforts.29 Concerns have been raised, however, that concentrating energy and resources on
improving the public measures may come at the cost of innovation and improvements in
other clinically important outcomes.29 In a 2015 survey of primary care physicians, half of
those surveyed felt that the increased use of physician quality metrics is negatively
impacting healthcare quality.30 A number of studies have specifically examined the impact
of quality metrics on healthcare quality and market share, a proxy for patient choice, to
more empirically assess the effect of public performance data.
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2.3.1. The Impact of Quality Metrics on Healthcare Quality
Conflicting evidence exists on the impact of publicly available healthcare quality
metrics on the quality of healthcare systems, providers, and health plans. A 2012 evidencebased practice report from AHRQ concluded that studies on this topic report inconsistent
results, particularly regarding metrics’ impact on outcome measures.31 A Cochrane Review
and a systematic review in the Annals of Internal Medicine echoed this finding, stating that
there is an inconsistent association between publicly available metrics and the quality of
healthcare precluding firm conclusions about the relationship.32,33
The 2012 AHRQ report cited the potential for unintended negative effects in the
wake of public quality reporting, but studies on these consequences report mixed
findings.31 The reported reductions in mortality rates for coronary artery bypass graft
surgery (CABG) following New York State’s public release of CABG report cards have raised
questions about physician “cherry-picking” by turning away and referring the sickest
patients.34–36 Healthcare providers and facilities may also focus their quality efforts on the
specific outcomes published publicly to the detriment of others and on short-term metrics
rather than long-term improvements.37 These changes in provider behavior on account of
public reporting have complicated the pursuit of high quality evidence on the effect of
publicly available quality metrics on overall healthcare quality.
Though the impact of publicly reported metrics on the quality of healthcare is not
clear, the impact on the structures and processes of healthcare is more evident.31 The
results of a study in Wisconsin suggest that publicized quality ratings may increase the
number of quality improvement efforts undertaken by hospitals, particularly those with
low reported quality.38 Nursing homes were also shown to improve unreported measures
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of care processes through quality improvement efforts following the implementation of
public reporting.39 Both the Cochrane32 and Fung 33 reviews report positive associations
between public reporting and hospital-initiated quality improvement activities. Overall,
then, while the impact of quality metrics on healthcare outcomes is debated, publicly
reported quality data has consistently been associated with improvements in the
structures and processes of healthcare provision.

2.3.2 The Impact of Publicly Reported Quality Metrics on Provider Market Share
An assumption underlying many studies on the impact of metrics on healthcare
quality asserts that public reporting will incentivize providers and facilities to improve
quality in order to retain or attract patients. A number of studies have used administrative
claims to test that assumption by assessing patient response – in the form of market share
and patient volume – to publicly reported quality metrics.
The evidence on the impact of hospital report cards on market share is conflicting.
Hospital performance on one specific hospital-based procedure, coronary artery bypass
graft (CABG), received significant attention in the 1990s as states began publicly reporting
hospitals’ mortality rates for the procedure. Following the publication of New York state
surgery mortality reports, one study reported that hospitals with higher mortality rates
had small but significant decreases in the growth rate of market share (1.8 percentage
points).40 However, another study reported that significant market share gains for high
quality hospitals were short-lived, disappearing three months after report card
publication.41 A study of Pennsylvania’s CABG mortality report cards reported nonsignificant changes in the number of CABG surgeries per quarter at high- and low-mortality
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hospitals 42 Significant changes were, however, seen in the surgeon-level analyses; highmortality surgeons and those without report cards performed 4.76 and 8.04 fewer
surgeries per quarter after the release of the report cards.42
Apart from CABG-specific report cards, overall hospital ratings and performance
data for other hospital services have generally shown very limit impact on market share. A
study of 30 hospitals in Cleveland, Ohio reported that hospital outlier status was not
significantly associated with market share.43 Similarly, the publication of graft survival
rates for kidney transplants had a limited impact on patient registration, with only
registrations for young patients (aged 18-40 years) decreasing at low performing
hospitals.44 A 2005 commentary published in the Journal of the American Medical
Association summarized the body of literature on the impact of public report cards. The
authors concluded that there is “limited evidence” that public report cards influence
market share by allowing consumers to make more informed choices between providers.35
The responsiveness of hospital markets to public quality information may be limited
by the often-urgent nature of the hospital selection process as well as differences in
insurance network status and location. Several studies have examined the effects of public
report cards in markets where decision-making may be less impacted by urgency, cost,
and/or location. One such study investigated the impact of Medicare’s Home Health
Compare report cards on the market share of home health agencies among Medicare
patients.45 Given that the home health care market uniquely demands no travel costs or
copayments, the authors hypothesized that report cards may have a greater impact on the
home health care market than the markets for other healthcare providers and services.
Consistent with this hypothesis, the study results suggested that a one standard deviation
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increase in quality scores for functional outcomes could be expected to increase an
agency’s annual market share for hospital-discharged and community dwelling patients by
0.6 and 0.9 percentage points, respectively.45 Similar results were reported in an analysis of
the skilled nursing facility (SNF) market, though the impact of specific metrics for SNFs
differed. 46 Specifically, an increase from the 25th to the 75th percentile on the performance
metric reflecting patient pain control was associated with a 0.1-0.7-percentage point
increase in market share, depending on market size. However, a performance metric
reflecting rates of patient delirium was not found to be associated with market share.39
Although they provide very different services than home health agencies and skilled
nursing facilities, fertility clinics are similarly situated in that patients generally select
clinics in the absence of significant time pressures and insurance network considerations.
In a study on the impact of the introduction of online fertility clinic report cards in 1998,
market share increased for fertility clinics with higher birth rates and decreased for clinics
that treated primarily younger patient populations or did not report quality information.47
Model simulations predicted that increasing the reported birth rate by 0.13 percentage
points, equivalent to increasing from the 25th percentile of clinics to the 75th, would result
in an increase in market share of 2.9 percentage points. 47
The results of several market share studies suggest that patient demographics may
play a role in the impact of public report cards. The authors in the fertility clinic study
suggested that the demographics of patients undergoing fertility treatments, who are
disproportionately wealthy, young, and highly educated, likely contributed to their finding
that public quality information impacted market share.47 Similarly, patients with higher
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education levels demonstrated a slightly larger response to report cards in an analysis of
nursing home market share using Medicare claims data.39
In conclusion, the impact of public report cards on provider market share is debated
but is likely minimal. Statistically significant changes in market share following public
release of quality data for skilled nursing facilities and home health care were limited in
magnitude. The largest documented market share changes were seen in the fertility clinic
market, which may reflect the disproportionately well educated, wealthy demographics of
patients undergoing fertility treatments and the lack of insurance networks for the
services.

2.4 Patient Perceptions of Healthcare Quality Metrics
The publication of two systematic reviews concluding that quality metrics have no
or minimal impact on hospital market share48,49 has raised questions as to the factors
underlying the negative findings. Several theories about these factors have been posited.
Specifically, researchers have suggested that capacity constraints may limit referrals to
high quality providers, that patients may be unable to change providers due to insurance
networks, and that the stability of quality ratings of over time contributes to a lack of
attention-grabbing “news” surrounding report cards.34,49 Furthermore, in order for publicly
reported quality metrics to impact patient selection of health care providers, patients must
use and act upon these metrics. For patients to act upon quality data, 1) report cards must
exist; 2) patients must know about them and have access to them; 3) patients must
understand and believe the rankings; and 4) patients must act on the rankings.35 A number
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of studies have investigated each of these underlying processes involved in the use of
report cards during patient selection of healthcare facilities and providers.

2.4.1 Patient Awareness of Healthcare Quality Metrics
The current body of literature suggests that patient awareness of healthcare report
cards is limited. A study of nearly 12,000 adults with chronic illness in 2008 and 2012
reported that awareness of hospital and physician quality measures was generally low and
showed substantial regional variation.50 In 2008, approximately a quarter (25.5%) of
patients were aware of publicly available hospital quality metrics, while half as many
(12.8%) were aware of physician quality information. Awareness of physician quality
metrics varied geographically, ranging from 6.9% (Maine) to 19.3% (Detroit). Similarly,
patients in the Midwest more commonly reported awareness of hospital quality metrics
than those on the West Coast. From 2008 to 2012, awareness of physician, but not hospital,
comparative quality information increased, though the magnitude of that change, 3.7
percentage points, was small.50,51
Conflicting results have been reported on the impact of demographic characteristics
on patient awareness of quality measures. In a nationally representative survey of patients
with chronic illnesses, demographic factors had limited impact on patient awareness of
quality metrics, which was generally low among individuals of all races, educational
backgrounds, and income levels.51 Patients also report low awareness of quality metrics for
other types of healthcare providers. Many focus group participants who had recently help
loved ones select home health care agencies were not aware that ratings for these agencies
existed.52 Notably, whether patients want to be aware of comparative quality information is
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debated. When interviewed, many patients expressed perceptions that “ignorance [is]
bliss” when it comes to hospital practices. 53
Public awareness of commercial or employer-provided reports appears to be
substantially higher than knowledge of government reports, including Hospital Compare.
Huesch et al., who investigated Google search behavior, reported that searches for Health
Grades, a physician rating and comparison database, occurred as many as 80 times more
often than searches for Hospital Compare from 2012-2013.54 In a survey of nearly 1,000 (n
= 927) individuals with employer-sponsored HMO health insurance, 63% reported having
seen employer report cards.55 A similar proportion (65%) of a nationally representative
sample (n = 2,137) was aware of online physician ratings.56 Ease of accessibility to quality
information may not have a significant impact on patient awareness. When an employer
group mailed quality ratings on local hospitals directly to employees’ homes, only 61%
reported being exposed to the ratings either by seeing the report or hearing about it from
someone else.57 Awareness declined substantially over time; two years later, only 6%
remembered seeing the report.57 While the awareness of these report cards exceeds that of
non-profit and governmental report cards, it is still far lower than awareness of ratings for
cars (87%), movies/books (82%), and restaurants (81%).56 In conclusion, low levels of
patient awareness for objective quality information may present a considerable barrier to
the widespread use of this data by patients in healthcare decision-making.

2.4.2 Patient Understanding of Healthcare Quality Metrics
The ability of patients to properly interpret and understand publicly available
quality metrics has gained considerable attention among quality researchers. A number of
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studies have investigated the degree to which patients are able to understand quality
metrics and the influence of the quality data presentation on patients’ levels of
understanding.
Comprehension tests have been used to assess the degree to which participants are
able to correctly interpret healthcare quality data. In these tests, participants are presented
data and asked questions regarding the information contained in that data. For example, a
participant may be presented with information about a quality metric presented in a bar
chart with a benchmark bar representing the state average for that metric. A participant
may then be asked, “Do bigger bars on the chart show better or worse quality?” and “Does
Facility A have a better score on this measure than typical facilities in this state?”58 Two
studies on nursing home quality data reported that, for each comprehension question
asked, approximately 70-90% of participants answered correctly.59,60 However, the
percentage of correct responses was much lower (47%) when information was presented
only in a bar graph.60 In another study, participants answered, on average, about 5.4 of 8
comprehension questions correctly, a finding interpreted by the authors as suggesting high
levels of understanding.58 In qualitative interviews, however, many patients were confused
about how to interpret various indicators related to hospital-acquired infections (HAI).53
Additionally, some expressed confusion about the distinction between the number of cases
and rates, whether longer length of stay reflected higher quality of care, and why a high
score on a process measure did not necessarily result in a high score on a corresponding
outcome measure.53
Many, but not all, studies on the presentation of quality metrics report a significant
association between presentation format and patient comprehension. Several studies have
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identified simplification of data presentation as a key change to improving understanding.
Simplification may include limiting the amount of information displayed. In a study by
Peters et al., patients were best able to identify the hospital with the highest quality when
hospital profiles were focused only on quality and non-quality hospital information was
omitted from hospital profiles.61 Similarly, the likelihood that seniors selected the lowest
cost Medicare Part D plan in a choice experiment increased when less non-cost related
information about the plans was presented.62 Limiting the number of providers, facilities,
or health plans, presented simultaneously to patients may also improve their
comprehension of quality metrics.59,62,63 Furthermore, ratings presented in a star format
with a scale of one star to three stars may be clearer to patients than those presented on a
scale of one star to five stars.59 However, not all forms of simplification have been shown to
improve comprehension. Presenting patients with a lesser number of quality metrics was
not associated with comprehension in a study testing patient understanding of nursing
home quality metrics.59 The number of quality metrics displayed was also a weak predictor
of patient comprehension of hospital quality information.64
Beyond simplification, the use of evaluative symbols in addition to or in place of
numerical or graphical data has been shown to promote patient understanding of quality
information. In focus groups and cognitive testing, many participants have qualitatively
expressed preferences for star systems rather than percentages, letter grades, or numerical
scales.14,60 Others, however, see symbols as more difficult to interpret or a way to “hide
something” that would have been revealed if rates or percentages were displayed.53,65
When comparing different forms of data presentation, colored dots59 and stars60,66
outperform other symbols and numbers in promoting patient understanding of quality
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metrics, and bar graphs are consistently,59,60 but not exclusively,67 associated with the
lowest levels of comprehension. Bar charts were commonly misinterpreted in patient
interviews; one patient remarked “the bar chart says nothing.”65
The impact on comprehension of evaluative word labels (e.g. excellent, good, fair,
poor) added to graphical or numerical information is debated in the literature. While the
addition of word labels to bar graphs59 or evaluative tables60 has been shown to improve
comprehension, this finding is not consistent.68 Word labels may have a greater impact on
patient understanding of quality measures when the labels are used to clarify whether a
high or low number is better for a specific indicator (e.g. mortality rate, infection rate).53
Additionally, when the addition of general word labels that broadly define what quality
metric stars represent, (e.g. “doctor quality,” rather than “quality rating” or “star rating”)
may improve patients’ understanding of what quality stars actually measure.69 Similarly, in
qualitative interviews on comparative information for health plans, patients expressed a
desire for clear representations of the meaning of quality stars.65 In the absence of this
information, patients may misunderstand what the stars actually represent; one patient in
a qualitative study interpreted “quality indicators” as representing the extent to which a
health care plan pays attention to patients.65
Patient comprehension of benchmarking and risk-adjusted quality measure varies
considerably based on the presentation of the information. Qualitative interviews have
suggested that many patients struggle to understand the definition of risk adjustment.53 In
one study that presented hypothetical physician quality information for coronary artery
bypass grafts, fewer than a quarter of patients selected the physician with the lowest riskadjusted patient mortality rate when the that metric was presented alongside observed
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patient mortality rates and number of operations completed.70 However, when only riskadjusted data was presented to participants, either in a bar graph (53%) or with
benchmarked symbols (66%), the majority of patients selected physicians with the highest
quality (i.e., lowest risk-adjusted mortality rate).70 These results are consistent with
reports that the presentation of quality metrics in both absolute and relative
(benchmarked) forms simultaneously may create confusion among patients.65 Despite the
finding that benchmarking may improve patient comprehension of risk-adjusted quality
measures, benchmarked quality data may still be confusing and/or undesirable to patients.
Symbols based on benchmarks have confused patients in cognitive testing.65 Furthermore,
patients in focus groups found little value in comparing a pharmacy’s quality to a state
average, stating, “I don’t really care what the state average is,” and “what if I don’t know
what the state average is necessarily? What if the whole state is doing poorly?”14
In several focus groups, patients suggested that presenting an overall performance
scale in addition to more specific quality metrics would aid in the identification of highquality pharmacies and hospitals. 14,53,71 These qualitative findings are consistent with
experimental data demonstrating that survey participants were more consistently able to
identify high quality nursing homes when an overall performance measure was included in
addition to specific quality metrics.59 Another study examined patient choices when
presented with three pieces of quality information for each of five hospitals, including an
overall safe practices score and specific hospital acquired infection and mortality rates.67
When one hospital had the best overall score but another hospital had the best infection
and mortality rates, more patients (46%) indicated that they would choose the hospital
with the best overall score than one with the best component scores (34%), suggesting a
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reliance on general quality scores for decision-making.67 Many patients, however, do not
want to be presented with only a single, overall performance metric. Participants in several
focus groups expressed a desire to see more detailed quality information beyond just an
aggregated, overall measure,14,71 suggesting that overall and specific scores may appeal to
different subgroups of the population seeking comparative quality information.
Demographic characteristics have consistently been associated with patient
comprehension of healthcare quality data. Three studies on nursing home quality
information reported that more educated participants more often correctly interpreted
quality information when compared to less educated respondents.58,63 Participants with at
least a college education were also more often able to identify the “best” hospital67 or
surgeon70 when presented with quality information than their lower educated
counterparts. However, higher health literacy and numeracy, rather than education level,
may more strongly predict comprehension of quality information.64,72 Age is also
significantly associated with patient understanding of quality data, with younger patients
consistently demonstrating higher levels of understanding than older patients.58,63,64
Overall, patient understanding of quality metrics is relatively limited, though some
presentations of quality data may promote higher degrees of comprehension. Simplifying
the amount and type of information displayed, presenting information with symbols like
stars or colored dots, and adding evaluative word labels (e.g. excellent, good, fair, poor) to
charts and graphs may improve patient understanding of quality information. Finally,
patient preferences for benchmarked data and overall performance scores vary
considerably, and though risk-adjusted quality scores present a more accurate picture of
provider quality, risk-adjustment may be difficult for patients to understand or interpret.
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2.4.3 Patient Perceptions of Trustworthiness of Healthcare Quality Metrics
Patients who access and understand quality metrics can only be expected to
consider the quality information during provider selection if they believe both the source
and the measurement of the metrics to be credible. Only a fraction of the quality
information to which patients are exposed is disseminated by non-profit organizations
that, like PQA and NCQA, are dedicated to measure development and validation. The quality
metrics designed by these organizations – and others - may be published by governmental
organizations. Employers and insurers regularly circulate quality information, and
personal conversations with family and friends often yield informal provider assessments
and recommendations. Furthermore, healthcare-specific (e.g. healthgrades.com,
ratemds.com) and general ratings websites (e.g. yelp.com, google.com) provide patients
with easy access to opinions on and experiences with healthcare providers and facilities.
The relative credibility of and trust in these sources of information among patients will
impact the degree to which validated quality metrics are used in patient decision-making.
When surveyed, patients often express high degrees trust in the opinions of their
family, friends, and existing physicians. One survey of a nationally representative sample of
individuals with chronic diseases asked participants the extent to which they would trust
the information about health care quality they received from each of seven sources of
information on a scale of “a lot”, “a little” and “not at all.” The results indicated that patients
very often placed “a lot” of trust in information received from their doctor (83.4%), their
hospital (56.0%) and their friends and family (47.4%). In comparison, fewer than one
quarter placed “a lot” of trust in information received from their employer (23.2%) or a
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government agency (24.5%).73 In qualitative cognitive interviews exploring patient
perspectives on comparative information on health plans, some patients especially valued
the opinion of family doctors on the plans,65 while others felt that “family doctors do not
know how their fellow clinicians do their work.”65 Similarly, participants in a focus group
on comparative provider information for hospitals all agreed that the opinions of family
and friends are highly trustworthy, with one participant remarking, “It's simple, you rely on
the experiences of the people you know.”71 The group debated the merits of physicians’
recommendations, however, with some asserting that “you will tend to listen to your
[primary care physician]” and others maintaining, “you can’t expect that the PCP knows
everything about this.” 71
In contrast to the high degree of trust placed in the opinions of family and friends,
patients often express concerns over the trustworthiness of quality information provided
by insurers, employers, and government agencies. Nearly a quarter of older adults
surveyed felt that Medicare performance data would serve primarily to help save the
government money rather than to help patients receive better care.74 When asked to rate
the trustworthiness of CAHPS and HEDIS data, only 13.5% and 15.1% of patients perceived
the data to be “very” trustworthy. However, most patients (69.6%, 70.2% respectively) felt
that these sources were “somewhat” trustworthy, suggesting that patients may not
consider agency quality information to be categorically untrustworthy.75 Notably, in the
same survey, subjective patient comments included alongside objective CAHPS and/or
HEDIS data were perceived as no more trustworthy as the objective measures75 despite
evidence that many patients find narrative comments desirable.76 Focus group participants
have also expressed skepticism towards metrics on the use of evidence-based medicine.77
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When presented with a hypothetical quality metric, “uses treatments proven to get results,”
many participants wanted to know who had decided that a treatment was proven effective
and were concerned about bias from industry-sponsored trials.77
Published opinions of former patients were also viewed with skepticism among
patients in cognitive testing of health plan quality information, with one patient remarking,
“the ‘opinion of ex-patients;’ Well maybe only two patients were questioned? So I’d like to
know more about this.”65 A participant in the same study noted regarding the quality
information on health plans, “I’d never make a decision based on this kind of information.
Perhaps rather on personal experiences of others, I would ask others,”65 reflecting again
the perception that the opinions of family and friends are more trustworthy than agencydeveloped quality metrics. Participants in another focus group questioned the credibility of
comparative information and expressed a desire to see the sources of the information as
well as a disclaimer about the reliability of specific measures and a declaration of conflicts
of interest.71
Demographic characteristics have been shown to impact the degree of trust that
patients have towards healthcare quality information received from varying sources. Males
have demonstrated higher levels of trust in provider sources of information and are less
likely to trust personal sources than females.73 Evidence on the impact of age and education
on attitudes towards information sources is conflicting. One study reported that age had no
impact on the level of trust that patients had on different sources of quality information.73
Higher levels of education have been associated with increased trust in provider and
institutional sources of information and decreased trust in information provided by family
and friends.73
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In conclusion, patients exhibit some skepticism towards quality metrics provided by
insurers, employers, or government, expressing concerns about bias and ulterior motives.
They feel significantly more comfortable with quality as assessed by trusted physicians,
family, or friends. The degree to which demographic characteristics like age and education
level influence patients’ perceptions of objective quality information as credible is debated
and should be explored in future research.

2.5 Patient Selection of Healthcare Providers
Healthcare is increasingly focused on shared decision-making between patients and
practitioners.78,79 However, prior to shared decision-making taking place, patients must
first select a healthcare provider. The degree to which patients feel that they have sufficient
choice of physicians80 is associated with patient trust in their doctors which, in turn, may
increase self-efficacy, self-rated health, health related quality of life, and adherence to
physician recommendations.81,82 Therefore, a clear understanding of the factors involved in
patient selection of healthcare providers may ultimately promote increased patient
engagement and outcomes.

2.5.1 Patient Selection of Healthcare Providers: Functional Quality
Patients looking to select a high-quality healthcare provider often look for a
provider with a high degree of functional quality. In contrast to technical quality, which
reflects staff competence, compliance to professional standards of care, and technical
accuracy in diagnosis and treatment, functional quality refers to the manner in which care
is delivered.83 In surveys and focus groups, patients often discuss quality by describing
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provider courtesy, communication, understanding, caring, and physical environment, all of
which describe attributes of functional quality.83 When moderators of focus groups among
Medicaid beneficiaries posed the question, ‘what are the most important things for getting
good quality care,” participants focused the discussion primarily on interpersonal themes,
including attentiveness, communication, and respect.84 One participant remarked, “When
I’m talkin’ to my doctor, is he listening, does he know my fears, does he understand what
my needs are when I leave him, what my concerns are?”84
Among surveys specifically focused on patient selection of healthcare providers,
physician bedside manner and communication consistently rate highly among patients as
determinant factors. When patients in one survey were asked to denote the importance of
40 different factors when selecting a primary care physician, nearly all patients considered
‘physician spends adequate time answering questions’ (94%) and ‘physician discusses
illness in a way I can understand’ (91%) to be important or very important.85 In another
survey, female patients were asked to rate the importance of a variety of physician
characteristics on a scale of 1-6 when considering selecting three types of physicians: an
obstetrician-gynecologist (OBGYN), a family physician, and a surgeon.86 For OBGYN and
family physicians, factors related to interpersonal communication, including ‘listens to me,’
‘explains things clearly,’ ‘respectful,’ ‘easy to talk to,’ and ‘caring,’ were rated more highly
(mean ratings: 5.7-5.9) than those related to clinical competence (mean ratings: 4.8-5.5). In
contrast, clinical competence was rated as more important to patients when selecting a
surgeon; patients responded that ‘expert in my particular problem’ (mean rating: 5.8) was
equally as important as interpersonal communication factors (mean ratings: 5.7-5.9) when
evaluating surgeons.86 Bedside manner was also important to patients selecting a spine
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surgeon (mean rating, on a scale of 1-10: 8.01), though this indicator of functional quality
was not as important to that patient population as board-certification (9.26).87 Among
patients undergoing elective joint arthroplasty, physician manner and physician quality
were rated as similarly important to patients (mean ratings 4.68 and 4.64, respectively, on
a scale of 1-5).88
Functional quality encompasses not only characteristics related to interpersonal
communication but also physical appearances of providers and facilities. In a survey on the
selection of a primary care physician, the physical appearance of the doctor and the
doctor’s office were rated by patients as more important (mean rating 8.00-8.15 on a scale
of 1-10) than wait time as at the office (7.39), cost of care to the patient (6.46), and
proximity of the office (5.94), factors often assumed to be the most important to American
patients.89 Similarly, the appearance of clinic facilities was more important to patients
selecting spine surgeons (mean rating 7.47 on a scale of 1-10) than recommendations by
family members, friends (6.51), or other physicians (6.37) and online reviews (6.11-6.26).
87

In addition to prioritizing communication and facilities, patients consistently view
convenience as an important, but not necessarily critical, factor when selecting a healthcare
provider. Factors related to convenience, including waiting time, proximity, and the
availability of weekend and evening hours, were viewed as only moderately important
among patients selecting primary care physicians.89 Convenient location and out-of-pocket
costs were also reported as moderately important to patients when selecting a surgeon for
total joint arthroplasty (mean rating 3.5, on a scale of 1-5); these factors were significantly
less important to that patient population than physician manner (4.68) and quality
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(4.64).88 In another survey, only about half of patients (55%) reported that convenient
office location was important or very important when selecting a primary care physician;
far more felt that factors relating to communication and reputation were important (8994%). 85
Overall, patients consistently report placing considerable value on aspects of
functional quality when they select healthcare providers. Patients demonstrate strong
preferences for physicians with superior bedside manner and communication skills. The
importance of these attributes, which also include respectfulness, willingness to answer
questions, and a caring nature, exceeds that of convenience. Patients also prefer providers
and offices with professional appearances, again more strongly than they prefer
convenience, suggesting that outward appearance may serve for patients as a proxy
measure for quality.

2.5.2 Patient Selection of Healthcare Providers: Technical Quality
When surveyed on their priorities when selecting physicians, patients commonly
place substantial emphasis on physician board certification. When asked to rate the
importance of a variety of factors when choosing a spine surgeon, patients rated board
certification highest (mean rating: 9.26, on a scale of 1-10).87 This rating exceeded the
ratings patients assigned to being within their insurance network (8.1) and bedside
manner (8.01). In the same way, a different set of patients considered board certification to
be the most important factor when selecting a primary care physician (average rating:
9.31) and scored certification significantly higher than the second and third most
important factors, physical appearance of the doctor’s office (8.15) and doctor (8.0).89
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These results were again echoed in a survey of primarily female plastic surgery patients,
with board certification (average rating: 9.2) tying surgeon reputation (average rating: 9.2)
as the most important factor during physician selection.90 In another survey asking
patients to rank the importance of primary care physician characteristics, board
certification lagged behind satisfaction ratings but was consistently ranked as more
important than objective quality metrics.91 This suggests that board certification may be a
more readily understood measure of technical quality than specific metrics.
The relative importance of provider reputation, as assessed by friends, family or
other providers, when patients select providers is debated in the literature. Reputation was
viewed as less important than interpersonal communication and technical expertise among
women surveyed about preferences for OBGYNs, family physicians, and surgeons.86 In
contrast, recommendations from friends and family were rated as more important than
several potential measures of technical expertise in a different survey of patients on
selecting a primary care physician. 89 Yet another survey reported that similar proportions
of patients considered physician reputation (89%) and provider communication (91%) to
be important or very important when selecting a primary care physician.85 Therefore,
though the literature is not conclusive on the importance of reputation relative to other
factors when selecting providers, reputation is consistently shown to be important to
patients. Consistent with this assertion, the vast majority of older adults interviewed on
how they selected a surgeon reported that surgeon and hospital reputation were
“extremely” or “very” important to deciding on a surgeon (80% and 79%, respectively).74
The impact of the source of the provider reputation, namely, friends/family versus
other physicians, on its perceived importance also varies by study. The women surveyed in
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the Mavis et al. study rated reputation among other doctors (mean rating, scale 1-6: 5.25.5) as more important than reputation among friends or family (4.8-5.0).86 When asked
why they felt that a particular surgeon or hospital had a good reputation, twice as many
older adults responded that comments from their referring doctor (64%), rather than
comments from friends or family (31%), had influenced their perception of the provider’s
reputation.74 Patients selecting a spine surgeon rated recommendations by family and
friends members (mean rating, scale 1-10: 6.51) as similarly important to physician
recommendations (6.51).
Information on provider reputation in the form of recommendations by family,
friends, or a physician, may be more important to patients than objective quality
information. Sinaiko conducted a survey to examine patient decision-making in the context
of a hypothetical tiered insurance plan.92 In the presented insurance plan, higher quality
physicians were assigned to Tier 1 and lower quality physicians to Tier 2.92 In the absence
of any information beyond tier classification, the vast majority of participants selected high
quality, Tier 1 physicians (84%) and indicated that the doctor’s tier ranking was ‘very
important’ to their choice (59%). However, when told that a friend or family had seen a
Tier 2 doctor and had a good experience, far fewer participants selected a Tier 1 doctor
(44%), and nearly as many selected the “recommended” Tier 2 doctor (39%). When a
primary care physician had recommended a Tier 2 physician, two-thirds (67%) of patients
selected the recommended physician over the higher quality, Tier 1 physician (24%).92
Simulations of the effect of introducing higher copayments for Tier 2 physicians suggested
that the differential between Tier 1 and Tier 2 copayments would need to exceed $300 to
counteract the impact of the peer or provider recommendations for lower quality
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physicians.92 Peer and physician recommendations were also more important to patients
selecting a plastic surgeon than objective quality ratings, though only marginally.90
Specifically, patients asked to rate the importance of various factors when choosing a
plastic surgeon rated reputation (mean rating 9.2, on a scale of 1-10), friend referral (7.77)
and physician referral (7.76) as slightly more important than physician quality (7.56).90
Information regarding providers’ reputations may not only be shared by friends,
family, and other providers but also in the form of anonymous patient satisfaction ratings.
Patients selecting healthcare providers have generally expressed views that anonymous
satisfaction ratings are important to decision-making. Patient satisfaction ratings were
viewed as more important when selecting a primary care physician than quality metrics,
credentials, and health plan ratings.91 However, anonymous reviews have consistently been
rated as less important than recommendations from friends and family.87
In conclusion, board certification is the most commonly reported objective technical
quality measure used by patients to select providers. However, given that nearly 80% of
physicians are board certified,93 measure is unlikely to serve as a differentiating factor
between physicians. Beyond board certification, patients are much less likely to use
objective quality metrics in decision-making than other factors they perceive to be credible
sources of quality information, including provider reputation and recommendations from
physicians, family, and friends.

2.5.3 Patient Selection of Healthcare Providers: Effect of Demographic
Characteristics
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Demographic characteristics have consistently been associated with small but
significant differences in patient preferences during healthcare provider selection. When
selecting an OBGYN, older patients and those with less education placed a higher priority
on factors related to interpersonal communication.86 Furthermore, women at either end of
the age spectrum (≥40 years or ≤ 26 years), minority, and unmarried women placed a
higher value on having a female OBGYN than their white, median age, married
counterparts.86 However, women placed a much lower emphasis on provider gender when
selecting other types of physicians, including primary care physicians89 and surgeons.94
Patient education level may also impact the relative priority that patients place on
functional and technical characteristics during provider selection. In one study, those with
lower levels of education placed a greater emphasis on attributes related to functional
quality and less priority on technical competence. Specifically, women with a high school
education or less rated interpersonal communication attributes as more important when
selecting family physicians and surgeons than did women with at least some college.86
Similarly, interpersonal skills were ranked as more important to primary care physician
selection among those with a high school education than their more educated
counterparts.91 Another study found that increasing education level was positively
correlated with the importance that patients assigned to the prestige of a provider’s
medical school, residence, or fellowship.94 Patients who considered ‘convenient office
location’ to be an important factor when selecting a primary care physician were more
likely to be those with lower education levels, a finding attributed by the authors to
difficulty with transportation in that group.85 In conclusion, a variety of demographic
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characteristics have been associated with patient preferences for healthcare providers,
including age, race, gender, and education level.

2.6 Patient Perceptions of Pharmacists as Healthcare Providers
The role of pharmacists has expanded considerably over the last 20 years.
According to the Pharmacy Workforce Center’s 2014 National Pharmacist Workforce
Survey, the proportion of pharmacists who provided medication therapy management and
immunizations increased from 13% and 15% respectively, in 2004 to 60% and 53% in
2014.95 While the growing emphasis on the role of pharmacists as healthcare providers is
clearly evident to those within pharmacy practice, the diffusion of pharmacists’ new roles is
likely slower among patients. A longitudinal segmentation analysis by Schommer et al.
identified market segments based patient perceptions of the pharmacist’s role.96 The
largest segment, to which nearly half of patients belonged, was characterized by the
perception that medication information should be, and/or is, provided primarily by the
physician. Another segment contained the approximately one-fifth of patients who
maintained not only the aforementioned reliance on physicians but also believed talking
with a pharmacist takes too much time and that pharmacist roles should be legally or
ethically restricted.96 The proportion of patients in each of these segments remained steady
over the 15 year study period from 1995-2010 despite efforts to promote the role of
pharmacists as healthcare providers during that time.96 Additional literature on pharmacist
expectations of community pharmacists is summarized in Chapter 2.8.
These findings suggest that a significant subgroup of patients may be unlikely to
view pharmacists as healthcare providers or select a pharmacy in a manner consistent with
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preferences for healthcare providers. As a result, these patients’ preferences during
pharmacy selection may be more analogous to their preferences during retail or grocery
store selection than their priorities during physician selection. Notably, however,
marketing research suggests that many of the same variables that impact health care
decision-making play a role in retail or grocery store selection. For example, individuals
with higher incomes are more likely to frequent a specialty grocery or warehouse club,97,98
while those with lower incomes and education levels are more likely to shop at a
supercenter.97 Men have also demonstrated stronger preferences for fast grocery store
service but weaker preferences for friendly service than their female counterparts.99,100
Preferences for grocery stores may also vary by age; a study of older adults (55+) reported
that the importance of convenience and special discounts decreased and increased,
respectively, with age.101 Grocery store shoppers also cite factors regarding location
convenience, hours of operation, wait time, and service quality as important during store
selection.99,102,103 In conclusion, customer priorities for healthcare providers and retail
services maintain considerable overlap such that most of the attributes used in this study
of patient selection of community pharmacies are likely to be relevant to respondents
regardless of whether or not they perceive pharmacists to be healthcare providers.

2.7 Patient Selection of Pharmacy Channel
Before patients select a community pharmacy, they must first make the decision to
visit a brick-and-mortar pharmacy over a mail order or internet pharmacy. Mail order
pharmacies have grown in size and popularity, in large part due to insurance mandates or
incentives to use this channel. The market share of mail order pharmacies doubled from
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6% in the late 1980s to 12% in 2000 and again to 23.5% in 2010.104 Nearly every (96.7%)
employer sponsored insurance plan now offers a mail service pharmacy option.104 Because
the decision between pharmacy channels acts as a form of selection bias to filter the
population of patients deciding on community pharmacies, consideration of the
distribution of mail order pharmacy usage is warranted.
A study examining channel selection in insurance programs that incentivize or
mandate mail order pharmacy use reported that the strongest predictors of using a
community pharmacy were living within a 5-minute drive of a community pharmacy,
having filled previous prescriptions exclusively at community pharmacies, and having no
maintenance medications.105 Younger adults (<55 years) also more commonly selected
community pharmacies than older patients.105 Nevertheless, mail order pharmacy use
remains high among older adults, with 56.7% of surveyed adults over 65 years of age
indicating that they had used a mail-order pharmacy at least once.104 Approximately one in
eight (12.3%) reported using mail order based on insurance plan requirements,104 and one
in four for insurance reasons that included price incentivization.106 Mail-order users in a
rural, elderly population were primarily male, non-Hispanic white, retirees with employerprovided insurance. Additionally, each additional prescription drug taken by a patient
increased the likelihood of mail-order pharmacy use by 21%.106
Although online pharmacies vary considerably in their legitimacy, accredited online
pharmacies present a credible alternative to mail order and community pharmacies. The
number of online pharmacies – both accredited and not – has increased rapidly in the past
decade,107 yet awareness and patronage of this channel remains limited. A 2012 study
among emergency department patients reported that a slight majority (57%) of patients
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were aware that online pharmacies existed, but very few (5.4%) had ever used one.108
Despite concerns that patients use illegitimate pharmacies to circumvent the need to
obtain a prescription,109 the majority of online pharmacy users used pharmacies
administered by their insurance companies. Additionally, a much higher proportion of
patients who used online pharmacies used them for convenience (66%), cost (40%), or
because it was required by their insurance carrier (7%) than to avoid obtaining a
prescription (2%).108 Patients who select community pharmacy as their pharmacy
distribution channel may therefore systematically differ in their priorities and preferences
for pharmacy care than patients who opt to receive their medications from mail order
and/or internet pharmacies.

2.8 Patient Perceptions of Community Pharmacies: A Systematic Literature Review
Understanding consumer perceptions is a fundamental task of all businesses
including pharmacies. That understanding can be used to better serve customers and
influence perceptions of the business. The complex interplay between consumer
preferences, expectations, perceptions, and satisfaction has been extensively explored in
marketing literature. It has been posited that a customer’s satisfaction, or dissatisfaction,
with a service experience reflects their perceptions of the service meeting, exceeding, or
failing to meet their expectations for that service.110–112 Evidence also suggests that some
attributes of the service experience have greater impact on perceptions than others.110,113
The importance of understanding perceptions of healthcare consumers has
intensified light of the inclusion of patient satisfaction measures in the Centers for
Medicare and Medicaid Services’ value-based purchasing program114 and the growing
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emphasis on incorporating patient preferences into treatment approaches.115 Associations
between patient expectations, preferences, and satisfaction have been explored for a
number of healthcare settings and services.116–118 In primary care settings,119 total knee
arthroplasty,120 and orthopedic interventions to the hand,121 patient expectations were
significant determinants of post-visit or post-intervention satisfaction. Treatment
preferences and patient expectations have also been found to be predictors of satisfaction
among patients with acute and sub-acute low back pain.122 Similarly, patient preferences
for strength improvement over pain reduction were associated with satisfaction with
carpel tunnel release surgery.123
Patient satisfaction is associated with a number of meaningful outcomes for
healthcare providers, including patient appointment attendance and retention. A survey of
specialty pharmacy customers who switched pharmacies over the course of a year
reported that 12% of patients switched due dissatisfaction with customer service.124
Dissatisfaction has also been given as a reason for patients not keeping appointments with
their dieticians125 and general practitioners.126 Visit satisfaction has also been identified as
a determinant of intent to keep follow-up appointments127 and customer loyalty in retail
and service markets.128,129
The pharmacy literature has examined patient preferences and expectations for
community pharmacies. Internationally, pharmacy preferences have been found to differ
between countries because of differences in medication out-of-pocket costs, pharmacist
roles and available services, medical culture, and other factors.130,131 A comparison of
pharmacy preferences in Poland and the UK found that patients in the UK gave greater
preference to pharmacy consultations than Polish patients, who placed greater emphasis
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on medication prices and promotions.131 These differences may reflect the higher prices
Polish patients pay for their medications compared to their UK counterparts. Patients in
Australia rated location as less important than Polish and British patients.130,131 A recent
discrete choice experiment conducted on patient preferences for community pharmacies
focused on attributes surrounding the UK’s pharmacist-managed Minor Ailments Service; a
comparable service does not yet exist in the US. 132

2.8.1 Literature Review Aims
Because of the difficulty in comparing pharmacy preferences in different countries
with corresponding structural and cultural differences, this paper will limit its literature
review to patient perceptions of community pharmacies in the United States. Specifically,
this paper will summarize the body of knowledge on patient preferences for, expectations
of, and satisfaction with community pharmacies in the United States.

2.8.2 Literature Review Methods
A systematic literature review was conducted in October 2016. MEDLINE and
CINAHL were searched for the following terms in the title or abstract: “patient choice” OR
“consumer choice” OR “patient selection” OR “consumer selection” OR “patient
preferences” OR “consumer preferences” AND “ pharmacy” OR “community pharmacy” OR
“pharmacy services.” Google Scholar was searched using three sets of search terms:
“patient preferences” AND “community pharmacy”; “patient expectations” AND
“community pharmacy”; and “patient satisfaction” AND “community pharmacy.” Title and
abstracts were first screened for inclusion and exclusion criteria, and duplicates were
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removed. Full-text articles were then screened for eligibility, with reasons for exclusion
recorded, according to the PRISMA guidelines.133 Inclusion criteria included: (1) directly
evaluates patient expectations of, preferences for, or satisfaction with general community
pharmacy practice; and (2) published in the last 10 years (2006-present). Exclusion criteria
included: (1) Does not directly assess patient expectations, preferences, or satisfaction; (2)
Does not broadly assess patient perceptions for community pharmacy practice, or focuses
on specific pharmacy services; and (3) was not conducted in the United States. The search
over all databases yielded 3,114 results. In addition, the citations included in review
articles and articles included in the full-text screens were searched for relevant literature
not captured in the systematic literature search. After applying the inclusion and exclusion
criteria at the title, abstract, and full-text screening stages, a total of ten original research
articles were found. The flow of articles throughout these stages is depicted in the PRISMAstyle diagram contained in Figure 1. Articles are summarized in Table 1, and results are
presented in Figure 2.
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Figure 1. PRISMA diagram of systematic literature review on patient preferences for,
expectations of, and satisfaction with community pharmacies in the United States.

Records identified through
database searching
(n = 3,114 )

Additional records identified
through other sources
(n = 1)

Records after duplicates removed
(n = 2,748)

Records screened
(n = 2,748)

Full-text articles assessed
for eligibility
(n = 28)

Studies included in
qualitative synthesis
(n = 10)

Records excluded
(n = 2,720)

Full-text articles excluded, with reasons
(n = 16)
Not conducted in the US (n = 11)
Not focused on general pharmacy
services (n = 3)
Does not directly assess patient
expectations, satisfaction, or
preferences (n = 4)
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Table 1. Summary of literature assessing patient preferences for, expectations of, and satisfaction with community pharmacies in the United
States.
Author
(Year)

Construct
Assessed

Population

Method

Findings

Patterson
(2013)

Patient satisfaction
with and
preferences for
community
pharmacies; Patient
awareness of
pharmacy services

Stratified random sample
from prescription and
clinical pharmacy service
records of a single
independent pharmacy (n =
241)

Survey; 21 items on patient
satisfaction, 8 items on service
awareness and use, open
ended question on patronage
motive

Collum (2013)

Patient
expectations for
and satisfaction
with community
pharmacist
communication

Purposive sample of
patients who receive care
at a clinic-based community
pharmacy; Patients aged 65
years or older who filled at
least 8 unique prescription
medications between
November 1, 2011, and
January 31, 2011 (n = 19)

Structured telephonic
interview conducted by one
trained data collector using an
established script; 52
questions on patient
expectations and use of
literacy-based communication
techniques

Service awareness: The majority of patients were
aware that pharmacists dispensed prescriptions
(92.5%). Patients were less commonly aware that the
pharmacy offered herpes zoster vaccinations (34.9%)
and adherence packaging (34.0%). Patronage motives:
Patients most commonly selected their pharmacy
based on relationships with staff (43.6%), convenience
(28.2%), and local pharmacy ownership (15.4%).
Satisfaction: The majority of patients reported that
the pharmacy services they received were excellent
(70.5%) or very good (22.9%). A lower proportion
(40.1%) felt that the pharmacist’s efforts to help them
improve their health or stay health were “excellent.”
Other areas of lower satisfaction included the
pharmacist’s interest in their health and the amount
of time the pharmacist offers to spend with patients.
Patient expectations: A minority of patients expected
the pharmacist to counsel on a new medication's
indication (33%), how to take a new medication
(44.4%), and what may happen if the patient is
nonadherent (22.2%). A slightly higher proportion
expected to be counseled on a new medication’s side
effects (55.6%). Satisfaction: Most patients (73.7%)
reported being very satisfied with pharmacy
counseling. Many more patients felt that the
pharmacist spends enough time answering questions
on new prescriptions (94.7%) than on old
prescriptions (58.8%).
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Table 1. Summary of literature assessing patient preferences for, expectations of, and satisfaction with community pharmacies in the United
States.
Author
(Year)

Construct
Assessed

Population

Method

Findings

Cretton-Scott
et al. (2011)

Patient preferences
for pharmacist
attire

Convenience sample of
adult patients at a chain
pharmacy (n = 43) and an
independent pharmacy (n =
43)

Survey; Patients were shown
four sets of photographs with
different combinations of
pharmacist attire (business
casual or business formal; with
or without white coat)

Most patients reported that the pharmacists in formal
business attire and white coats were most
professional (62.8%), knowledgeable (54.1%), and
competent (58.2%). However, the majority of patients
saw pharmacists in business casual attire as most
approachable (52%).

Franic et al.
(2008)

Patient preferences
for community
pharmacies

Convenience sample of
adult patients at two
independent pharmacies (n
= 81), two grocery store
pharmacies (n = 44), two
community chain (n = 27),
and three discount store
pharmacies (n = 23)

Survey; Rated, on a scale of 1
to 5 for each of 26 attributes
the attribute’s importance
when selecting a pharmacy
and the degree to which a
perceived difference exists
between pharmacies

Competent, knowledgeable, and friendly staff and
pharmacists were seen as the most important and
differentiating attributes. Location, confidentiality,
prescription prices, and hours of operation were also
important but not differentiating. Pharmacy hours of
operation were important to patrons of all types of
pharmacies except independent community
pharmacies. Location was a determinant attribute
only for patients patronizing grocery store and
discount store pharmacies.

Malewski
(2015)

Patient satisfaction
with community
pharmacies

Convenience sample of
adult pharmacy patients at
10 chain pharmacies (n =
326)

Survey; 30 items addressing 4
areas of patient satisfaction:
satisfaction with the
relationship with and service
received from the pharmacist,
pharmacy facility satisfaction,
pharmacy accessibility, and
pharmacy financial concerns

Overall satisfaction with pharmacist customer service
(88.4%) and the pharmacy experience (92.5%) was
high and higher among suburban patients than urban
patients. Patients expressed high degrees of
confidence in pharmacists’ ability to dispense
prescriptions correctly (85.7%) and trust that
pharmacists give accurate information about their
medication therapy (91.1%). The vast majority of
patients agreed with statements that pharmacists are
understanding (81.2%), listen carefully (81.8%), and
explain things in an understandable way (81.2%).
Fewer patients felt that pharmacists are willing to
establish a personal relationship (67.3%).
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Table 1. Summary of literature assessing patient preferences for, expectations of, and satisfaction with community pharmacies in the United
States.
Author
(Year)

Construct
Assessed

Population

Method

Worley
(2006)

Patient perceptions
of pharmacistpatient
communication,
commitment, and
relationship quality

Random sample of
community dwelling older
adults (≥ 65 years) filling at
least one prescription
medication for diabetes at
a nonmail order pharmacy
(n = 221)

Shiyanbola
(2014)

Patient preferences
for pharmacy
quality information

Convenience sample
recruited from a rural and
urban geographical location
(n = 34)

Survey; Questions on patients'
perceptions of their
pharmacist's participative
behavior/ patientcenteredness (13 items) their
own participative behavior (12
items), pharmacist - patient
communication (5 items),
relationship quality (8 items,
including satisfaction), and
relationship commitment (5
items).
Surveys + a semi-structured
focus group; surveys assessed
demographic and health
characteristics of participants
as well as their understanding
of specific quality metrics.

Findings
Predictors of patient perceptions of a high-quality
pharmacist-patient relationship included pharmacist
participative behavior/patient-centeredness and
pharmacist-patient interpersonal communication.
Relationship quality was, in turn, predictive of a
patient's relationship commitment to their
pharmacist.

Several focus group participants stated that they
would access pharmacy quality information that was
made publicly available. Many rural patients,
however, expressed a reluctance to use quality
measures given their relationships with their
pharmacy’s owner(s) and the credibility of their local
pharmacies. Additionally, patients felt that customer
service, including feeling comfortable with a
pharmacist, feeling like you can ask questions, and
knowing that the pharmacist is going to take time to
answer questions, are important attributes during
pharmacy selection that are not captured in objective
quality metrics.
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Table 1. Summary of literature assessing patient preferences for, expectations of, and satisfaction with community pharmacies in the United States.
Author
(Year)

Construct
Assessed

Population

Method

Shiyanbola
(2015; Int J
Clin Pharm)

Patient perceptions
and expectations of
a quality pharmacy

Purposive sample of older
adults (≥65 years) who had
filled a prescription at a
community pharmacy in
the last 90 days (n = 60)

Six semi-structured focus
groups conducted in a group
interview format

Shiyanbola
(2015; BMJ
Open)

Patient preferences
during pharmacy
selection

Convenience sample
recruited from a rural and
urban geographical location
(n = 34)

Semi-structured focus group

Worley
(2007)

Patient
expectations of a
community
pharmacist

Nationwide sample of adult
(≥ 18 years) patients (n =
500)

Survey; Patients were asked to
indicate on a Likert Scale (1 =
very strongly disagree to 7 =
very strongly agree) the
degree to which they agreed
with statements regarding the
role of the community
pharmacist and patient

Findings
The most commonly identified expectation for
pharmacists’ roles was that staff would inform them
when the refill medications looked different than they
had in previous fills. Participants expected that
pharmacists deliver care in a manner that is friendly,
respectful, and private. They did not expect
pharmacists to look through their medications, which
they perceived as the physician’s role. Structural
pharmacy characteristics, including convenient
location, short wait times, and home delivery, as well
as relationship-oriented attributes like pharmacist and
staff responsiveness, helpfulness, and friendliness,
were very important to the focus group participants. It
was noted that “good” pharmacies have pharmacists
that are friendly and willing to establish a long-term
relationship.
Participants expressed preferences for pharmacies
scoring highly on validated quality measures, but only
in certain situations. These situations included if they
or someone they knew had a negative experience or
error and if they were moving to a new area.

Patients most commonly agreed that pharmacists
should listen to patients when they have a medication
question (mean, 6.0), be approachable to discuss a
patient’s medication concerns (6.0), and make sure
that patients understand how to use their medications
(5.8). They felt less strongly that pharmacists should
talk with patients if the patient does not have any
medication questions (4.4), greet patients at the
counter (4.7), and show an interest in working with
patients to meet their healthcare needs (5.2).
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Figure 2. Summary of the Patient Experience at Community Pharmacies
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2.8.3 Literature Review Results
Patient Expectations for Community Pharmacies
Consistent with the early, product-focused nature of pharmacy practice,134 patient
expectations for community pharmacy practice often center on dispensing roles. In one
study, patients who were asked about their awareness of services offered by pharmacists
most commonly reported awareness of prescription dispensing (92.5%) and influenza
vaccinations (87.1%).13 Similarly, the most commonly identified expectation for
pharmacists’ roles in the medication refill process among a group of older adults was that
staff would inform them when the refill medications looked different than they had in
previous fills.28 The same older adults also expected pharmacists to provide good customer
service by delivering care in a manner that is friendly, respectful, and private.28
Patient expectations of pharmacist activities beyond simple dispensing were more
varied are relatively low. Patients in one study strongly agreed that pharmacists should be
approachable, listen to patients’ medication concerns, and make sure that patients
understand how to use their medications.135 However, in a survey of older adults
prescribed at least eight unique medications, only 44.4% expected the pharmacist to
counsel on how to take a new medication.136 While a slightly higher proportion expected to
be counseled on a new medication’s side effects (55.6%), only a third of those patients
expected the pharmacist to provide counseling on the medication’s indication.136 Similarly,
many older adult focus group participants did not expect pharmacists to look through their
medications, as they felt that their physicians were responsible for medication
management.28 This finding was consistent with the relatively weak level of expectation in
another study that pharmacists show an interest in working with patients to meet their
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healthcare needs.135 Finally, the independent pharmacy patients who were nearly all aware
of pharmacist dispensing roles were much less commonly aware that pharmacists could
provide compounded prescriptions (52.5%) and herpes zoster vaccinations (34.9%).13

Patient Preferences for Community Pharmacies
Evidence for pharmacy preferences has come primarily from qualitative research
assessing patient perspectives on preferred attributes when selecting a pharmacy. One
study presented participants with an open-ended question asking why they chose their
pharmacy.13 The most common reasons offered were relationships with staff (43.6%),
convenience (28.2%), and local pharmacy ownership (15.4%). Some respondents (<10%)
also mentioned pharmacy atmosphere, personnel competency, pharmacy reputation, and
wait times as motives for pharmacy patronage.13 Similar findings were reported following
a series of focus groups among older adults.28 Those patients preferred certain structural
pharmacy characteristics, including convenient location, short wait times, and home
delivery, as well as relationship-oriented attributes like pharmacist and staff
responsiveness, helpfulness, and friendliness.28 Pharmacist and staff characteristics were
also consistently rated as very important by patients who were asked to indicate, on a
scale of one to five, the degree to which each of 26 attribute was important to them when
choosing a pharmacy.12 In that survey, respondents expressed strong preferences for
pharmacies with competent, knowledgeable, and friendly pharmacists and staff.
Furthermore, these attributes were perceived as most differentiating between competing
pharmacies.12 Location, prescription prices, and hours of operation were also important to
most patients but were not seen as differentiating factors.12 The authors concluded that
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pharmacy personnel, rather than characteristics of the pharmacy site, were the primary
determinant attributes for pharmacy selection.12
Pharmacy patrons maintain preferences for not only specific attributes of
pharmacies but also general pharmacy settings (i.e., independent, chain, grocery store, and
mass merchandiser). In a survey among older adults with diabetes, patients most
commonly reported patronizing a retail chain pharmacy (48.6%), independent pharmacies
(26.2%), and grocery store pharmacies (12.9%).137 Specific pharmacy preferences may also
drive selection of one pharmacy setting over another. In a survey by Franic et al.,12
pharmacy hours of operation were important to patrons of all types of pharmacies except
independent community pharmacies. Location was a determinant attribute, or an attribute
that was viewed as both important and differentiating, only for patients patronizing
grocery store and discount store pharmacies.12 Finally, certain preferences may drive
pharmacy loyalty. In one survey, patients who had selected a pharmacy based on pharmacy
atmosphere, the availability of a unique service, and personnel competency were
significantly less likely than those without those specific motives to have visited another
pharmacy in the last 12 months.13
Cretton-Scott et al. explored patient preferences for a very different pharmacy
attribute: pharmacist attire.138 Patients were presented with four sets of photographs
featuring a pair of pharmacists in casual or formal business attire with or without white
coats.138 Patients commonly reported that the pharmacists in formal business attire and
white coats were most professional (62.8%), knowledgeable (54.1%), and competent
(58.2%). However, the majority of patients saw pharmacists in business casual attire as
most approachable (52%). Over three-fourths of patients (77.5%) preferred pharmacists in

50

white coats, but preferences for the attire under the white coats were split between
business casual and business, likely reflecting a perceived trade-off between
professionalism and approachability.138
The degree to which patients prefer pharmacies that provide high quality
medication management has not yet been extensively explored; patient preferences for
these services may be poorly formed due to low expectations for and limited experience
with pharmacist cognitive services.13,28,136 When presented with validated pharmacy
quality measures established by the Pharmacy Quality Alliance (PQA), many patients
maintained that these measures were not appropriate for rating pharmacies.14 Still, when
the same patients were asked whether they would use quality measures to choose a
pharmacy, they often responded affirmatively.14 Many rural patients, however, expressed a
reluctance to use quality measures given their relationships with their pharmacy’s
owner(s) and the credibility of their local pharmacies. One patient asserted that he or she
couldn’t imagine anybody not wanting to know whether their pharmacy was doing what
they’re supposed to be doing.14 Participants in another set of focus groups expressed
preferences for pharmacies that scored well on validated quality measures, but only in
certain situations.15 These situations included a scenario in which they or someone they
knew had a negative experience or error and if they were moving to a new area.15

Patient Satisfaction with Community Pharmacies
Satisfaction, a complex construct associated with both preferences and expectations,
is generally high among community pharmacy patrons. In a survey of 241 patients at an
independent community pharmacy, the majority of patients reported that the pharmacy
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services they received were excellent (70.5%) or very good (22.9%).13 Similar levels of
satisfaction were seen among older adults prescribed at least eight medications, with
73.7% reporting being very satisfied with pharmacy counseling.136 Another study
compared the satisfaction of 326 patients at urban and suburban chain-pharmacies.139
Overall satisfaction with pharmacist customer service (88.4%) and the pharmacy
experience (92.5%) was high, though satisfaction differed by location, with suburban
patients reporting higher levels of satisfaction than their urban counterparts. High levels of
satisfaction reflected patients’ high degrees of confidence in their pharmacists’ abilities to
fulfill the common patient expectations for pharmacists discussed above. Specifically, the
vast majority of patients expressed confidence in their pharmacists’ abilities to dispense
prescriptions correctly (85.7%) and trusted their pharmacists to give accurate information
about their medication therapy (91.1%).139
Beyond general satisfaction, patients have consistently reported high degrees of
satisfaction with the specific manners in which pharmacists provided care. The vast
majority of surveyed patients in one study agreed with statements that pharmacists are
understanding (81.2%), listen carefully (81.8%), and explain things in an understandable
way (81.2%).139 In another survey, over 90% of patients marked as “excellent” or “very
good” the ability of pharmacists to answer questions, the degree of courtesy and respect
shown by the pharmacy staff, and the professionalism of the staff.13 Although not directly
assessing satisfaction, most participants in a series of focus groups among older adults felt
that “good” pharmacies have pharmacists that are friendly and willing to establish a longterm relationship.28 Patients also reported appreciating helpful staff at their current
pharmacies.28 A group of older adults with diabetes reported maintaining a relationship
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with the same pharmacist for an average of 11.2 years,137 suggesting a high degree of
satisfaction.140
Though patients are generally satisfied with pharmacists’ communication skills and
abilities to fulfill basic expectations for prescription dispensing, pharmacy patrons report
lower levels of satisfaction with more complex pharmacist services. Far more patients in
one survey were satisfied with pharmacists’ provision of medication information (91.1%)
than their willingness to establish a personal relationship (67.3%).139 Additionally, many
more patients in another survey felt that their pharmacist spends enough time answering
questions on new prescriptions (94.7%) than on old prescriptions (58.8%).136 An even
lower proportion (40.1%) felt that the pharmacist’s efforts to help them improve their
health or stay health were “excellent.”13 The other areas in which patients were least
satisfied included the pharmacist’s interest in their health and the amount of time the
pharmacist offers to spend with patients.13
Patient satisfaction with pharmacy services reflects their satisfaction with not only
pharmacists and their staff but also with the pharmacy’s location and appearance. In two
studies, most patients reported that pharmacies are conveniently located.28,139 The vast
majority of those surveyed in another study (87.4%) felt that pharmacies have good
appearances.139 However, fewer patients in that study maintained that pharmacy layouts
are organized in a way to ensure privacy,139 and satisfaction with the privacy of
conversations with the pharmacist was relatively low in another group of patients.13

2.8.4 Literature Review Discussion
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Overall, patient expectations and preferences for community pharmacies revolve
predominately around dispensing functions and relationship-oriented attributes, and
satisfaction with these aspects and overall pharmacy practice is high. Patients expect that
pharmacists will dispense their prescriptions accurately while providing good customer
service. Additionally, patients prioritize long-term relationships with pharmacists that are
fostered by friendly and responsive care. This priority is consistent with patient
preferences for other healthcare providers, including physicians. Fostering long-term
patient-pharmacist relationships may further improve satisfaction with care141 and reduce
healthcare costs,142 as is seen in studies on the impact of long-term patient-physician
relationships.
Satisfaction with the customer service and medication information provided by
pharmacists is notably high and exceeds consumer satisfaction with the general
environments in which pharmacists practice, including supermarkets, retail stores, and
discount stores.143 Patients also report a greater degree of satisfaction with the medication
information they receive from community pharmacists than they do during a
hospitalization.144 However, community pharmacies have been less successful in ensuring
that patients feel that they have spent adequate time with their pharmacist. Many patients
reported that they do not feel that pharmacists are willing to establish a long-term
relationship or spend ongoing time with them. This challenge is not unique to pharmacy, as
patients’ satisfaction with the amount of time spent with physicians is lower than their
satisfaction with other aspects of care.145 Indeed, community pharmacists have expressed a
desire to devote more of their time to patient consultations and medication
management,146 but time pressures often limit opportunities for increasing time spent with
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patients.147 Given the association between increased pharmacist counseling and improved
medication adherence148,149 as well as the low levels of patient satisfaction with the amount
of time spent with pharmacists, future community pharmacy practice models should focus
on increasing the ability of pharmacists to dedicate time to patient-centered, rather than
dispensing, functions to improve outcomes and satisfaction.
Patient expectations for more cognitively demanding pharmacist tasks, including
health and medication management, are more limited, and few patients appear likely to
select pharmacies based on these services. However, further research is needed to explore
the modern patient’s decision-making process during pharmacy selection and patients’
relative preferences for new and/or high-quality pharmacy services. As the scope of
pharmacy practice continues to increase, efforts should be made to increase patient
expectations for pharmacists and encourage patients to select pharmacies based on the
provision of high-quality medication management. At the same time, pharmacists should
focus on increasing patient satisfaction with pharmacists’ efforts to improve their health by
embracing their burgeoning role as healthcare providers and prioritizing the development
of long-term relationships with patients.

2.8.5 Literature Review Conclusion
Patients express high levels of satisfaction with most attributes of pharmacy
practice. However, these satisfaction levels may reflect relatively low expectations for
pharmacists focused primarily on dispensing roles and customer service. Many patients
maintain preferences for long-term relationships with their pharmacists but do not feel
that their pharmacists are willing to establish such relationships. New models of pharmacy
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practice should focus on expanding patients’ expectations for cognitive services and
improving the capacity for pharmacists to dedicate time to patient-centered activities.

2.9 Multiple Pharmacy Use
Underlying many of the aforementioned studies on patient interactions with
community pharmacies are assumptions that patients select a single pharmacy according
to consistent expectations and preferences. Though the majority of patients fill their
prescriptions at only one pharmacy, the proportion of patients who use two or more
pharmacies simultaneously may be increasing. An analysis of Medical Expenditure Panel
Survey data over seven years reported that multiple pharmacy use increased 18.7% from
2003 to 2009, from 36.4% to 43.2%.150 Individuals more likely to use multiple pharmacies
include those who use a mail order pharmacy, are less than 40 years, and are female.151
Consistent with this finding, multiple pharmacy users most commonly used two
pharmacies (vs. three or more) per year (70%), most frequently combining use of a mail
order pharmacy and a community pharmacy.150 The overall prevalence of the simultaneous
use of mail order and community pharmacies is debated in the literature. Nearly a quarter
(23.3%) of older adults in Texas reported use of both a mail order and a community
pharmacy.152 However, in another study, only 6.9% of 324,968 patients with multiple
prescriptions split their prescriptions between the two channels.105
The current literature on patient selection of pharmacies has not examined the
process of patient decision-making surrounding the use of multiple pharmacies.
Accordingly, it is not well understood whether patients have different priorities for
pharmacy selection depending on the medication(s) to be filled at that pharmacy. For
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example, given the demographics of individuals who most commonly use multiple
pharmacies, a young adult female may choose to receive birth control by mail order
pharmacy given the consistency of this prescription. She may simultaneously elect to fill
her antidepressant at a community pharmacy as she works with a physician to optimize the
drug and dosage.
In conclusion, an assumption that an individual patient has consistent preferences
for a community pharmacy may be violated if that patient maintains different priorities for
pharmacy services based upon the specific medication to be filed there. However, although
multiple pharmacy use is increasing, patients who patronize multiple pharmacies most
commonly combine use of a community pharmacy and a mail order pharmacy. It may still
therefore be reasonably assumed that a patient will exhibit consistent decision-making
preferences when selecting a community pharmacy.

2.10 Segmentation in the Healthcare Market
Market segmentation identifies consumer subsets based on common behaviors,
attitudes, and preferences, enabling businesses to more effectively create tailored
messaging and targeted marketing. Although traditionally used to study retail markets,
healthcare providers and facilities have increasingly recognized the utility of market
segmentation in identifying patient segments with different healthcare needs and
preferences. The Deloitte Center for Health Solutions conducted and disseminated one of
the most widely recognized healthcare market segmentation efforts. Patients in each of
Deloitte’s market segments differ with regards to their views and attitudes towards the
healthcare system and health policy; healthcare resource utilization; satisfaction with
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healthcare providers; use of information sources and technology; and payment systems.153
While the Deloitte market segmentation offers insight into segments based on broad
healthcare utilization and preferences, many other studies have taken more targeted
approaches to segmenting patients by their needs and priorities for specific healthcare
services.
Segments in the market for primary care practitioners often consist of patients who
prioritize either cost, convenience, technical quality of care, or interpersonal aspects of
care. In a latent class analysis of British patients’ preferences for general practitioner
appointments, three classes of patients were identified.154 Members of the class with the
highest probability of membership (0.54) preferred attributes reflecting cost and
convenience. The other classes, with membership probabilities of 0.20 and 0.26, strongly
preferred a thorough examination and having a doctor that knows you well, respectively.154
Segmentation studies of pharmacy customers have largely focused on identifying
market segments based on patient perceptions of pharmacist roles or preferences for
specific pharmacy services. A longitudinal segmentation analysis of community pharmacy
patients reported that the majority of patients belonged to a segment termed “reliance on
physician,” reflecting the prevalence of perceptions that physicians are better qualified
than pharmacists to give medication-related information.96 Another segmentation analysis,
a latent class analysis conducted among Australian pharmacy patrons, identified classes
based on patient preferences for pharmacy-based asthma services.155 The classes varied
primarily based on preferences for the intensity of the asthma services and level of
pharmacist involvement and ranged from a class preferring a lower intensity service
(“Minimalistic Model” class) to higher intensity service (“Holistic Model” class). The highest
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proportion of patients belonged to the intermediate class characterized by preferences for
a medium intensity service (“Partial Model” class).155 This latent class analysis was
conducted among a specific patient population, namely, asthma patients who were poorly
controlled, and examined preferences for a specific and specialized pharmacy service. A far
broader segmentation analysis of the community pharmacy market was conducted using
cluster analysis but was published over 30 years ago.10

2.11 Theoretical Foundations
2.11.1 Donabedian Model of Healthcare Quality
First proposed by Donabedian in 1966,156 the Donabedian structure, process, and
outcome model was conceived as a theoretical foundation for the assessment of healthcare
quality.156 Donabedian recognized that healthcare outcomes that are often influenced by
many factors other than the quality of care received. Accordingly, he recommended that
structures and processes of care be considered alongside outcomes in the evaluation of
healthcare quality. He considered processes of care, defined as the activities associated
with care provision and the manner in which care is provided, to be a reflection of whether
“good” medical care had been applied.156 Structures of care were defined as the settings in
which care takes place and the structures and operations that support the processes of
care.156
The Donabedian model has frequently been employed as a theoretical basis for
community pharmacy-based research. A 2013 effort to define professional pharmacy
services within the community pharmacy setting centered on Donabedian’s framework,
incorporating organizational structure, processes of care, and outcome measures into the
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definition.157 Additionally, the model has informed much of the existing literature on
patient perceptions and understanding of pharmacy.15,27,28 Structures, as they specifically
relate to community pharmacy, may include the ability to request refills online, the
availability of programs like appointment-based medication synchronization and home
delivery, and location.28 Processes within the community pharmacy setting often reflect the
nature of the interpersonal relationship between the patient and the pharmacist or
pharmacy staff. These may include the amount of time a pharmacist takes to communicate
with patients, the friendliness and helpfulness of the staff, and the degree to which the
pharmacy staff shows concern and knows an individual’s needs.28 Community pharmacy
outcomes, though traditionally limited to the ability of the pharmacist to accurately fill
prescriptions, have expanded to include clinically-focused measures.16

2.11.2 SERVQUAL Framework
SERVQUAL is a multi-item instrument for measuring customer perceptions of
service quality111 based on a conceptual framework of the way in which consumers
compare their expectations for a service with their perceptions of the service they
received.111 Critics of SERVQUAL assert that service quality is better conceptualized
through an attitudinal model than an expectations/disconfirmation model and that the
framework fails to incorporate foundational research in the social sciences.158 However,
the framework is widely used to study service quality in diverse industries, and even
developers of competing frameworks suggest that the elements of SERVQUAL “should
probably be put on any first pass at a list of attributes for a service.”159
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Ten determinants of service quality underlie the SERVQUAL framework: tangibles,
reliability, responsiveness, communication, credibility, security, competence, courtesy,
understanding/knowing the customer, and access. Hedvall et al. applied a body of
qualitative pharmacy research to define each of these determinants in the context of
community pharmacy (Table 1). 160 Additionally, a critical examination of the performance
of an adapted SERVQUAL instrument161 when assessing customer satisfaction with
community pharmacy services reported that the instrument demonstrated high convergent
and criterion validity as well as high overall internal reliability.162
For this study, both the Donabedian Model and the SERVQUAL framework were
used to inform the attribute selection process in order to more comprehensively approach
the complex nature of community pharmacy practice, in which healthcare services are
provided in a retail setting.163
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Table 1. SERVQUAL dimensions, as understood in a community pharmacy settings, adapted
from Hedvall et al.160
Dimension

Pharmacy-Specific Definition
Approachability and ease of contact; the pharmacy is easy to
locate, opening hours are convenient, the products are well
Accessibility
displayed, items in the self-service sector are easy to find, and
the pharmacy is easy to contact by phone
Customers are informed about prescription and nonprescription medicines, questions concerning health and related
Communication
matters, prices of services and products in a language the
consumers understand
The pharmacists possess the skills and knowledge necessary to
Competence
perform their duties in the pharmacy
Courtesy
The staff is polite, respectful, considerate, and friendly
The pharmacist is trustworthy and honest and has the
Credibility
customer’s best interests at heart
The medicine is dispensed accurately, is correctly priced, and is
Reliability
available at the time promised to the customer
The staff is willing and ready to perform the service required by
Responsiveness
the customer, and there is an available stock of all medicines
required
Freedom from risk or doubt that confidential information about
Security
the customer’s medicines and health status will go beyond the
pharmacy.
The pharmacy has adequate physical attributes, such as the size
Tangibles
of the premises, equipment, furnishings, and a comfortable
place to wait while prescriptions are being made up
The staff makes the effort to understand his/her needs, findings
Understanding/Knowing
out his/her specific requirements, and gives individual
the Customer
attention
2.11.3 Random Utility Theory
Random utility theory provides a theoretical basis for analyzing the choices made by
participants in a discrete choice experiment. Underlying discrete choice experiments is an
assumption that the choices that participants make reveal their preferences for the
attributes used to differentiate alternatives. That is, it is assumed that consumers have
preferences for attributes and, when presented with a choice of alternatives, will choose a
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particular alternative if and only if that option conveys higher utility than any of the
presented alternatives.164 Furthermore, random utility theory posits that the utility for a
given individual is a latent construct that cannot be directly observed by researchers.165
The latent utilities are thought to be a function of both explainable preferences and a
random component.164,165 This random component, which comprises all unobserved or
unidentified factors that impact respondents’ choices in a DCE,165 may be attributed to
unobservable or unobserved attributes, preference variations within or between
individuals, or error.164 The random utility theory necessarily underlies this research given
the use of a discrete choice experiment to assess patient preferences.
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Chapter 3: Methods
3.1 Introduction to Discrete Choice Experiments
This study elicited patient preferences for community pharmacy attributes using a
discrete choice experiment (DCE). In discrete choice experiments, participants are
presented with a series of choices in which they must select their preferred choice between
two or more alternatives that differ on a number of selected attributes. Through analysis of
participants’ choices, the effects of specific attributes on choice selection can be estimated.
3.2 Survey Instrument
3.2.1 Model Identification
For the discrete choice experiment, participants received a series of choices
between pharmacies that differ on the basis of six attributes reflecting pharmacy
structures, processes, and outcomes. Each of the six attributes had no more than three
levels. The inclusion of six attributes was consistent with International Society for
Pharmacoeconomics and Outcomes Research (ISPOR) guidelines166 and common practices
in pharmacy DCEs.167 The selection of an appropriate number of attributes and levels may
improve choice consistency, or the variability in stated preferences that is not explained by
attributes and preference weights.168 As the number of attributes and the variability in the
levels of the attributes increase, the difficulty of the choice decision increases, and choice
consistency is reduced.169
A status quo or opt-out option was not included. The omission of a status quo option
allowed this experiment to assess patient preferences in the absence of status quo bias and
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pharmacy loyalty, known to be dominating factors in pharmacy selection.15,170 The lack of a
status quo option is consistent with the majority of discrete choice experiments of
pharmacy services.167
Cost and location were held constant throughout the experiment to control for these
potentially dominating factors.171 Although guidelines for appropriate attribute selection
recommend the inclusion of all attributes important to an individual’s decision-making to
prevent respondents from making inferences about omitted variables, the exclusion of
dominant attributes has been recommended to prevent participant decision-making from
becoming deterministic based on a single attribute.164,172 In order to reduce the likelihood
of introducing omitted variable bias by excluding salient attributes, participant instructions
included above each choice set delineated the assumptions of constant cost and location. 164
The presentation of these instructions is consistent with ISPOR recommendations for
studies that do not include a cost attribute.166 Keeping cost and location consistent also
reflects real world pharmacy selection for many patients. Medication costs for insured
patients are often identical at in-network pharmacies, and most patients live within a fivemile radius of several pharmacies.173

3.2.2 Attribute Selection
An initial list of sixteen potential attributes for inclusion in the discrete choice
experiment was formed based on published literature on patient selection of healthcare
providers and expert opinion. Pilot testing (n=12) of a DCE with these sixteen attributes
was then conducted. Pilot test participants were selected through purposive sampling, and
testing was continued until saturation was reached. Pilot testing sessions lasted 25-45
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minutes. Feedback from the pilot tests was used to reduce the number of attributes to six,
refine the wording of specific attributes, and select the final levels for the included
attributes.
The sixteen attributes evaluated in the pilot tests are presented in Table 2. The
following criteria were then applied during the attribute reduction process based on
feedback received during the pilot tests. First, attributes that were confusing or not well
understood by a majority of patients were eliminated if the confusion regarding the
attribute would not be ameliorated by a change in its wording. This step reflects
recommendations that pilot tests be used to identify and exclude attributes that are not
well understood and/or not relevant to the participant population.164,174 Specifically,
appropriate attributes have been described as those that are salient, plausible, and capable
of being traded.172 Secondly, attributes that left substantial room for participant
interpretation were eliminated to lessen the impact of unnecessary variability based on
differences of interpretation. This step is consistent with recommendations that the
attribute development process ensure that the desired meaning is evoked during attribute
presentation.172
Thirdly, where focus groups revealed a consensus of participant opinion that an
attribute was unimportant, the inconsequential attribute was eliminated. Universally
unimportant attributes do not necessarily require elimination from discrete choice
experiments, as they will simply yield very low importance scores, but inclusion of these
attributes would be contrary to recommendations that all included attributes be salient to
the respondent population.172 Furthermore, the inclusion of unimportant attributes may
unnecessarily increase the task complexity, thereby introducing random variability into the
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responses.174 Lastly, the reduction in the number of attributes from sixteen to six
necessitated the final inclusion of only those attributes that would best advance the
experiment’s ability to capture meaningful data on why patients choose pharmacies and
differentiate market segments. The inclusion of attributes that were not meaningful to any
patients would not have advanced either of these goals.
Finally, a decision was made to include an hours of operation attribute while
eliminating the wait time attribute. While pilot test participants ascribed varying levels of
importance to each of these attributes, both assessed the degree to which patients
prioritize the underlying construct of accessibility. Conceptual overlap between attributes,
or inter-attribute correlation, can obscure the estimation of the main effects of each
attribute individually.175,176 Hours of operation was selected over wait time for a number
of reasons, primarily due to the attribute’s superior ability to produce novel, actionable
findings. While it is well understood from existing pharmacy and medical literature that
many or most patients prioritize short wait times for healthcare services, much less is
known about the degree to which the differences in the typical hours of operation for
grocery, mass merchandiser, chain, and independent pharmacies impact the pharmacy
selection process. While hours of operation may be an important factor in the ability of
community pharmacies to best serve their patients, the long shifts characteristic of
pharmacies with extended hours of operation are associated with decreased pharmacist
job satisfaction.177 The negative effects of shifts ≥ 12 hours on job satisfaction, intention to
leave current job, and burnout are well documented in other healthcare professionals.178,179
A clearer understanding of the hours most important to patients may improve pharmacies’
ability to create schedules that balance patient accessibility and pharmacist engagement.
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Specific details about the data reduction process for specific attributes are included
in Table 3. Based on expert opinion and pilot testing feedback, a new attribute, “The
pharmacist is willing to establish a personal relationship with me”, was selected for
inclusion.
Feedback on attribute levels was also gathered in the pilot tests and used to select
the most appropriate levels for the included attributes. The initial levels presented during
the pilot testing phase of the experiment were selected based on real world levels. During
the pilot testing, participants were asked to provide their interpretation of those levels and
indicate where a change from one level to another would provide meaningful information
for pharmacy selection. The final selection of attribute levels required an assessment of the
balance between the need for sufficient variation to yield precise, meaningful utility
estimates 174,175,180 and the demonstrated reduction in choice consistency as the number of
attribute levels increases.169 Two levels were specified for half of the attributes, and the
remaining three attributes each had three levels, consistent with recommendations to limit
levels to three or four per attribute.166
Following pilot testing, the number of levels for the attributes “staff
friendliness/courtesy” and “pharmacist communication” was reduced from four (Always,
Very Often, Sometimes, Rarely) to two (Always, Sometimes). This change was made for two
reasons. First, pilot test participants indicated that they felt that a “rarely” level was
implausible. Secondly, there was considerable variability in pilot test participants’
interpretation of the “very often” level. Some respondents felt that “very often” is “almost
always,” while others felt that “very often” was considerably closer to “sometimes” than
“always.” The ISPOR Task Force recommendations for Conjoint Analysis note that levels
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which require subjective interpretation by the respondents should be excluded in order to
avoid the introduction of unnecessary ambiguity and variability.166 Finally, pilot test
participants noted that the difference between “always” and “sometimes” for those two
attributes was both meaningful and plausible.
The number of levels for the two quality-specific attributes was also reduced
following pilot test feedback. Participants maintained that little meaningful difference
existed when two alternatives varied by only one star level but felt that a difference of two
star levels did indicate variability between the options. Therefore, the five levels differing
by one star (,,,,) were reduced to three levels differing by
two stars (,,). The final six attributes and their levels are included in
Table 4.
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Table 2. Sixteen Attributes Initially Included in Pilot Testing, based on Donabedian Framework
Attributes
Pharmacy Structure
Pharmacy Closing Time

Counseling Space

Ease of Prescription Fill Process

The staff is available to reduce wait times
Pharmacy Processes
The Pharmacy Staff is Friendly and
Courteous
The Pharmacist Shows Concern and Knows
Your Needs
Health and Medication-focused
Communication; Existing Prescriptions
Health and Medication-focused
Communication; New Prescriptions
Health and Medication-focused
Communication; Oral Communication
Waiting Time
Resolving Medication-Related Problems
Medication Appropriateness
Pharmacy Outcomes
Drug-Drug Interactions
Helping Patients Get Needed Medications
(Medication Adherence)
Overall Pharmacy Quality
Patient Satisfaction - Yelp.Com Rating

Levels

Source

Traditional hours (8:00am-8:00pm)
Extended hours on weekdays (7:00am-10:00pm)
Extended hours on weekdays and weekends (7:00am-10:00pm weekdays; open Saturday and Sunday)
No Private Space (e.g. counsel at pharmacy counter);
Semi-Private Space (e.g. extension of pharmacy counter);
Private Space (e.g. closed room)
The pharmacy has systems in place that make it easier to fill your medications. Examples of these systems
may include medication synchronization, automatic refill notification via phone call or text, and online
prescription management
Levels: Yes, No
Always; Very Often; Sometimes; Rarely

12,181,182

Always; Very Often; Sometimes; Rarely

10,12,132,154,18

183

183

3,184

Always; Very Often; Sometimes; Rarely

12,15,185

The staff at the pharmacy level asks if you are having any problems with your medicine
Levels: Always; Very Often; Sometimes; Rarely

183,184

When you have a new prescription filled the staff level tells you what to avoid when taking your medicine or
what to do if you have bad reactions
Levels: Always; Very Often; Sometimes; Rarely
The pharmacist explains things about your medications in a way that is easy to understand
Levels: Always; Very Often; Sometimes; Rarely

183

10 minutes; 20 minutes

12,132,186

When problems arise, your pharmacist level works with you to resolve them.
Level: Always; Very Often; Sometimes; Rarely
Your pharmacist level reviews your medications to make sure they are the best for you
Levels: Always; Very Often; Sometimes; Rarely

183

 (Much Below Average);  (Below Average);  (Average);  (Above Average); 
(Much Above Average)
 (Much Below Average);  (Below Average);  (Average);  (Above Average); 
(Much Above Average)
 (Much Below Average);  (Below Average);  (Average);  (Above Average); 
(Much Above Average)
; ; ; ; 

14,15

183

14,15

14,15

56,187,188
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Table 3. Attribution Reduction Process: Reasons for Exclusion
Reason for Exclusion
Consensus of
Unclear/Misunderstood
Staff availability to reduce
wait times
The pharmacist shows
concern and knows your
needs

Variability in Interpretation
Yelp.com rating
Ease of prescription fill
process

Unimportance
Medication appropriateness

Redundancy
Communication regarding new
prescriptions
Wait Time

Communication regarding
existing prescriptions
Resolving medicationrelated problems
Medication adherence
quality measure
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Table 4. Final Attributes and Levels for Inclusion in the Discrete Choice Experiment
Attribute
Pharmacy Hours of Operation189

Levels
9am-9pm Weekdays;
9am-7pm Saturday;
10am-6pm Sunday

Donabedian
Framework
Structure

Service Quality
Dimension
Access

Process

Courtesy

Process

Communication

Process

Understanding/Knowing

8am-10pm 7 days/week

Staff Friendliness/Courtesy

8am-6pm Weekdays; 10am-3pm
Saturday; Closed Sunday
Always
Sometimes

Pharmacist Communication

Always
Sometimes

The pharmacist is willing to

Yes

establish a personal relationship

No

the Customer

with me139
Quality Measure, Overall



Outcome

Competence

Outcome

Safety



Quality Measure, DDI14,15
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3.2.3 Experimental Design
A fractional factorial design was employed. Only full factorial designs allow for the
independent estimation of all main and interaction effects, including three-way and higher
order interactions. In contrast, fractional factorial design limits the analysis to estimating
main and two-way interaction effects. Therefore, the use of a fractional factorial design
requires the assumption that three-way and higher order interaction effects do not
confound the main and two-way interaction effects. Despite the limitation that this
potentially unmet assumption may bias the estimates of effect, fractional factorial designs
are considered sufficient for a model used to estimate only main effects or in a subset of
possible interactions.180,190 Furthermore, the full factorial design is simply not feasible
without a prohibitively large sample size and number of choice sets. A 2014 review of
discrete choice experiments in healthcare reported that 88% of healthcare-related DCEs
published from 2009-2012 reported using a fractional factorial design, compared with 6%
using a full factorial design.191
Sawtooth Lighthouse Studio v9.2 (Orem, UT) was used to assign profiles for a total
of 120 random choice tasks using complete enumeration. In complete enumeration, the
alternatives presented within each task are as different as possible.192,193 This minimal
overlap improves statistical efficiency and the precision of main effect estimates.
Furthermore, minimal overlap in one study did not increase fatigue, perceived difficulty, or
consistency compared to more moderate overlap.194 In this study, the use of complete
enumeration rather than balanced overlap, which allows for a greater degree of overlap,
was associated with a 23% increase in efficiency.
Two prohibitions were introduced into the study design based on pilot testing
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feedback. Pilot test participants found the combination of a one star rating on one of the
quality metrics and a five-star rating on the other metric to be implausible. When this
combination appeared, they expressed distrust of the pharmacy quality ratings and placed
little to no value on the metrics when making their selections. Therefore, for each of the
quality metrics, a prohibition was introduced such that a single pharmacy could not have a
one star rating on one of the quality metrics (overall or DDI) and a five-star rating on the
other. The efficiency of the design with the prohibitions was only 91% of that without the
prohibitions, but this loss of design efficiency was considered acceptable given the likely
increase in response efficiency as a result of eliminating implausible scenarios. Indeed, the
ISPOR task force on experimental designs for discrete choice experiments cautions that
implausible combinations may increase the potential for bias; introduce unobserved,
heterogenous interpretations by respondents; and/or lower response efficiency. 180
Participants were randomly assigned to one of 12 blocks consisting of 10 random
choice tasks. The profiles of two additional choice sets were created separately for the
assessment of internal validity. First, a dominant scenario was created. Secondly, a single
hold-out scenario for all participants, regardless of block placement, was created using a
separate complete enumeration design process. These two fixed scenarios were added for
the assessment of internal validity, as discussed later in this chapter. Thus, the total
number of choice tasks provided to each participant was 12.
The number of choice tasks was selected based on empirical literature and expert
opinions on the effects of the number of tasks on experimental precision and reliability.
Additional consideration was given to the appropriate number of tasks when individuallevel utility estimates will be made, as was done for the latent class analysis. The optimal
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balance of minimizing task complexity and optimizing design efficiency when selecting the
number of choice tasks is debated in the literature. Several studies have assessed changes
in response variability when study participants are provided with varying numbers of
choice tasks. The results have commonly suggested that the number of attributes, the
number of attribute level differences, and the number of alternatives presented in each
task have a greater impact on respondent fatigue and choice consistency than the number
of choice tasks.195–198 An appropriate number of tasks for a typical discrete choice
experiment may range from 5199 or 6200 to 24 or more.201,202 However, several researchers
have recommended an intermediate number (8-16) of choice tasks given diminishing
empirical gains from additional choice tasks.198,201,203,204 Accordingly, the mean number of
choice tasks used in healthcare-related discrete choice experiments is reportedly 12-14
tasks per respondent.205–207
The selection of the number of choice tasks per respondent for this study required
additional consideration given the proposed use of individual-level utility estimates during
latent class modeling. Sawtooth recommends the inclusion of at least 10 choice tasks if
individual-level utility estimates are intended.208 Health-related discrete choice
experiments that employed latent class modeling for segmentation have predominately
used 12-16 choice sets per respondent.209–211
Blocking was introduced into the experimental design in order to lower the number
of tasks required of each participant while maintaining acceptable levels of statistical
efficiency. 164 Two ISPOR task force reports on conjoint analysis note that blocking is often
necessary to increase the response efficiency of large designs,166,180 and the vast majority of
DCEs on pharmacy services used blocked designs167 The 12-block design increased the
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efficiency of the study 8-fold compared with a design consisting of only one block. Though
Sawtooth is capable of generating up to 999 questionnaire versions, or blocks, the 12-block
design was selected due to diminishing returns of efficiency with additional blocks.
Furthermore, with the 12-block design, approximately 40 participants were assigned to
each block, well above the recommended minimum of 20 participants per version.164
Because there is no gold standard for evaluating experimental design,166 the
strength of the study design was evaluated from a number of perspectives. First, an
efficiency test was conducted through Sawtooth’s “test design” feature. The logit report
with simulated responses for 500 participants estimated the standard errors for the effect
estimates to range from 0.01417 to 0.03191. These estimates meet the suggested guideline
that effect estimates for main effects be no larger than 0.05.212 Secondly D-efficiency, a
relative measure, was compared between several potential experimental designs, including
complete enumeration vs. balanced overlap, designs with different number of
questionnaire versions, and designs with and without prohibitions. Finally, it was
confirmed that Sawtooth’s internal assessment for design deficiencies did not flag any
attributes or levels as deficient.
Internal validity was assessed using a hold-out and a dominant scenario. The use of
tests for rationality and validity is common213 and recommended166 but raises theoretical
concerns about rational explanations for irrational responses. For example, participants
may exhibit lexicographic preferences, in which they select an alternative based on the
attribute they believe is most important rather than the overall trade-offs of all
alternatives. Such preferences may result in the rational selection of the dominated
alternative.214 It has also been suggested that participants may base their choices on
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assumptions and inferences about how the alternatives may differ on attributes not
included in the experiment.214 Because these participants are indeed expressing rational
and valid preferences, deleting those who fail the dominant scenario may lead to bias and
reduced efficiency.164 Accordingly, and based on ISPOR recommendations, respondents
failing the internal validity assessment were not dropped from the data set. Rather, the
frequency of response errors and a discussion of associations between response errors and
demographic characteristics are presented in the results.166
Attribute randomization was used to reduce the potential for bias that would
adversely impact the study’s internal validity. The Sawtooth attribute randomization
feature randomizes the order in which attributes are presented across respondents while
holding that order constant within each respondent. Pilot test participants strongly favored
a consistent attribute order, reporting that consistency dramatically decreased cognitive
burden. Furthermore, attribute randomization was consistent with ISPOR
recommendations166

3.2.4 Sociodemographic and Health Information
Health and sociodemographic characteristics included in the survey as well as the
levels presented to survey respondents are listed in Tables 5-8. Patient-specific health and
sociodemographic characteristics have been shown to influence preferences for health
providers and/or understanding of quality ratings. Basic demographic information
collected included sex, age, race, household annual income, and highest level of education
completed. These characteristics have been associated with preferences during healthcare
provider selection215,216 as well as use and understanding healthcare quality metrics and
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ratings.217,218 Several of these demographic characteristics are also mentioned as individual
characteristics of clinical and policy interest in the ISPOR Good Research Practices for
Conjoint Analysis Workforce.166
In addition to basic demographic information, the survey collected information on
marital status, urbanicity, and US census region of residence. Marital status was included in
light of a study on hospital selection among elderly males reporting that widowed men
were less likely to select a high-quality hospital, as assessed by US News & World Report,
than their married counterparts.219 Urbanicity data was collected given the documented
impact of urbanicity on patient priorities for and satisfaction with their
pharmacies.5,12,14,139 US census region of residence was included in the survey because a
recent study found that greater proportions of patients in the Midwest and West used mail
order pharmacies than those in the Northeast and South,105 suggesting that priorities
during pharmacy selection may vary by region.
Several health-related characteristics were also collected in the questionnaire. A
single, validated screening question was used to identify participants with inadequate
health literacy.220 Health literacy may influence patient understanding of quality
information and the extent to which quality data is prioritized during health care provider
selection.61,221,222 Current pharmacy patronage was also collected. In a determinant
attribute analysis conducted by Franic et al., patients who patronized independent
community pharmacies ascribed less importance to pharmacy hours of operation than
customers of other types of community pharmacies.12
Self-reported health status was collected with the survey question “would you say
that your health is excellent, very good, good, fair, or poor?” Self-reported health status has
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been associated with awareness of quality information, but its impact on the use of such
information during healthcare decision-making may be limited. A study among older adults
found that patients with better self-reported health were less likely to be aware of
physician quality information.218 However, patients in another study who reported good or
excellent health were more likely to report having seen comparative quality information
than their less healthy counterparts.51 However, this increased exposure to quality
information was not associated with increased use of the information when choosing a
healthcare provider.51 Harris surveyed patients regarding their use of formal quality
information, information from doctors and nurses, and recommendations from friends and
family when selecting a healthcare provider. In that survey, health status was not shown to
impact the likelihood of using quality information.223
Patient activation, measured in this study with a single question assessing patient
confidence in their ability to manage their health, has garnered attention in healthcare
research due to its association with health outcomes and patient perceptions of their care
experiences.224 In a study examining patient awareness and use of comparative quality
information, patients with lower activation scores were less likely than highly activated
patients to have seen and used comparative quality information for physicians and
hospitals.51 Similarly, Hibbard et al. reported that patients with high activation
demonstrated higher comprehension of quality information and were more likely to choose
a high quality hospital in a hypothetical scenario than less activated patients.72 However,
activation was not associated with awareness of physician quality information in a study
among older adults.218 Patient confidence, as used in this study, is associated with health
outcomes and health behaviors, and the measure is closely correlated with other
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engagement measures.225 Furthermore, the assessment of patient confidence requires only
a single question and does not necessitate payment of a licensing fee.
Finally, this survey collected information on a patient’s current number of chronic
medications and the number of chronic medications which they currently manage for an
individual for whom they serve as a primary caregiver. This measure impacted choice of
pharmacy setting among older adult Department of Defense beneficiaries6 and emergency
department patients.108 The number of chronic medications used was also associated with
multiple pharmacy use among US adults.151 Additionally, the proportion of patients with
chronic diseases varied substantially in the healthcare market segments identified by the
Deloitte Center for Health Solutions.153 Information on both the patient’s and their care
recipients’ medication use was collected given the high prevalence of informal caregiving in
the US226 documented role of caregivers in medication management.227,228 Furthermore, a
discrete choice experiment of community pharmacy preferences among Australian
consumers specifically included both patients and unpaid caregivers.130
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Table 5. Sociodemographic Characteristics Included in Questionnaire
Sociodemographic
Characteristics
Levels
Sex

Male; Female

Source
166,215–218

Age

18-24; 25-34; 35-44; 45-54; 55-64; 65-74; ≥75

166,215–218

Race

Non-Hispanic, White; Non-Hispanic, Black; Hispanic, Other

166,215,218,223

Household Annual Income

Highest Level of Education

≤$25,000; $25,001-$50,000, $50,001-$75,000; $75,001-

166,215,218

$100,000; $100,001-$150,000; >$150,000
Less than High School; High School Degree; Some College;

166,215–218

Bachelor’s Degree; Some Post-Graduate; Post-Graduate Degree

Marital Status

Never Married; Married; Separated/divorced/widowed

219

US Census Region of Residence

Northeast; Midwest; South; West

105

Urbanicity

Urban; Suburban; Rural

5,12,14,139
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Table 6. Health Characteristics Included in Questionnaire
Health Characteristics
Health Literacy Screening
Question
Self-Reported Health Status
Number of Chronic
Medications, Self

Levels

Source

Adequate, Inadequate

215

Excellent, very good, good, fair, poor

51,218,223

None; 1-3; 4-7; 8-11, ≥11

6,108,229

Chain pharmacy (i.e. CVS); Independent
Current Pharmacy

Pharmacy; Grocery Pharmacy (i.e. Kroger);

Patronage

Mass Merchandiser Pharmacy (i.e. Walmart);

12

Mail Order Pharmacy
Number of Chronic

None; 1-3; 4-7; 8-11, ≥11

6,108,229

Know Pharmacist’s Name

Yes/No

12,230

Health Confidence

High (≥ 7), Low (<7)

218,225

Medications, Care Recipients
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Table 7. Level Selection for Demographic Characteristics on Questionnaire

Sex

Male; Female

Source for Level
Selection
231

Age

18-24; 25-34; 35-44; 45-54; 55-64; 65-74; ≥75

231

Race

Non-Hispanic, White; Non-Hispanic, Black; Hispanic, Other

231

<$25,000; $25,000-$49,999; $50,000-$74,999; $75,000-$99,999; $100,000-

232,233

Characteristic

Household Annual Income
Highest Level of Education

Levels

$149,999; ≥$150,000
Less than High School; High School Degree; Some College; Bachelor’s Degree;

231,234

Some Post-Graduate; Post-Graduate Degree

Marital Status

Never Married; Married; Separated/divorced/widowed

234,235

US Census Region of Residence

Northeast; Midwest; South; West

235

Urbanicity

Urban; Suburban; Small Town, Rural

236
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Table 8. Level Selection for Health Characteristics in Questionnaire
Levels

Source for
Level Selection

Characteristic
Single Question Health Literacy Screening

Adequate, Inadequate

220

Self-Perceived Health Status

Excellent, very good, good, fair, poor

237

Number of Chronic Medications, Self

Interval

229

Chain pharmacy (i.e. CVS); Independent Pharmacy; Grocery Pharmacy
Current Pharmacy Patronage

(i.e. Kroger); Mass Merchandiser Pharmacy (i.e. Walmart); Mail Order

12

Pharmacy
Number of Chronic Medications, Care

Interval

229

I Know My Pharmacist’s Name

Yes; No

12,230

Health Confidence

High (≥ 7), Low (<7)

225,238

Recipients

Automatic Refill; E-mail or Text Message Refill Reminders;
Appointment-Based Medication Synchronization; Medication
Synchronization (without an appointment); Medication
Pharmacy Services

Adherence Packaging (e.g. blister packaging, pill box
organization); Medication Therapy Management; Immunization,
Influenza; Immunization, Non-Influenza; Prescription
Compounding; Home Delivery; Smartphone App
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3.3 Participant Selection and Data Collection
3.3.1 Administration of Discrete Choice Experiment
A Qualtrics research panel was used to gather a sample of American adults (≥ 18
years) for the online administration of the discrete choice experiment. Online
administration of DCEs is increasingly common in health economics,213 and patient
preferences did not significantly differ between those responding to the health state
valuation instrument face-to-face and online.239 In order to proceed to the survey,
participants must have answered “yes” to the question “Have you filled a prescription at a
pharmacy, other than a mail-order pharmacy, within the last 12 months.” This screening
criteria was instituted to exclude those who had not recently filled a prescription at a brickand-mortar pharmacy. A gender quota was implemented to ensure that the proportions of
males and females did not exceed a 60/40 split for either gender. While the Qualtrics panel
is opt-in such that participants are not randomly selected, the panel has been shown to
have an acceptable level of national representativeness.240 Furthermore, compared with
the demographic composition of other opt-in panels, Qualtrics has more representative
proportions of older adults, racial minorities, those with low levels of educational
attainment, and those living in urban and rural areas.240 This study was approved by the
Virginia Commonwealth University Institutional Review Board.
Prior to the discrete choice experiment, participants were provided information
about the forthcoming choice tasks and the pharmacy quality measures. The specific
wording and information presented was selected based on expert opinion, ISPOR
guidelines for discrete choice experiments, existing literature, and feedback from the pilot
testing. Because past literature has identified the potential for patient confusion over
85

whether a higher or lower number is better for a specific quality indicator,53 participants
were supplied with specific information that the ratings would appear on a scale of one to
five stars, where more stars were better. A scale of the star levels, along with their
evaluative word labels (i.e. “much below average” to “much above average”) was also
presented prior to the start of the experiment. The addition of word labels to the star
ratings reflects the real-world presentation format of quality metrics on Medicare’s
Hospital Compare and Nursing Home Compare websites. The addition of world labels is
also associated with improved understanding of quality stars.65,69 Based on pilot testing
feedback, a statement was added to the survey instructions noting, “An overall rating is
computed based on a number of scores on specific aspects of pharmacy practice.
Accordingly, an overall quality rating may differ from any single, specific rating.” While
past studies have reported that the presentation of an overall performance measure in
addition to specific quality metrics aids in the identification of high-quality providers,14,53,71
pilot test participants commonly felt confused when the two scores differed.
The instructions prior to each choice task presented the hypothetical scenario under
which participants would be making their choice (i.e. having moved to a new location) and
the key assumptions of this DCE, namely that price and location were held constant. Finally,
an example choice task was provided. The three primary elements included in the presurvey introduction – the context of the study scenario, a description of the quality
attributes and levels, and the example choice task – are consistent with ISPOR
recommendations.166
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3.3.2 Sample Size
There is no gold standard for determining the sample size for a DCE.166 Sample size
recommendations vary considerably and include both set sample sizes (e.g. 100
respondents) and sample sizes calculated based on parametric approaches.166,241 Formulas
for sample size calculation may require input of population proportions, variance, expected
parameter values, statistical power and/or the number of parameters estimated, choice
sets, and alternatives.241 Considerable variability exists in the sample sizes used in
published healthcare-related DCEs, and very few (6%) report use of parametric approaches
for sample size estimation.241 Given the lack of consensus on optimal approaches for
sample size calculations, the need for parameter value estimates for sample size
calculations, and the limited use of parametric approaches in health economics thus far, a
calculation-based approach to sample size calculation was not used in this study.180,241
This study targeted a sample size of 500. The target sample size was decided upon
after considering expert recommendations, common practices for healthcare-related DCEs,
and the a priori plan to conduct a latent class analysis. Two reports from the ISPOR Good
Research Practices for Conjoint Analysis Task Force cite recommendations that conjoint
analyses include at least 300 study participants.166,180 A review article of discrete choice
experiments in healthcare stated that the mean sample size of conjoint analysis studies in
health care was 259 respondents.166 Furthermore, Monte-Carlo simulations suggest that
sample sizes over 100 are acceptable for latent class analysis, with sample sizes of 500
resulting in precise parameter estimates even under conditions of low data quality.242
Accordingly, recent latent class analyses in healthcare report sample sizes of
approximately 200-500.209,210,243
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Additional consideration was given to the a priori analysis plan to evaluate the
community pharmacy preferences of the subgroup of patients taking chronic medications.
An estimated 50% of all Americans live with a chronic condition. 244–246 With the use of
chronic medications come concerns about high levels of nonadherence247 and an increased
risk for drug-drug interactions between two prescribed medications248 or a prescribed and
an over-the-counter (OTC) medication.249 A sample size of at least 250 patients taking
chronic medications was targeted in order to have a sufficient number of patients for a
valid and meaningful subgroup analysis. All study participants, per the inclusion criteria,
must have reported filling a prescription at a non-mail order pharmacy in the last 12
months. In an average month, the vast majority (>80%) of prescriptions filled for adult
patients are chronic medications.250 Additionally, the prescribing rate for antibiotics, the
most commonly prescribed acute medications, among non-elderly adults is approximately
350 prescriptions per 1,000 patients.251 The assumption was thus made that at least half of
the 500 study participants would be taking at least one chronic medication, yielding a
predicted sample size of 250 for the subgroup analysis.

3.4 Data Analysis
3.4.1 Data Analysis, Sample Characteristics
The sample characteristics were summarized using Sawtooth v9.2. Continuous
variables were presented as mean (SD), and categorical variables were presented as the
proportion of respondents in each group. The number of participants failing the dominant
scenario was also summarized. Chi-square and ANOVA tests were used to assess whether
categorical and continuous, respectively, health and demographic characteristics varied
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between those who failed the scenario and those who did not, with p < 0.05 denoting
statistical significance.

3.4.2 Data Analysis, Study Aim 1
Sawtooth v.9.2 (Sawtooth Software, Orem, UT) was used to conduct a conditional
logit regression (CL) to analyze the effect of attribute levels on consumer preferences for
community pharmacies. For the primary CL analysis, only main effects were
considered,192,213 and preferences were estimated using effects coding166,252,253 with the
following model:254

𝑈𝑖 = 𝛽1 𝐺𝑟𝑜𝑐𝑒𝑟𝑦𝐻𝑜𝑢𝑟𝑠𝑖 + 𝛽2 𝐶ℎ𝑎𝑖𝑛 𝐻𝑜𝑢𝑟𝑠𝑖 + 𝛽3 𝐴𝑙𝑤𝑎𝑦𝑠𝐹𝑟𝑖𝑒𝑛𝑑𝑙𝑦𝑖 + 𝛽4 𝐴𝑙𝑤𝑎𝑦𝑠𝐸𝑥𝑝𝑙𝑎𝑖𝑛𝑠𝑖
+ 𝛽5 𝑅𝑒𝑙𝑎𝑡𝑖𝑜𝑛𝑠ℎ𝑖𝑝𝑖 + 𝛽6 𝑄𝑢𝑎𝑙𝑖𝑡𝑦3𝑆𝑡𝑎𝑟𝑖 + 𝛽7 𝑄𝑢𝑎𝑙𝑖𝑡𝑦5𝑆𝑡𝑎𝑟𝑖 + 𝛽8 𝐷𝐷𝐼3𝑆𝑡𝑎𝑟𝑖
+ 𝛽9 𝐷𝐷𝐼5𝑆𝑡𝑎𝑟𝑖 + 𝜀𝑖

Where the overall utility of alternative i is a function of estimated coefficients 𝛽1 to 𝛽9 , the
attribute levels of alternative i, and a random error term. Estimated regression coefficients
were expressed as part-worth utilities. Sawtooth was also used to calculate attribute
importance values, which reflect the difference each attribute could make in an
alternative’s utility and are used to characterize the relative importance of each attribute.
The model fit was assessed by evaluating the chi-square comparing the log
likelihood of the full and null models, with the degrees of freedom calculated by subtracting
the number of attributes from the total number of levels to obtain the number of additional
effects in the full model.192,252 T-ratios were used to evaluate the significance of individual

89

attributes. A p-value < 0.05 denoted statistical significance.
3.4.3 Data Analysis, Study Aim 2
For Study Aim 2, the effects of sociodemographic and health characteristics on
patient preferences for community pharmacy attributes were described. Though this aim
was descriptive in nature, subgroup comparisons were made using Sawtooth Software’s
CBC/Hierarchical Bayes (CBC/HB) module. CBC/HB estimates individual-level utility data
and normalizes it using zero-centered differentials. Through this process, individuals are
made to having same utility scaling, ensuring that they will be equally weighted within the
population. T-tests and one-way ANOVAs were then used to assess for the significance of
the differences in part-worth utilities between subgroups, with understanding of the
caution required with repeated testing of differences. It is well known that repeated
testing of differences between subgroups inflates the probability of a false positive result,
and the p-value denoting statistical significance should be adjusted accordingly.255,256 The
Bonferroni adjustment was used for post-hoc pairwise comparisons.

3.4.4 Data Analysis, Study Aim 3
The Sawtooth Latent Class Segmentation (CBC/LC) module was used for the
proposed community pharmacy market segmentation. Latent class models allow for
preference heterogeneity by identifying segments with similar preferences, estimating
those preferences, and assessing the probability that each study participant belongs to each
segment.257 The CBC/LC module requires the user to pre-specify the number of segments,
or classes, in the population. The module was run five times to create segmentation
solutions with two to six segments. Measures of model fit were then compared between the
90

five solutions. The model that best described the patterns of participant responses was
identified based on the Consistent Akaike Information Criterion (CAIC), where the smallest
value or the inflection point indicates the appropriate number of segments.257 The CAIC is
the evaluation criterion provided in the CBC/LC module and has performed well in
independent simulations testing decision-making criteria for the number of classes in
latent class analyses.258 In addition to CAIC, consideration was given to obtaining
interpretable and meaningful market segments. Once the optimal solution was selected,
the sizes, part-worth utilities, and attribute importance values were estimated and
reported for each segment.
Descriptive statistics, mean/SD for continuous variables and proportions for
categorical variables, were calculated for each market segment. The health and
demographic characteristics of the members in each class were compared with chi-square
and one-way ANOVA tests for categorical and continuous variables, respectively, where p <
0.05 denoted statistical significance.
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Chapter 4: Results
4.1 Sample Size and Characteristics
A total of 773 respondents began the survey. Thirty-two participants were excluded,
including thirty who entered the survey through the survey panel administrator but did not
begin the choice task and two who failed to complete the choice experiment, for a total
sample size of 741. The two participants who began the choice tasks but did not complete
the experiment withdrew after the third and eighth choice tasks.
Demographic and health characteristics of the survey respondents and the US adult
population are presented in Table 9. The sample was predominately female (55.8%), nonHispanic white (83.1%), and married (63.2%). Middle-aged adults were slightly
overrepresented relative to national estimates, with participants most commonly reporting
an age of 35-54 years (40.9% vs. 35% nationally) or 55-64 years (22.9% vs. 16%
nationally).259 Young adults (18-24 years) and older adults (≥65 years) were
underrepresented in the study population (3.5% vs. 12.9% nationally and 12.2% and
18.3% nationally). Nearly two-thirds of participants (62.7%) reported an annual household
income level above the median US household income. Study respondents were more highly
educated than the general population. Compared to the population at large, participants
were more likely to report attaining at least a high school diploma/GED (98.8% vs. 87.1%)
and at least a Bachelor’s degree (47.4% vs. 30.6%).260 Consistent with national estimates of
population by US Census region of residence, approximately one-third of study participants
reported residing in the South (34.0% vs. 37.1% nationally), and a quarter lived in the
Midwest (25.3% vs. 21.7% nationally).261 However, respondents were much more likely to
live in the Northeast (29.5% vs. 17.9% nationally) and much less likely to live in the West
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(11.3% vs 23.3% nationally) than the general population.261 Survey participants more
commonly reported living in a suburban area (47.2%) than an urban (24.8%) or rural
(17.2%) area.
The estimated prevalence of inadequate health literacy in the study population was
6.1%. Low health confidence was more common (15.2%) than low health literacy. Most
participants perceived their health to be very good (38.6%) or good (31.2%). The
proportion of participants reporting fair or poor health (14.0%) was slightly lower than
has been reported nationally (17.5%). The vast majority of respondents reported use of at
least one chronic medication (85.1%), with an average of 2.7 medications reported per
study participant. Among only those study participants who reported chronic medication
use, the average utilization was 3.2 chronic medications.
The proportion of participants reporting any chronic medication use did not vary
significantly by age (p = 0.559) and ranged from 81.5% in the youngest respondents (18-24
years) to 88.9% in those over 65 years of age. However, the mean number of chronic
medications did increase significantly with age (p = 0.0179), from 2.3 among 18-24 year
olds to 4.6 in those over 75 years of age. The reported use (p = 0.284) and number (p =
0.122) of chronic medications did not vary by sex. The majority (58.9%) of participants
reported responsibility for at least one medication for a direct care recipient. The mean
number of chronic medications taken by care recipient(s) was 3.5. Caregivers were most
commonly 35-44 (26.4%) and 25-34 years old (23.5%). The majority of respondents
reported filling their prescriptions primarily at a chain pharmacy (51.5%), and
approximately one-third (35.1%) stated that they know their pharmacist’s name.

93

Pharmacy Patronage and Demographic Characteristics
A number of demographic and health characteristics were associated with type of
pharmacy patronized (Table 10). Mail order pharmacy use was significantly higher among
older adults (≥ 65 years; 18.9%) than those under 65 years of age (4.2%). Consequently,
while older adults comprised only 12.2% of the total study sample, nearly 4 in 10 (38.7%)
of those reporting primary use of a mail order pharmacy were older than 65 years. A
greater proportion of the lowest income respondents (<$25,000; 21.7%) patronized
independent pharmacies than the highest income participants (≥$150,000; 6.8%), who
more often reported use of a chain pharmacy (61.0% vs. 45.4%). Independent pharmacy
patronage was least common (4.8%) amongst participants living in the West, where mail
order pharmacy use was more common than in other areas of the country (10.8% vs 5.15.9%). Compared with their rural counterparts, suburban participants more commonly
patronized chain pharmacies (58.8% vs. 40.9%) and less commonly used independent
pharmacies (6.6% vs. 16.5%). The proportion of independent pharmacy patrons reporting
that they knew their pharmacist’s name (59.3%) was nearly double that of those using
chain (32.7%), grocery (35.2%), and mass merchandiser pharmacies (31.0%).

Pharmacy Services Utilization
Of the eleven services surveyed, automatic refill service was the most commonly
utilized, with 57.9% of participants reporting use (Table 11). The proportion of
respondents using automatic refill was higher among those patronizing grocery (65.1%),
mail order (63.6%) and chain (60.4%) pharmacies than independent pharmacies (45.7%).
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The use of technological services, including e-mail or text message reminders and
smartphone apps, was highest among patrons of chain and mail order pharmacies. Nearly
half of chain (45.4%) and mail order (47.7%) patrons reported using e-mail or text
message reminders, compared with 17.3%-31.0% among patients at other types of
pharmacies. Similarly, pharmacy-based smartphone apps were more commonly used by
chain and mail order pharmacy patrons (13.7% and 11.4%, respectively) than by
customers of independent, grocery, and mass merchandiser pharmacies (4.9%-7.1%). The
use of appointment-based medication synchronization was highest among patients at
independent pharmacies (16.1%). Among patrons of brick-and-mortar pharmacies, home
delivery was most commonly used by patients at independent pharmacies (24.7%).

4.2 Survey Responses
The median time to survey completion was 5 minutes, 38 seconds (IQR: 3 minutes,
58 seconds - 8 minutes, 11 seconds). Median elapsed time did not vary by health literacy,
age, sex, level of education, or health confidence. The median time per choice task was 12
seconds. Respondents’ time per choice task significantly decreased as they progressed
through the experiment (p<0.001). Median time per choice task was 29 seconds for the
first completed choice task, 19 for the second, 15 for the third, and 10-13 for the remaining
tasks. The median time for the dominant choice task was 13 seconds.
In the dominant scenario, 93.4% of participants selected the dominant choice. Males
more commonly failed the dominant scenario (8.9%) than females (4.9%). Respondents in
rural areas who, on average reported lower levels of education and health literacy than
their more urban counterparts, less commonly failed the dominant scenario (1.6%) than
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those from small towns (5.1%) and suburban (6.0%) and urban (12.0%) areas. The median
time spent on the survey by participants failing the dominant scenario was not significantly
different than that of those who did not fail. Thirteen (1.8%) and two (0.3%) respondents
always selected the alternative on the left or right, respectively. Overall, the left alternative
was selected in 47.3% of random choice tasks.
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Table 9. Baseline Characteristics of the Study Respondents, Overall, Compared with the US
Adult Population
Baseline Characteristics
Male Sex
Age
18-24 years
25-34 years
35-44 years
45-54 years
55-64 years
65-74 years
≥75 years
Race
Non-Hispanic, White
Non-Hispanic, Black
Hispanic
Other
Household Annual Income
<$25,000
$25,000-$49,999
$50,000-$74,999
$75,000-$99,999
$100,000-$149,999
≥$150,000
Highest Level of Education
Less Than High School/GED
High School Degree
Some College
Associate’s Degree
Bachelor’s Degree
Some Post-Graduate
Graduate Degree
Marital Status
Never Married
Married
Separated/Divorced/Widowed

Study Respondents, n (%)
325 (44.2)

U.S. Adult Population (%)
48.6

26 (3.5)
151 (20.5)
164 (22.3)
137 (18.6)
169 (22.9)
81 (11.0)
9 (1.2)

12.9
17.8
16.8
18.2
16.2
10.3
8.0

608 (83.1)
54 (7.4)
34 (4.6)
36 (4.9)

62.4
12.3
17.1
8.2

98 (13.3)
176 (24.0)
170 (23.1)
131 (18.0)
100 (13.6)
59 (8.0)

22.2
22.7
16.7
12.1
14.1
12.3

9 (1.2)
140 (19.1)
151 (20.5)
87 (11.8)
219 (29.8)
33 (4.5)
96 (13.1)

12.9
27.6

161 (22.0)
463 (63.2)
109 (14.9)

36.7
49.2
18.9

29.0
19.0
11.6
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Table 9. Baseline Characteristics of the Study Respondents, Overall, Compared with the US
Adult Population, Continued
Baseline Characteristics
Region of Residence
Northeast
Midwest
South
West
Urbanicity
Urban
Suburban
Small Town
Rural
Health Literacy
Inadequate
Self-Perceived Health
Excellent
Very Good
Good
Fair
Poor
No. of Chronic Medications
Self, mean (SD)
Care Recipients, mean(SD)
Type of Pharmacy
Chain
Independent
Grocery
Mass Merchandiser
Mail Order
I Know My Pharmacist’s Name
Yes
No
Unsure
I do not interact with the same
pharmacist regularly
Health Confidence
Mean (SD)
High (≥7)

Study Respondents, n (%)

U.S. Adult Population (%)

217 (29.5)
186 (25.3)
250 (34.0)
83 (11.3)

17.9
21.7
37.1
23.3

184 (24.8)
348 (47.2)
79 (10.7)
127 (17.2)
45 (6.1)
120 (16.3)
285 (38.6)
230 (31.2)
84 (11.4)
19 (2.6)

71.2
9.5
19.3
26

82.5
17.5

2.74 (3.32)
2.03 (3.56)
379 (51.5)
81 (11.0)
106 (14.4)
126 (17.1)
44 (6.0)
258 (35.1)
316 (42.9)
76 (10.3)
86 (11.7)
8.56 (2.03)
628 (84.8)
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Table 10. Population Characteristics, Overall, by Current Pharmacy Patronage
Number (%), by current pharmacy patronage
Mass
Chain
Independent
Grocery
Merchandiser
381 (51.6)
81 (11.0)
106 (14.4)
126 (17.1)
155 (40.9)
38 (46.9)
48 (45.7)
60 (47.6)

Number (%)
Male Sex

Mail Order
44 (6.0)
24 (54.6)

Agec
18-24 years
25-34 years
35-44 years
45-54 years
55-64 years
65-74 years
≥75 years

16 (4.2)
86 (22.7)
89 (23.5)
66 (17.4)
85 (22.4)
32 (8.4)
5 (1.3)

4 (4.9)
23 (28.4)
19 (23.5)
15 (18.5)
11 (13.6)
9 (11.1)
0

1 (0.9)
20 (18.9)
22 (20.8)
23 (21.7)
26 (24.5)
12 (11.3)
2 (1.9)

4 (3.2)
21 (16.7)
29 (23.0)
25 (19.8)
34 (27.0)
13 (10.3)
0

1 (2.3)
1 (2.3)
5 (11.4)
7 (15.9)
13 (29.6)
15 (34.1)
2 (4.6)

Non-Hispanic, White 304 (81.3)
Non-Hispanic, Black
30 (8.0)
Hispanic
21 (5.6)
Other
19 (5.1)
Household Annual Incomec
<$25,000 44 (11.7)
$25,000-$49,999 83 (22.0)
$50,000-$74,999 79 (21.0)
$75,000-$99,999 78 (20.7)
$100,000-$149,999 57 (15.1)
≥$150,000
36 (9.6)
Highest Level of Educationa
Less Than High School/GED
3 (0.8)
High School Degree 70 (18.5)
Some College 79 (20.9)
Associate’s Degree 39 (10.3)
Bachelor’s Degree 123 (32.3)
Some Post-Graduate
15 (4.0)
Graduate Degree 50 (13.2)
a
c
p < 0.05; p < 0.001

71 (87.7)
4 (4.9)
1 (1.2)
5 (6.2)

90 (84.9)
10 (9.4)
4 (3.8)
2 (1.9)

105 (83.3)
7 (5.6)
6 (4.8)
8 (6.4)

37 (84.1)
3 (6.8)
2 (4.6)
2 (4.6)

21 (25.9)
20 (24.7)
17 (21.0)
12 (14.8)
7 (8.6)
4 (4.9)

10 (9.4)
20 (18.9)
33 (31.1)
18 (17.0)
18 (17.0)
7 (6.6)

16 (12.7)
41 (32.5)
34 (27.0)
18 (14.3)
8 (6.4)
9 (7.1)

6 (13.6)
12 (27.3)
7 (15.9)
6 (13.6)
10 (22.7)
3 (6.8)

4 (4.9)
10 (12.4)
26 (32.1)
8 (9.9)
21 (25.9)
5 (6.2)
7 (8.6)

1 (1.0)
19 (18.1)
19 (18.1)
15 (14.3)
32 (30.5)
5 (4.8)
14 (13.3)

0 (0)
31 (24.8)
22 (17.6)
19 (15.2)
34 (27.2)
3 (2.4)
16 (12.8)

1 (2.3)
8 (18.2)
5 (11.4)
6 (13.6)
10 (22.7)
5 (11.4)
9 (20.5)

Race
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Table 10. Population Characteristics, Overall, by Current Pharmacy Patronage, Cont.

Chain

Number (%), by current pharmacy patronage
Mass
Independent
Grocery
Merchandiser

Mail
Order

Marital Status
Never Married 87 (23.2)
Married 243 (64.8)
Separated/Divorced/Widowed 45 (12.0)
Region of Residencea

24 (29.6)
42 (51.9)
15 (18.5)

18 (17.1)
68 (64.8)
19 (18.1)

28 (22.2)
76 (60.3)
22 (17.5)

4 (9.1)
33 (75.0)
7 (15.9)

Northeast 127 (33.7)

26 (32.1)

20 (18.9)

32 (25.4)

Midwest 85 (22.6)
South 129 (34.2)
West
36 (9.6)

20 (24.7)
31 (38.3)
4 (4.9)

29 (27.4)
38 (35.9)
19 (17.9)

41 (32.5)
38 (30.2)
15 (11.9)

11
(25.0)
11(25.0)
13 (29.6)
9 (20.5)

Urban 91 (24.0)
Suburban 204 (53.8)
Small Town
32 (8.4)
Rural 52 (13.7)

28 (34.6)
23 (28.4)
9 (11.1)
21 (25.9)

29 (27.4)
50 (47.2)
9 (8.5)
18 (17.0)

29 (23.0)
50 (39.7)
23 (18.3)
24 (19.1)

7 (15.9)
20 (45.5)
5 (11.4)
12 (27.3)

Inadequate

9 (11.1)

7 (6.6)

7 (5.6)

0

15 (18.5)
26 (32.1)
25 (30.9)
10 (12.4)
5 (6.2)

16 (15.1)
43 (40.6)
34 (32.1)
12 (11.3)
1 (0.9)

18 (14.3)
42 (33.3)
48 (38.1)
15 (11.9)
3 (2.4)

4 (9.1)
18 (40.9)
15 (34.1)
4 (9.1)
3 (6.8)

2.8 (2.5)
2.6 (4.5)

3.3 (5.2)
2.6 (5.6)

2.7 (3.4)
1.7 (2.5)

4.5 (2.8)
2.9 (3.9)

48 (59.3)
21 (25.9)
10 (12.4)

37 (35.2)
42 (40.0)
12 (11.4)

39 (31.0)
68 (54.0)
8 (6.4)

10 (22.7)
19 (43.2)
7 (15.9)

2 (2.5)

14 (13.3)

11 (8.7)

8 (18.2)

8.1 (2.0)
63 (77.8)

8.6 (1.9)
93 (87.7)

8.4 (2.1)
104 (82.5)

Urbanicityc

Health Literacy
22 (5.8)

Self-Perceived Health
Excellent 67 (17.7)
Very Good 156 (41.2)
Good 106 (28.0)
Fair 43 (11.4)
Poor
7 (1.9)
Chronic Medications
Self, mean (SD) 2.4 (2.7)
Care Recipients, mean(SD) 1.8 (2.8)
I Know My Pharmacist’s
Namec
Yes 124 (32.7)
No 165 (43.5)
Unsure 39 (10.3)
I do not interact with the same
51 (13.5)
pharmacist regularly
Health Confidence
Mean (SD) 8.6 (2.0)
High (≥7) 326 (86.0)
a
c
p < 0.05; p < 0.001

8.9 (2.4)
38 (86.4)
100

Table 11. Pharmacy Services Utilization by Current Pharmacy Patronage
Number (%), by current pharmacy patronage

Refilla

Automatic
E-mail or Text Message
Remindersa
Appointment-Based
Medication
Synchronizationa
Medication
Synchronization
Adherence Packaging
Medication Therapy
Management
Influenza Vaccine
Non-Influenza Vaccine
Prescription
Compounding
Home Deliverya
Smartphone Appa
a
p < 0.05

Number (%)
429 (57.9)

Chain
229 (60.4)

Independent
37 (45.7)

Grocery
69 (65.1)

Mass
Merchandiser
63 (50.0)

Mail Order
28 (63.6)

276 (37.2)

172 (45.4)

14 (17.3)

30 (28.3)

39 (31.0)

21 (47.7)

44 (5.9)

18 (4.8)

13 (16.1)

4 (3.8)

6 (4.8)

3 (6.8)

42 (5.7)

17 (4.5)

6 (7.4)

6 (5.7)

10 (7.9)

60 (8.1)

26 (6.9)

12 (14.8)

10 (9.4)

8 (6.4)

4 (9.1)

19 (2.6)

8 (2.1)

2 (2.5)

5 (4.7)

3 (2.4)

1 (2.3)

198 (26.8)
57 (7.7)
25 (3.4)

101 (26.7)
37 (9.8)
12 (3.2)

18 (22.2)
2 (2.5)
3 (3.7)

30 (28.3)
6 (5.7)
3 (2.8)

33 (26.2)
7 (5.6)
6 (4.8)

15 (34.1)
4 (9.1)

90 (12.2)
77 (10.4)

30 (7.9)
52 (13.7)

20 (24.7)
4 (4.9)

3 (2.8)
7 (6.6)

7 (5.6)
9 (7.1)

30 (68.2)
5 (11.4)

3 (6.8)

1 (2.3)
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Table 12. Characteristics of Those Who Failed the Dominant Scenario
Baseline Characteristics
Male Sexa
Age
18-34 years
35-44 years
45-54 years
55-64 years
≥ 65 years
Race
Non-Hispanic, White
Non-Hispanic, Black
Hispanic
Other
Household Annual Income
<$25,000
$25,000-$49,999
$50,000-$74,999
$75,000-$99,999
≥ $100,000
Highest Level of Education
Less Than High School/GED
High School Degree
At Least Some College
Bachelor’s Degree
At Least Some Post-Graduate
Marital Status
Never Married
Married
Separated/Divorced/Widowed
Region of Residence
Northeast
Midwest
South
West
a

Failed Dominant
Scenario, n (%)
29 (59.2)

All Respondents, n (%)
325 (44.2)

20 (40.8)
10 (20.4)
9 (18.4)
7 (14.3)
3 (6.1)

177 (24.0)
164 (22.3)
137 (18.6)
169 (22.9)
90 (12.2)

38 (79.2)
2 (4.2)
6 (12.5)
2 (4.2)

608 (83.1)
54 (7.4)
34 (4.6)
36 (4.9)

7 (14.3)
12 (24.5)
12 (25.5)
10 (20.4)
8 (16.3)

98 (13.3)
176 (24.0)
170 (23.1)
132 (18.0)
159 (21.6)

1 (2.0)
14 (28.6)
14 (28.6)
11 (22.5)
9 (18.4)

9 (1.2)
140 (19.1)
238 (32.4)
219 (29.8)
129 (17.6)

12 (24.5)
33 (67.4)
4 (8.2)

161 (22.0)
463 (63.2)
109 (14.9)

17 (35.4)
10 (20.8)
12 (25.0)
9 (18.8)

217 (29.5)
186 (25.3)
250 (34.0)
83 (11.3)

p < 0.05
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Table 12. Characteristics of Those Who Failed the Dominant Scenario, Continued
Baseline Characteristics
Urbanicitya
Urban
Suburban
Small Town
Rural
Health Literacy
Inadequate
Self-Perceived Health
Excellent
Very Good
Good
Fair
Poor
No. of Chronic Medications
Self, mean (SD)
Care Recipients, mean(SD)
Type of Pharmacy
Chain
Independent
Grocery
Mass Merchandiser
Mail Order
I Know My Pharmacist’s Namea
Yes
No/Unsure/No Regular
Pharmacist
Health Confidence
Mean (SD)a
High (≥7)
a
p < 0.05

Failed Dominant Scenario,
n (%)

Study Respondents, n (%)

22 (44.9)
21 (42.9)
4 (8.2)
2 (4.1)

184 (24.9)
348 (47.2)
79 (10.7)
127 (17.2)

5 (10.2)

45 (6.1)

14 (28.6)
12 (24.5)
17 (34.7)
5 (10.2)
1 (2.0)

120 (16.3)
285 (38.6)
230 (31.2)
84 (11.4)
19 (2.6)

2.77 (2.4)
1.96 (2.2)

2.74 (3.32)
2.03 (3.56)

27 (55.1)
7(14.3)
3 (6.1)
11 (22.5)
1 (2.0)

379 (51.5)
81 (11.0)
106 (14.4)
126 (17.1)
44 (6.0)

30 (61.2)

263 (35.5)

19 (38.8)

478 (64.5)

7.98 (2.7)
38 (77.6)

8.56 (2.0)
628 (84.8)
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4.3 Main Model Results
The log likelihood for the conditional (CL) logit model was -3136.5, and the chisquare value for the difference between the full and null model was 3999.5. At nine
degrees of freedom, this value is statistically significant at a level of p < 0.001. The utility
values and attribute importance values from the main model are presented in Tables 13
and 14, respectively. The preference estimates had the anticipated directions. Expanded
hours, pharmacist effort to establish a patient-pharmacist relationship, and improved
communication, quality, and friendliness were all significantly associated with increased
utility.
Overall, study participants expressed the strongest preferences for quality-related
pharmacy attributes. The attribute importance value (AIV) was highest for the specific,
drug-drug interaction quality measure presented as, “Pharmacy ensured there were no
patients who were dispensed two medications that can cause harm when taken together”
(40.3). The overall pharmacy quality measure yielded the second-highest AIV (31.3).
Patients, on average, expressed weaker preferences for pharmacy hours of operation (AIV:
9.6), staff friendliness/courtesy (7.6), pharmacist communication (5.1), and pharmacist
efforts to get to know them (6.1).
In addition to examining the direction of the model’s utility values and the
proportion of participants selecting the dominant alternative, the validity of this discrete
choice experiment was further assessed by analyzing the results of the fixed, holdout
scenario. First, the individual utility values calculated through Sawtooth’s Hierarchical
Bayes estimation function were used to predict responses to the holdout scenario.262
Accurate predictions were made for 62.6% of participants. Then, the Sawooth Software
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Market Research Tool (SMRT) was used to predict, on a group level, the proportion of
participants expected to select each alternative in the fixed scenario. SMRT predicted that
59.1% of participants would choose the first alternative; in practice, 65.3% of patients
selected that alternative.
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Table 13. Main Model Results, Utility Values

Quality Dimension

Access

Courtesy

Attribute

Pharmacy Hours of Operation

Staff Friendliness/Courtesy

Communication

Pharmacist Communication

Understanding/
Knowing the Customer

The Pharmacist Makes an
Effort to Get to Know Me

Competence

Quality Measure, Overall

Safety

Quality Measure, DDI

Levels
8am-6pm Weekdays; 10am-3pm
Saturday; Closed Sunday

Utility

SE

-0.23150

0.02600

0.08449

0.02635

Always
Sometimes
Always

0.14701
-0.15092
0.15092
-0.10049
0.10049

0.02685
0.01613
0.01613
0.01631
0.01631

No

-0.12117

0.01618

Yes

0.12117

0.01618








-0.65055
0.06208
0.58847
-0.82821
0.06647
0.76174

0.03323
0.02623
0.03264
0.03385
0.02619
0.03317

9am-9pm Weekdays;
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7 days/week
Sometimes
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Table 14. Main Model Results, Attribute Importance Values

Quality Dimension

Attribute

Mean Importance Value

Rank

Access

Pharmacy Hours of Operation

9.61

3

Courtesy

Staff Friendliness/Courtesy

7.61

4

Communication

Pharmacist Communication

5.09

6

Knowing the Customer

Pharmacist Makes an Effort to Get to Know Me

6.10

5

Competence

Quality Measure, Overall

31.34

2

Safety

Quality Measure, DDI

40.25

1
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Figure 3. Main Model Attribute Importance Values

MAIN MODEL: ATTRIBUTE IMPORTANCE VALUES
Hours of Operation
10%
Friendliness/Courtesy
8%

Communication
5%

Quality Measure, DDI
40%

Pharmacist Makes an
Effort to Get to Know Me
6%

Quality Measure, Overall
31%
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4.3. Subgroup Results
Comparisons of the zero-centered Hierarchical Bayes individual utility estimates
across demographic and health characteristics suggest that a number of these traits are
associated with patient preferences for community pharmacy attributes. The utility values
and attribute importance values of demographic and health characteristic-based subgroups
are presented in Tables 15-39.
The utility values of both the overall and drug-drug interaction (DDI)-specific
quality metrics varied across several demographic subgroups. When utilities were
compared by sex, women had higher utilities for five star ratings on the overall quality
metric (83.0) and the drug-drug interaction (DDI)-specific metric (103.8) than their male
counterparts (76.2 and 94.5, respectively). The utility values ascribed to a five-star rating
on the DDI metric were also higher among white, non-Hispanic respondents compared to
those who identified as a member of an “other” race (101.1 vs. 69.5). Patients who
indicated that they do not know their pharmacist’s name, were unsure, or reported that
they did not regularly interact with the same pharmacist more strongly preferred a 5-star
score on the DDI metric (100.8) than those who did know their pharmacist’s name
(96.6).Finally, excellent (102.5) and very good health (106.7) were associated with
stronger preferences for 5-star scores on the DDI metric than good (92.2), fair (90.5), and
poor self-reported health (92.7), though only the difference between those with very good
and good health was significant in pairwise comparisons.
The utility values associated with pharmacists’ efforts to get to know their patients
also varied significantly across different populations, including residence-, health statusand health literacy-based subgroups. Rural (20.6) patients more strongly preferred this
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attribute than those in suburban areas (14.1), and utility values were higher among those
with inadequate health literacy (26.0) than for their higher literacy counterparts (16.3).
The utility ascribed to pharmacist effort to establish a patient-pharmacist relationship was
also higher in those who reported being in good health (19.9) compared to those with very
good (13.6) health. However, the effect of self-perceived health status on strength of
respondents’ preferences for this attribute was not consistent, as the utilities among those
with excellent (18.3) and poor health (20.0) were not significantly different.
Few subgroup differences were seen in the utility ascribed to the
friendliness/courtesy, communication, and hours of operation attributes. The utility values
of friendliness/courtesy varied significantly only across residence-based subgroups, with
rural and small town respondents expressing stronger preferences than their suburban
and urban counterparts for friendliness and courtesy (small town: 23.7; urban: 16.4). The
comparison of utilities by race revealed that white, non-Hispanic respondents had, on
average, a lower utility value for pharmacist communication (13.6) than participants who
identified as members of an “other” race (23.8). Patients who knew their pharmacist’s
name also assigned higher utility to pharmacist communication (16.7) than those without a
patient-pharmacist relationship (13.4). Finally, only the number of chronic medications
was associated with a difference in the strength of respondent preferences for the most
extended pharmacy hours (“chain hours”; 8am-10pm 7 days/week). Those who reported
that they or their direct care recipient take at least 11 different prescription medications
were the only subgroups for whom the utility of the second most extensive hours (“grocery
hours”; 9am-9pm Weekdays, 9am-7pm Saturday, 10am-6pm Sunday) was negative (-5.2
and -0.47, respectively). Consequently, in increase in utility when moving from “grocery” to
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“chain” hours was much larger among the highest medication users (>11 medications,
32.0) than for those reporting use of fewer than 11 medications (8.5-19.5).
Utility values did not significantly vary by age, income level, highest level of
education attained, or level of health confidence. However, a number of trends were
identified in the comparison of these subgroups. The importance of a patient-pharmacist
relationship declined as education increased, decreasing from 25.4 and 19.9 for those with
less than a high school education and a high school degree, respectively, to 14.1 and 15.8
among those with a bachelor’s degree and at least some post-graduate education.
Additionally, the utility value of the most extended pharmacy hours presented (“chain
hours”; 8am-10pm 7 days/week) was 1.9 among those with less than a high school
education, far lower than the 14.8-22.8 among those with higher levels of education. The
utility of chain pharmacy hours was also higher among survey respondents in the
Northeast (24.4) and West (26.3) than in the Midwest (19.9) and South (16.4).
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Table 15. Subgroup Results, Utilities, by Sex

Sex

Attribute

Levels
8am-6pm Weekdays; 10am-3pm
Saturday; Closed Sunday

Hours of Operation

Friendliness/Courtesy
Communication
Pharmacist Knows Me

Overall Quality

DDI Quality
a

9am-9pm Weekdays;
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7 days/week
Sometimes
Always
Sometimes
Always
No
Yes


 a


 a

Male

Female

Utility

Utility

-27.9 (48.8)

-25.7 (47.0)

5.7 (30.9)

7.2 (28.6)

22.2 (42.5)
-19.7 (21.2)
19.7 (21.2)
-15.4 (16.1)
15.4 (16.1)
-16.0 (22.4)
16.0 (22.4)
-88.2 (37.5)
12.0 (18.2)
76.2 (41.7)
-106.9 (64.8)
12.4 (17.3)
94.5 (64.0)

18.6 (38.4)
-19.2 (19.8)
19.2 (19.8)
-13.8 (19.4)
13.8 (19.4)
-17.6 (22.7)
17.6 (22.7)
-93.3 (36.3)
10.3 (16.5)
83.0 (38.4)
-114.4 (54.1)
10.6 (14.9)
103.8 (51.0)

p < 0.05
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Table 16. Subgroup Results, Utilities, by Urbanicity
Urbanicity
Attribute

Hours of Operation

Friendliness/Courtesy
Communication
Pharmacist Knows Me

Overall Quality

DDI Quality
a

Levels
8am-6pm Weekdays; 10am-3pm
Saturday; Closed Sunday
9am-9pm Weekdays;
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7 days/week
Sometimes
Always a
Sometimes
Always
No
Yes







Urban

Suburban

Small Town

Rural

Utility

Utility

Utility

Utility

-23.2 (50.5)

-27.8 (46.7)

-29.0 (48.6)

-27.6 (46.7)

4.8 (29.0)

5.6 (28.4)

13.2 (34.1)

7.5 (30.3)

18.4 (41.8)
-16.4 (22.1)
16.4 (22.1)
-16.1 (18.3)
16.1 (18.3)
-17.9 (25.0)
17.9 (25.0)
-89.9 (37.2)
11.3 (21.4)
78.6 (40.9)
-102.8 (67.8)
10.3 (17.1)
92.5 (64.7)

22.2 (41.0)
-19.0 (18.4)
19.0 (18.4)
-13.3 (17.4)
13.3 (17.4)
-14.1 (20.3)
14.1 (20.3)
-91.1 (39.3)
11.1 (16.8)
80.0 (42.9)
-117.3 (55.0)
11.2 (16.0)
105.9 (52.8)

15.8 (41.8)
-23.7 (20.3)
23.7 (20.3)
-14.1 (20.1)
14.1 (20.1)
-20.6 (20.4)
20.6 (20.4)
-89.9 (36.0)
9.4 (13.1)
80.5 (35.8)
-102.0 (62.6)
13.8 (14.4)
88.2 (63.6)

20.1 (35.2)
-22.6 (22.8)
22.6 (22.8)
15.6 (17.6)
15.6 (17.6)
-20.6 (25.0)
20.6 (25.0)
-92.4 (31.2)
11.3 (16.1)
81.2 (32.0)
-109.8 (57.4)
11.9 (16.1)
97.9 (55.3)

p < 0.05
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Table 17. Subgroup Results, Utilities, by Age

Attribute

Hours of Operation

Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality

DDI Quality

Levels
8am-6pm Weekdays;
10am-3pm Saturday;
Closed Sunday
9am-9pm Weekdays;
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7 days/week
Sometimes
Always
Sometimes
Always
No
Yes







Age 18-34
Utility

Age 35-44
Utility

Age
Age 45-54
Utility

-26.6 (54.6)

-28.3 (46.7)

-22.3 (35.7)

-24.7 (47.2)

-35.1 (52.8)

5.5 (29.9)

5.7 (29.0)

7.4 (29.2)

5.0 (29.1)

11.8 (31.6)

21.1 (45.8)

22.6 (37.4)

15.0 (34.5)

19.7 (40.1)

23.3 (43.0)

-21.8 (25.1)
21.8 (25.1)
-14.3 (17.6)
14.3 (17.6)
-15.5 (21.3)
15.5 (21.3)
-88.9 (41.4)
10.7 (16.9)
78.2 (42.6)
-108.2 (59.0)
11.2 (16.8)
96.9 (56.2)

-19.9 (18.9)
19.9 (18.9)
-17.2 (18.5)
17.2 (18.5)
-16.0 (21.9)
16.0 (21.9)
-89.0 (36.8)
13.2 (21.1)
75.8 (40.7)
-110.1 (61.6)
11.4 (15.7)
98.7 (61.7)

-17.9 (20.0)
17.9 (20.0)
-13.3 (20.8)
13.3 (20.8)
-16.8 (22.6)
16.8 (22.6)
-96.9 (32.6)
11.9 (17.6)
85.0 (39.5)
-109.2 (62.3)
10.5 (17.3)
98.7 (59.4)

-18.8 (16.8)
18.8 (16.8)
-12.4 (14.2)
12.4 (14.2)
-19.5 (24.7)
19.5 (24.7)
-92.5 (34.6)
8.9 (14.7)
83.6 (37.9)
-115.6 (54.7)
13.3 (14.7)
102.3 (54.3)

-17.2 (19.5)
17.2 (19.5)
-15.9 (19.1)
15.9 (19.1)
-16.5 (22.0)
16.5 (22.0)
-87.5 (37.5)
11.0 (13.9)
76.5 (36.9)
-112.4 (58.6)
9.9 (15.8)
102.6 (54.0)

Age 55-64
Utility

Age ≥65
Utility
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Table 18. Subgroup Results, Utilities, by Race
Race

Attribute

Levels
8am-6pm Weekdays; 10am3pm Saturday; Closed Sunday
9am-9pm Weekdays;
Hours of Operation
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7 days/week
Sometimes
Friendliness/Courtesy
Always
Sometimes
Communication
Always c
No
Yes


Overall Quality
 a


DDI Quality

a
c
p < 0.05; p < 0.001

Pharmacist Knows Me

White, NonHispanic

Black, NonHispanic

Hispanic

Other

Coeff.

Coeff.

Coeff.

Coeff.

-28.4 (47.4)

-28.5 (56.8)

-10.0 (46.5)

-13.8 (42.5)

7.6 (30.0)

2.3 (25.4)

-0.4 (28.2)

2.8 (30.1)

20.8 (40.1)
-18.9 (20.0)
18.9 (20.0)
-13.6 (17.5)
13.6 (17.5)
-16.7 (22.6)
16.7 (22.6)
-91.9 (35.5)
11.1 (17.2)
80.8 (38.0)
-112.7 (56.8)
11.6 (15.7)
101.1 (55.6)

26.3 (48.0)
-20.7 (20.4)
20.7 (20.4)
-17.0 (18.0)
17.0 (18.0)
-14.6 (19.7)
14.6 (19.7)
-88.0 (38.2)
12.8 (15.7)
75.2 (43.7)
-110.7 (66.6)
10.2 (16.8)
100.6 (60.7)

10.4 (36.4)
-26.7 (27.3)
26.7 (27.3)
-18.2 (17.5)
18.2 (17.5)
-19.1 (11.8)
19.1 (11.8)
-90.1 (44.5)
10.6 (15.8)
79.5 (43.9)
-111.2 (58.0)
9.6 (15.3)
101.6 (55.5)

10.9 (36.0)
-20.3 (21.1)
20.3 (21.1)
-23.8 (23.6)
23.8 (23.6)
-18.5 (29.7)
18.5 (29.7)
-82.0 (49.2)
11.0 (21.7)
71.0 (59.6)
-80.7 (81.5)
11.2 (22.3)
69.5 (76.7)
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Table 19. Subgroup Results, Utilities, by Annual Household Income

Attribute

Hours of Operation

Friendliness/Courtesy
Communication
Pharmacist Knows Me

Overall Quality

DDI Quality

Levels
8am-6pm Weekdays; 10am3pm Saturday; Closed Sunday
9am-9pm Weekdays;
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7 days/week
Sometimes
Always
Sometimes
Always
No
Yes







<$25,000

$25,000$49,999

Income
$50,000$74,999

$75,000$99,999

≥$100,000

Utility

Utility

Utility

Utility

Utility

-21.6 (57.4)

-24.2 (43.8)

-30.7 (45.5)

-27.9 (50.8)

-27.0 (44.6)

3.5 (31.1)

5.6 (27.5)

9.9 (29.7)

2.4 (26.1)

8.8 (32.7)

18.1 (48.0)
-22.6 (22.7)
22.6 (22.7)
-14.3 (19.2)
14.3 (19.2)
-16.6 (23.2)
16.6 (23.2)
-89.8 (38.0)
11.8 (16.9)
78.0 (39.5)
-99.6 (65.2)
11.3 (19.3)
88.3 (63.4)

18.6 (39.5)
-19.7 (19.0)
19.7 (19.0)
-16.0 (21.4)
16.0 (21.4)
-19.6 (23.1)
19.6 (23.1)
-90.7 (36.6)
10.5 (14.8)
80.2 (38.8)
-113.8 (56.0)
11.6 (16.1)
102.2 (54.7)

20.8 (37.2)
-18.0 (20.5)
18.0 (20.5)
-12.8 (16.5)
12.8 (16.5)
-17.5 (25.8)
17.5 (25.8)
-92.1 (32.6)
13.5 (19.0)
78.7 (39.6)
-110.6 (59.3)
10.9 (16.3)
99.7 (56.0)

25.5 (43.6)
-20.7 (24.4)
20.7 (24.4)
-15.6 (15.5)
15.6 (15.5)
-16.6 (23.6)
16.6 (23.6)
-87.4 (40.8)
8.9 (20.5)
78.5 (40.4)
-113.3 (55.9)
13.2 (13.6)
100.1 (57.3)

18.2 (36.2)
-17.5 (15.9)
17.5 (15.9)
-14.0 (16.6)
14.0 (16.6)
-13.6 (15.9)
13.6 (15.9)
-94.3 (37.6)
10.8 (14.9)
83.5 (41.9)
-114.4 (60.5)
10.7 (15.4)
103.7 (57.5)
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Table 20. Subgroup Results, Utilities, by Education Level

Attribute

Hours of Operation

Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality

DDI Quality
a

Levels
8am-6pm Weekdays; 10am3pm Saturday; Closed Sunday
9am-9pm Weekdays;
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7 days/week
Sometimes
Always
Sometimes
Always
No
Yes a







Less Than
High School
Utility

Highest Level of Education Attained
High School
Bachelor’s
Degree
Some College
Degree
Utility
Utility
Utility

At Least Some
Post-Graduate
Utility

-2.1 (78.3)

-24.5 (46.8)

-27.1 (50.1)

-29.4 (49.7)

-25.1 (37.0)

0.2 (34.3)

9.7 (33.2)

4.3 (24.8)

6.2 (28.6)

7.9 (34.2)

1.9 (58.3)
-12.8 (21.4)
12.8 (21.4)
-26.7 (15.1)
26.7 (15.1)
-25.4 (34.6)
25.4 (34.6)
-99.3 (46.6)
16.1 (13.4)
83.2 (42.8)
-78.0 (59.3)
6.5 (18.3)
71.5 (54.2)

14.8 (43.5)
-20.2 (19.7)
20.2 (19.7)
-12.2 (17.8)
12.2 (17.8)
-19.9 (28.6)
19.9 (28.6)
-86.8 (38.3)
8.2 (18.3)
78.6 (40.4)
-104.7 (64.8)
11.6 (19.3)
93.1 (63.7)

22.7 (41.6)
-21.4 (21.6)
21.4 (21.6)
-15.0 (16.0)
15.0 (16.0)
-17.8 (22.5)
17.8 (22.5)
-91.2 (33.9)
11.9 (17.2)
79.3 (37.3)
-111.2 (57.5)
11.2 (15.4)
100.0 (55.1)

23.2 (37.6)
-18.9 (21.0)
18.9 (21.0)
-14.4 (19.4)
14.4 (19.4)
-14.2 (16.8)
14.2 (16.8)
-91.8 (36.8)
12.3 (17.1)
79.5 (41.0)
-117.3 (55.3)
12.4 (15.8)
105.0 (53.1)

17.2 (37.0)
-16.8 (18.0)
16.8 (18.0)
-15.8 (18.8)
15.8 (18.8)
-15.8 (22.4)
15.8 (22.4)
-93.4 (40.0)
10.0 (18.5)
83.4 (41.9)
-108.1 (63.7)
10.0 (13.9)
98.1 (61.7)

p < 0.05
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Table 21. Subgroup Results, Utilities, by Marital Status
Marital Status

Attribute

Hours of Operation

Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality

DDI Quality

a

Levels
8am-6pm Weekdays; 10am-3pm
Saturday; Closed Sunday
9am-9pm Weekdays;
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7 days/week
Sometimes
Always
Sometimes
Always
No
Yesa







Never Married
Utility

Married
Utility

Separated/Divorced
Widowed
Utility

-25.0 (44.1)

-28.7 (49.6)

-22.2 (45.9)

0.6 (24.8)

8.8 (31.8)

5.8 (25.5)

24.4 (41.1)

19.9 (40.3)

16.4 (39.1)

-19.0 (20.7)
19.0 (20.7)
-14.9 (17.3)
14.9 (17.3)
-13.5 (17.4)
13.5 (17.4)
-95.0 (33.7)
10.8 (14.3)
84.2 (35.3)
-117.2 (52.3)
12.9 (15.0)
104.3 (50.8)

-20.0 (21.5)
20.0 (21.5)
-14.4 (16.8)
14.4 (16.8)
-17.5 (23.1)
17.5 (23.1)
-88.7 (38.0)
11.1 (18.4)
77.6 (41.4)
-108.7 (62.4)
10.5 (16.2)
98.2 (59.9)

-18.3 (15.4)
18.3 (15.4)
-14.5 (23.4)
14.5 (23.4)
-19.1 (26.4)
19.1 (26.4)
-92.8 (37.8)
10.6 (19.1)
82.3 (40.2)
-109.4 (58.6)
13.3 (17.1)
96.1 (58.8)

p < 0.05
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Table 22. Subgroup Results, Utilities, by Census Region of Residence
US Census Region of Residence
Attribute

Hours of Operation

Levels
8am-6pm Weekdays; 10am3pm Saturday; Closed Sunday
9am-9pm Weekdays;
9am-7pm Saturday;
10am-6pm Sundayb
8am-10pm 7 days/week

Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality

DDI Quality

a

Sometimes
Always
Sometimes
Alwaysa
No
Yes







Northeast

Midwest

South

West

Utility

Utility

Utility

Utility

-27.2 (42.6)

-29.5 (54.5)

-24.2 (45.2)

-27.9 (52.7)

9.9 (32.0)

8.2 (28.1)

4.3 (28.6)

1.7 (28.3)

17.3 (39.5)

21.2 (44.4)

19.9 (35.7)

26.3 (46.0)

-20.2 (22.7)
20.2 (22.7)
-12.4 (17.3)
12.4 (17.3)
-18.8 (22.9)
18.8 (22.9)
-90.9 (37.9)
12.3 (17.5)
78.6 (40.7)
-110.4 (57.1)
11.4 (15.9)
99.1 (56.1)

-19.1 (20.6)
19.1 (20.6)
-14.6 (18.6)
14.6 (18.6)
-16.0 (21.2)
16.0 (21.2)
-92.7 (35.3)
10.2 (16.3)
82.6 (38.0)
-109.3 (59.9)
11.1 (16.9)
98.2 (58.5)

-19.0 (17.9)
19.0 (17.9)
-15.4 (18.3)
15.4 (18.3)
-15.1 (21.1)
15.1 (21.1)
-92.1 (35.6)
11.0 (17.3)
81.1 (38.0)
-113.9 (60.2)
11.5 (15.1)
102.4 (57.2)

-18.6 (18.9)
18.6 (18.9)
-17.6 (17.0)
17.6 (17.0)
-19.0 (28.1)
19.0 (28.1)
-83.7 (42.8)
9.5 (21.4)
74.2 (47.6)
-104.6 (66.6)
11.5 (18.3)
93.1 (63.4)

p < 0.05; b p < 0.01
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Table 23. Subgroup Results, Utilities, by Health Literacy and Pharmacist Relationship
Health Literacy

Attribute

Levels
8am-6pm Weekdays; 10am3pm Saturday; Closed Sunday
9am-9pm Weekdays;
Hours of Operation
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7 days/week
Friendliness/Courtesy Sometimes
Always
Communication
Sometimes
Always
Pharmacist Knows Me No
Yes

Overall Quality



DDI Quality


a
b
p < 0.05; p < 0.01

Pharmacist Relationship
I Don’t Know My
I Know My
Pharmacist’s
Pharmacist’s
Name/Unsure/No
Name
Regular Pharmacist
Utility
Utility

Adequate
Health Literacy
Utility

Inadequate
Health Literacy
Utility

-26.5 (47.9)

-31.4 (46.8)

-25.8 (46.1)

-27.2 (48.7)

6.4 (29.5)

9.0 (30.8)

5.7 (29.0)

7.0 (29.8)

20.1 (40.6)
-19.5 (20.4)
19.5 (20.4)
-14.5 (17.7)
14.5 (17.7)
-16.3 (21.0)b
16.3 (21.0)b
-91.3 (36.7)
11.1 (17.5)
80.2 (39.4)
-111.1 (59.8)
11.2 (15.8)
99.9 (57.7)

22.4 (36.5)
-18.6 (21.3)
18.6 (21.3)
-14.8 (22.0)
14.8 (22.0)
-26.0 (38.5)b
26.0 (38.5)b
-84.8 (43.4)
9.2 (18.5)
75.6 (48.3)
-103.1 (61.6)
13.6 (20.6)
89.5 (60.4)

20.1 (38.1)
-22.0 (20.9)a
22.0 (20.9)a

20.2 (41.5)
-18.1 (20.1)a
18.1 (20.1)a

-16.7 (20.0)
16.7 (20.0)
-18.5 (23.4)b
18.5 (23.4)b
-90.9 (36.1)
11.1 (18.9)
79.6 (37.8)
-107.4 (57.2)
10.8 (16.6)
96.6 (56.6)

-13.4 (16.7)
13.4 (16.7)
-15.9 (22.0)b
15.9 (22.0)b
-90.9 (37.7)
10.8 (16.9)
80.2 (41.1)
-112.5 (61.2)
11.7 (15.8)
100.8 (58.4)
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Table 24. Subgroup Results, Utilities, by Self-Perceived Health Status

Attribute

Levels
8am-6pm Weekdays;
10am-3pm Saturday;
Closed Sunday
9am-9pm Weekdays;
Hours of Operation
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7 days/week
Friendliness/Courtesy Sometimes
Always
Communication
Sometimes
Always
Pharmacist Knows Me No
Yes

Overall Quality



DDI Quality

a
a
p < 0.05

Excellent
Utility

Self-Perceived Health Status
Very Good
Good
Fair
Utility
Utility
Utility

Poor
Utility

-22.5 (43.0)

-26.5 (47.5)

-28.0 (46.1)

-28.9 (59.4)

-33.6 (47.4)

4.9 (27.5)

4.7 (28.2)

9.7 (32.4)

5.5 (26.7)

11.8 (36.8)

17.6 (34.7)
-20.0 (19.3)
20.0 (19.3)
-15.4 (18.3)
15.4 (18.3)
-18.4 (23.1)
18.4 (23.1)
-87.2 (37.5)
11.4 (17.3)
75.9 (41.7)
-113.3 (61.2)
10.7 (15.4)
102.5 (60.8)

21.8 (39.1)
-18.3 (19.5)
18.3 (19.5)
-14.7 (18.4)
14.7 (18.4)
-13.6 (17.7)
13.6 (17.7)
-94.2 (34.6)
10.6 (18.7)
83.5 (37.8)
-117.6 (55.3)
11.0 (16.2)
106.7 (51.4)

18.2 (41.7)
-21.2 (22.1)
21.2 (22.1)
-14.6 (17.9)
14.6 (17.9)
-19.9 (25.0)
19.9 (25.0)
-88.9 (39.4)
11.2 (17.3)
77.7 (41.4)
-103.9 (64.0)
11.7 (15.6)
92.2 (62.0)

23.5 (48.0)
-18.5 (20.6)
18.5 (20.6)
-13.2 (16.8)
13.2 (16.8)
-16.8 (22.4)
16.8 (22.4)
-91.5 (38.7)
9.8 (14.4)
81.7 (39.0)
-102.2 (61.0)
11.7 (13.9)
90.5 (60.9)

21.8 (39.6)
-17.4 (21.1)
17.4 (21.1)
-11.3 (15.7)
11.3 (15.7)
-20.0 (41.5)
20.0 (41.5)
-87.1 (34.7)
15.9 (20.1)
71.2 (44.7)
-109.2 (53.7)
16.5 (29.3)
92.7 (54.8)
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Table 25. Subgroup Results, Utilities, by Number of Chronic Medications, Self
Number of Chronic Medications, Self
Attribute

Hours of Operation

Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality

DDI Quality

Levels
8am-6pm Weekdays;
10am-3pm Saturday;
Closed Sunday
9am-9pm Weekdays;
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7 days/week
Sometimes
Always
Sometimes
Always
No
Yes







Zero

1-3

4-7

8-11

≥11

Utility

Utility

Utility

Utility

Utility

-21.6 (53.3)

-26.5 (46.1)

-32.3 (49.2)

-23.9 (54.4)

-21.7 (24.3)

3.7 (31.8)

6.2 (28.7)

11.9 (31.9)

2.2 (22.9)

-5.2 (15.7)

18.0 (41.2)
-20.7 (25.9)
20.7 (25.9)
-12.5 (18.9)
12.5 (18.9)
-14.6 (18.6)
14.6 (18.6)
-87.4 (41.6)
9.2 (21.2)
78.0 (44.6)
-107.0 (65.5)
7.8 (17.7)
99.2 (60.1)

20.3 (39.3)
-18.7 (18.8)
18.7 (18.8)
-14.6 (18.0)
14.6 (18.0)
-16.7 (21.9)
16.7 (21.9)
-91.3 (36.6)
11.6 (17.8)
79.7 (40.4)
-113.9 (56.9)
12.2 (15.5)
101.7 (55.3)

20.4 (42.9)
-20.3 (21.7)
20.3 (21.7)
-16.5 (18.9)
16.5 (18.9)
-19.8 (26.3)
19.8 (26.3)
-91.1 (36.7)
10.6 (14.9)
80.5 (36.4)
-101.5 (63.2)
10.9 (17.8)
90.6 (62.4)

21.7 (46.8)
-20.9 (16.3)
20.9 (16.3)
-13.0 (10.3)
13.0 (10.3)
-18.0 (25.7)
18.0 (25.7)
-93.4 (34.1)
10.4 (17.8)
83.0 (39.0)
-109.5 (72.7)
13.1 (8.1)
96.4 (71.6)

26.8 (27.2)
-21.9 (18.3)
21.9 (18.3)
-13.9 (11.7)
13.9 (11.7)
-6.6 (13.8)
6.6 (13.8)
-99.3 (29.5)
9.2 (8.9)
90.0 (29.4)
-133.7 (22.8)
13.6 (11.9)
120.1 (24.9)
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Table 26. Subgroup Results, Utilities, by Number of Chronic Medications, Care Recipient

Attribute

Hours of Operation

Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality

DDI Quality

a

Levels
8am-6pm Weekdays;
10am-3pm Saturday;
Closed Sunday
9am-9pm Weekdays;
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7
days/week a
Sometimes
Always
Sometimes
Always
No
Yes

Zero
Utility

Number of Chronic Medications, Care Recipient
1-3
4-7
8-11
Utility
Utility
Utility

≥11
Utility

-32.3 (52.2)

-23.1 (41.4)

-26.4 (44.9)

-20.5 (41.7)

-12.8 (60.4)

6.8 (30.8)

5.7 (28.4)

11.1 (30.4)

1.9 (21.3)

-0.47 (27.4)

25.5 (43.4)

17.4 (35.5)

15.2 (38.6)

18.6 (38.7)

13.3 (49.4)

-18.6 (21.2)
18.6 (21.2)
-14.1 (16.1)
14.1 (16.1)
-15.8 (20.6)
15.8 (20.6)

-20.5 (19.5)
20.5 (19.5)
-14.2 (18.9)
14.2 (18.9)
-18.3 (25.7)
18.3 (25.7)

-19.8 (20.8)
19.8 (20.8)
-15.4 (17.7)
15.4 (17.7)
-17.1 (20.0)
17.1 (20.0)

-18.9 (23.0)
18.9 (23.0)
-18.1 (22.1)
18.1 (22.1)
-15.2 (19.3)
15.2 (19.3)

-19.1 (20.6)
19.1 (20.6)
-17.2 (23.7)
17.2 (23.7)
-14.4 (20.1)
14.4 (20.1)



-87.7 (39.1)

-93.2 (34.4)

-94.7 (36.1)

-95.4 (38.9)

-87.3 (41.3)







10.5 (17.4)
77.2 (41.3)
-115.4 (55.4)
11.1 (15.5)
104.3 (52.5)

11.5 (19.5)
81.7 (39.1)
-107.9 (62.7)
12.4 (17.3)
95.4 (61.1)

10.1 (13.9)
84.6 (36.1)
-107.4 (61.3)
9.2 (14.7)
98.3 (59.7)

15.0 (17.9)
80.3 (44.1)
-114.1 (58.8)
11.8 (9.8)
102.3 (57.6)

9.7 (13.3)
77.6 (42.3)
-100.1 (67.9)
11.1 (18.4)
89.0 (67.3)

p < 0.05
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Table 27. Subgroup Results, Utilities, by Pharmacy Patronage
Pharmacy Patronage

Attribute

Hours of Operation

Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality

DDI Quality

Levels
8am-6pm Weekdays;
10am-3pm Saturday;
Closed Sunday
9am-9pm Weekdays;
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7
days/weeka
Sometimes
Always
Sometimes
Always
No
Yes

 a


 a


a

Chain
Utility

Independent
Utility

Grocery
Utility

Mass
Merchandiser
Utility

-31.4 (53.0)

-19.1 (39.0)

-25.1 (45.0)

-21.5 (42.3)

-21.4 (32.8)

7.3 (30.0)

6.4 (31.0)

3.3 (25.1)

7.7 (32.9)

4.4 (23.6)

24.1 (42.5)

12.6 (34.8)

21.8 (38.6)

13.8 (39.3)

17.0 (34.7)

-20.0 (22.2)
20.0 (22.2)
-13.6 (15.3)
13.6 (15.3)
-15.5 (22.3)
15.5 (22.3)
-89.2 (39.8)
10.8 (16.4)
78.3 (42.9)
-113.8 (52.8)
9.9 (15.9)
104.0 (48.8)

-16.4 (23.1)
16.4 (23.1)
-15.7 (20.6)
15.7 (20.6)
-19.3 (25.0)
19.3 (25.0)
-98.5 (31.9)
17.0 (22.5)
81.6 (39.5)
-100.2 (62.6)
11.7 (17.2)
88.5 (60.6)

-18.3 (16.7)
18.3 (16.7)
-13.9 (16.1)
13.9 (16.1)
-17.7 (20.7)
17.7 (20.7)
-91.3 (32.8)
9.5 (12.6)
81.8 (32.9)
-118.1 (59.7)
15.0 (16.0)
103.1 (63.3)

-21.1 (17.8)
21.1 (17.8)
-17.2 (23.7)
17.2 (23.7)
-18.4 (21.8)
18.4 (21.8)
-89.7 (36.2)
10.3 (20.0)
79.4 (40.8)
-103.8 (69.2)
13.4 (17.4)
90.5 (67.0)

-17.5 (14.0)
17.5 (14.0)
-15.8 (15.5)
15.8 (15.5)
-18.2 (25.8)
18.2 (25.8)
-96.6 (28.4)
9.3 (13.4)
87.3 (25.3)
-114.1 (64.9)
9.8 (8.8)
104.3 (64.0)

Mail Order
Utility

p < 0.01
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Table 28. Subgroup Results, Utilities, by Level of Health Confidence

Attribute

Hours of Operation

Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality

DDI Quality

Levels
8am-6pm Weekdays; 10am-3pm
Saturday; Closed Sunday
9am-9pm Weekdays;
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7 days/week
Sometimes
Always
Sometimes
Always
No
Yes







Health Confidence
Low Health Confidence High Health Confidence
Utility
Utility
-24.8 (50.4)

-27.1 (47.3)

7.0 (28.7)

6.5 (29.7)

17.9 (41.7)
-18.5 (21.5)
18.5 (21.5)
-13.8 (18.9)
13.8 (18.9)
-17.7 (30.9)
17.7 (30.9)
-88.8 (42.1)
12.6 (23.7)
76.2 (46.4)
-101.8 (65.3)
11.2 (20.9)
90.6 (58.8)

20.6 (40.0)
-19.7 (20.3)
19.7 (20.3)
-14.7 (17.8)
14.7 (17.8)
-16.6 (20.7)
16.6 (20.7)
-91.3 (36.2)
10.6 (16.3)
80.7 (38.7)
-112.3 (58.7)
11.4 (15.1)
100.9 (57.5)
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Table 29. Subgroup Results, Attribute Importance Values, by Sex
Sex
Attribute
Hours of Operation
Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality
DDI Quality

Male
Mean (SD)
14.1 (12.7)
7.3 (5.4)
5.4 (4.3)
6.1 (6.0)
29.2 (9.6)
38.0 (12.6)

Female
Mean (SD)
13.1 (11.9)
6.9 (5.2)
5.3 (5.2)
6.1 (6.5)
30.6 (9.6)
38.1 (13.7)

Table 30. Subgroup Results, Attribute Importance Values, by Urbanicity

Attribute
Hours of Operation
Friendliness/Courtesy
Communication
Pharmacist Knows Meb
Overall Quality
DDI Qualitya
a
b
p < 0.05; p < 0.01

Urban
Mean (SD)
14.0 (12.0)
7.0 (5.0)
5.8 (4.7)
6.6 (6.8)
29.6 (10.0)
37.0 (13.7)

Urbanicity
Suburban
Small Town
Mean (SD)
Mean (SD)
13.2 (12.5)
14.0 (12.8)
6.7 (4.9)
7.8 (5.9)
4.9 (4.8)
6.1 (4.5)
5.3 (5.6)
6.8 (6.1)
30.4 (9.6)
29.4 (9.8)
39.5 (12.2)
35.9 (13.1)

Rural
Mean (SD)
13.4 (11.7)
7.8 (6.4)
5.3 (5.0)
7.1 (7.1)
29.7 (9.0)
36.6 (14.7)
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Table 31. Subgroup Results, Attribute Importance Values, by Age

Attribute
Hours of Operation
Friendliness/Courtesy
Communication
Pharmacist Knows Meb
Overall Quality
DDI Qualitya
a

Age 18-34
Mean (SD)
14.5 (13.8)
7.8 (7.0)
5.4 (4.5)
5.9 (5.6)
29.5 (10.4)
36.9 (13.7)

Age 35-54
Mean (SD)
13.7 (11.6)
7.1 (4.8)
5.6 (5.3)
6.0 (5.8)
29.3 (9.7)
38.3 (13.1)

Age
Age 55-64
Mean (SD)
12.4 (8.8)
6.7 (5.0)
5.1 (5.8)
6.0 (6.4)
31.7 (8.5)
38.0 (13.3)

Age 65-74
Mean (SD)
12.8 (12.5)
6.6 (4.3)
4.9 (3.2)
6.5 (7.3)
30.4 (9.6)
38.8 (12.3)

Age ≥75
Mean (SD)
14.7 (14.4)
6.9 (4.3)
5.6 (5.3)
6.1 (6.1)
28.8 (9.3)
37.9 (14.0)

p < 0.05; b p < 0.01

Table 32. Subgroup Results, Attribute Importance Values, by Race
Race
White, NonHispanic

Black, NonHispanic

Hispanic

Other

Attribute
Hours of Operation
Friendliness/Courtesy

Mean (SD)
13.7 (12.4)
7.0 (5.1)

Mean (SD)
14.3 (14.7)
6.8 (5.9)

Mean (SD)
11.4 (11.0)
8.7 (8.5)

Mean (SD)
13.1 (8.5)
7.5 (5.0)

Communicationa
Pharmacist Knows Me

5.1 (4.6)
6.0 (6.3)

5.6 (5.0)
5.2 (5.4)

6.0 (5.0)
6.0 (3.6)

7.6 (6.9)
7.7 (7.7)

30.1 (9.5)
38.1 (13.3)

29.0 (10.1)
39.0 (12.9)

30.4 (10.1)
37.6 (13.9)

29.4 (10.6)
34.7 (11.7)

Overall Quality
DDI Quality
a
p < 0.05
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Table 33. Subgroup Results, Attribute Importance Values, by Household Income

Attribute
Hours of Operation
Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality
DDI Quality

≤25,000
Mean (SD)
15.4 (13.2)
7.7 (6.4)
5.8 (4.5)
6.2 (6.3)
29.3 (10.2)
35.6 (13.6)

Annual Household Income
$25,001$50,001$100,001$50,000
$100,000
$150,000
Mean (SD)
Mean (SD)
Mean (SD)
12.9 (11.2)
13.6 (12.0)
13.8 (13.3)
6.8 (5.3)
7.1 (4.7)
7.7 (6.6)
5.6 (6.2)
5.0 (4.0)
5.2 (4.4)
6.5 (6.8)
6.7 (7.0)
6.1 (6.6)
30.0 (8.8)
30.0 (9.3)
29.0 (11.0)
38.2 (13.7)
37.6 (13.4)
38.2 (13.2)

>$150,000
Mean (SD)
12.8 (12.0)
6.4 (3.7)
5.1 (4.3)
4.9 (4.3)
31.2 (9.3)
39.6 (11.9)

Table 34. Subgroup Results, Attribute Importance Values, by Education Level

Attribute
Hours of Operation
Friendliness/Courtesy
Communication
Pharmacist Knows Mea
Overall Quality
DDI Quality
a
p < 0.05

Less Than
High School
Mean (SD)
19.4 (14.0)
6.8 (3.0)
8.2 (4.6)
7.9 (10.9)
31.1 (12.8)
26.6 (16.6)

Highest Level of Education Attained
High School
Bachelor’s
Degree
Some College
Degree
Mean (SD)
Mean (SD)
Mean (SD)
14.2 (11.9)
13.7 (12.6)
13.2 (12.9)
7.1 (5.1)
7.4 (6.1)
7.1 (5.4)
5.2 (4.1)
5.2 (4.4)
5.3 (5.4)
7.1 (8.2)
6.5 (6.1)
5.1 (4.6)
29.3 (9.3)
29.6 (9.6)
30.1 (9.6)
37.2 (13.5)
37.7 (13.1)
39.2 (12.9)

At Least Some
Post-Graduate
Mean (SD)
12.7 (10.7)
6.6 (3.8)
5.6 (5.2)
5.9 (6.2)
31.1 (9.8)
38.1 (13.0)

128

Table 35. Subgroup Results, Attribute Importance Values, by Marital Status

Marital Status

Attribute

Never Married
Mean (SD)

Married
Mean (SD)

Separated/Divorced/
Widowed
Mean (SD)

Hours of Operation
Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality
DDI Quality

13.2 (11.4)
6.8 (5.5)
5.3 (4.6)
5.1 (4.5)
30.7 (9.5)
38.9 (12.5)

13.8 (13.0)
7.4 (5.5)
5.3 (4.4)
6.3 (6.5)
29.5 (9.6)
37.8 (13.5)

13.3 (10.5)
6.2 (4.2)
5.7 (6.5)
6.7 (7.6)
30.6 (9.6)
37.5 (12.7)

Table 36. Subgroup Results, Attribute Importance Values, by US Census Region of Residence

Attribute
Hours of Operation
Friendliness/Courtesy
Communication
Pharmacist Knows Me

Northeast
Mean (SD)
13.7 (11.3)
7.4 (6.0)
5.0 (4.3)
6.5 (6.6)

US Census Region of Residence
Midwest
South
Mean (SD)
Mean (SD)
14.2 (14.0)
12.7 (11.1)
6.9 (5.4)
6.8 (4.4)
5.4 (4.9)
5.3 (5.2)
5.6 (6.1)
5.8 (5.5)

West
Mean (SD)
14.1 (14.2)
6.9 (4.6)
5.9 (4.7)
7.2 (7.9)

Overall Quality
DDI Quality

29.7 (10.2)
37.8 (12.5)

30.3 (9.6)
37.5 (13.8)

28.9 (10.1)
36.9 (14.5)

30.4 (8.9)
39.0 (12.9)
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Table 37. Subgroup Results, Attribute Importance Values, by Health Literacy and Pharmacist Relationship
Health Literacy

Attribute
Hours of Operation
Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality
DDI Quality
b
p < 0.01

Adequate
Mean (SD)
13.5 (12.3)b
7.1 (5.3)
5.2 (4.8)
5.9 (5.7)
30.0 (9.6)
38.2 (12.9)

Inadequate
Mean (SD)
14.1 (12.0)b
6.9 (5.5)
6.5 (5.0)
8.7 (11.6)
29.2 (10.1)
34.6 (16.4)

Pharmacist Relationship
I Don’t Know My
I Know My
Pharmacist’s
Pharmacist’s
Name/Unsure/No Regular
Name
Pharmacist
Mean (SD)
Mean (SD)
13.6 (11.2)
13.5 (12.8)
7.7 (5.6)
6.8 (5.2)
5.8 (5.7)
5.1 (4.2)
6.7 (6.4)
5.7 (6.2)
29.8 (9.8)
30.1 (9.5)
36.4 (13.9)
38.9 (12.7)b

Table 38. Subgroup Results, Attribute Importance Values, by Self-Perceived Health Status

Attribute
Hours of Operation
Friendliness/Courtesy
Communication
Pharmacist Knows Meb
Overall Quality
DDI Qualitya
a
b
p < 0.05; p < 0.01

Self-Perceived Health Status
Excellent
Very Good
Good
Fair
Poor
Mean (SD)
Mean (SD)
Mean (SD)
Mean (SD)
Mean (SD)
Health
Literacy
Pharmacist
Relationship
12.8 (9.9)
12.6 (12.8)
13.8 (12.4)
16.5 (13.2)
16.5 (11.0)
7.2 (4.9)
6.7 (5.0)
7.6 (5.9)
6.7 (5.5)
6.8 (4.8)
5.3 (5.2)
5.3 (5.1)
5.5 (4.6)
5.2 (4.1)
4.8 (3.3)
6.5 (6.4)
5.0 (4.8)
7.0 (7.1)
6.4 (5.9)
7.7 (11.7)
29.0 (9.7)
30.8 (9.3)
29.6 (9.8)
30.0 (10.0)
28.4 (9.5)
39.2 (12.7)
39.5 (12.7)
36.6 (13.4)
35.3 (14.0)
35.7 (15.0)
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Table 39. Subgroup Results, Attribute Importance Values, by Number of Chronic Medications, Self

Attribute
Hours of Operation
Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality
DDI Quality

None
Mean (SD)
14.0 (12.6)
7.7 (6.8)
5.3 (4.4)
5.5 (4.8)
29.4 (10.3)
38.0 (13.2)

Number of Chronic Medications, Self
1-3
4-7
8-11
Mean (SD)
Mean (SD)
Mean (SD)
13.1 (12.0)
14.7 (13.0)
13.0 (14.4)
6.8 (4.8)
7.4 (5.7)
6.9 (4.8)
5.3 (5.0)
5.8 (5.0)
4.3 (2.9)
6.1 (6.0)
6.9 (7.6)
5.8 (8.2)
30.2 (9.2)
29.6 (10.2)
30.4 (9.6)
38.5 (12.9)
35.6 (14.2)
39.6 (13.2)

≥11
Mean (SD)
11.0 (6.1)
7.0 (5.5)
4.3 (3.6)
3.6 (3.0)
31.6 (9.3)
42.4 (7.1)

Table 40. Subgroup Results, Attribute Importance Values, by Number of Chronic Medications, Care Recipient(s)

Attribute
Hours of Operation
Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality
DDI Quality

None
Mean (SD)
14.3 (14.1)
6.9 (5.6)
5.2 (4.1)
5.7 (5.7)
29.2 (9.8)
38.8 (13.0)

Number of Chronic Medications, Care Recipient(s)
1-3
4-7
8-11
Mean (SD)
Mean (SD)
Mean (SD)
12.7 (10.1)
13.3 (11.7)
10.7 (11.4)
7.3 (5.0)
7.0 (5.6)
7.6 (5.5)
5.2 (5.3)
5.7 (4.4)
6.1 (6.2)
6.6 (7.3)
5.9 (5.8)
6.1 (4.6)
30.6 (9.1)
30.6 (10.2)
31.1 (10.8)
37.6 (13.3)
37.4 (13.2)
38.4 (14.2)

≥11
Mean (SD)
15.4 (13.0)
7.3 (4.8)
6.3 (6.5)
5.7 (5.1)
29.2 (9.8)
36.1 (14.0)
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Table 41. Subgroup Results, Attribute Importance Values, by Pharmacy Patronage
Pharmacy Patronage

Attribute
Hours of Operation
Friendliness/Courtesy
Communicationb
Pharmacist Knows Me
Overall Quality
DDI Quality
b
p < 0.01

Chain
Mean (SD)
14.6 (13.6)
7.2 (6.0)
4.9 (4.0)
5.8 (6.2)
29.6 (10.4)
38.0 (12.9)

Independent
Mean (SD)
12.7 (9.1)
7.1 (5.2)
6.1 (5.2)
7.3 (6.5)
31.6 (8.5)
35.2 (13.7)

Grocery
Mean (SD)
12.5 (11.9)
6.4 (4.3)
4.8 (4.5)
6.2 (5.8)
29.8 (8.4)
40.3 (12.5)

Mass
Merchandiser
Mean (SD)
12.8 (11.1)
7.4 (4.5)
6.5 (6.4)
6.3 (6.2)
29.8 (9.3)
37.2 (14.3)

Mail Order
Mean (SD)
11.4 (8.8)
6.2 (3.3)
4.9 (4.7)
6.2 (7.7)
31.2 (8.3)
40.0 (12.5)

Table 42. Subgroup Results, Attribute Importance Values, by Health Confidence
Health Confidence
Attribute
Hours of Operation

Low Health Confidence
Mean (SD)
14.4 (11.9)

High Health Confidence
Mean (SD)
13.4 (12.3)

Friendliness/Courtesy
Communication

7.0 (5.4)
5.4 (4.7)

7.1 (5.3)
5.3 (4.8)

Pharmacist Knows Mea
Overall Quality

7.3 (8.2)
30.0 (9.9)

5.9 (5.8)
30.0 (9.6)

DDI Quality
a
p < 0.05

35.9 (13.5)

38.4 (13.1)
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4.4. Segmentation Analysis Results
The Consistent Aikaike Information Criterion (CAIC) values were compared
between latent class solutions with two to five groups. The CAIC was lower for the threeclass solution (5698.589) than for the solutions with two (5706.163), four (5741.502), and
five solutions (5806.839). All of these CAIC values were lower than that of the CL analysis
(6362.10), suggesting that respondent preferences for community pharmacy attributes
were indeed heterogeneous. The three-class solution, selected based on its CAIC value,
converged after 39 iterations. Furthermore, the average maximum membership probability
of the three-class solution was 0.9445, similar to that of the two class (0.9460), and higher
than that of the four (0.8092) and five (0.7596) class solutions.
The utility values for each of the three identified classes are presented in Table 40.
Based on the revealed preferences of the respondents in each class, the three classes were
termed the “Quality Class,” the “Relationship Class,” and the “Convenience Class.” The
probability of respondents belonging to the Quality Class was highest (67.6%), followed by
the Relationship Class (28.3%), and the Convenience Class (4.2%). The attribute
importance values (AIV)and relative importance of each attribute within each class are
presented in Table 41 and Figures 4-5.
The Quality Class was defined primarily by strong expressed preferences for the DDI
(utility: 129.9, AIV: 45.5) and the overall (mean utility: 95.0, mean AIV: 33.3) quality
measures. Differences in these two attributes combined could therefore account for nearly
80% of the difference in the utility of two pharmacy alternatives. The mean AIV of hours of
operation, the third most strongly preferred attribute among members of the Quality Class),
was only 7.9. In the Relationship Class, the quality measures were still the most strongly
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preferred attributes, with AIVs of 24.7 for overall quality and 22.6 for DDI-specific quality.
Notably, although these quality attributes were the most important attributes relative to
the other attributes, they accounted for only 48% of the difference in the utility of two
pharmacy alternatives, compared to the 78% seen in the Quality Class. The AIVs for
friendliness/courtesy, communication, and pharmacist effort to get to know their patients
(10.8, 9.0, and 11.5, respectively) were two to three times as high as those seen in the
Convenience and Quality Classes. Finally, the smallest class, the convenience class, was
distinct in its high utility ascribed to the pharmacy hours of operation, for which the AIV
exceeded 50% (50.3). In that class, the quality metrics accounted for only a third of utility
differences (33.7).
Significant differences in utility values were seen between at least two of the groups
for all six attributes. The utilities of pharmacist effort to get to know their patients and
friendliness/courtesy were significantly higher in the Relationship Class than the other two
segments. The Quality Class significantly differed from the other two class in having a
lower utility associated with pharmacist communication and higher utilities ascribed to
five star ratings on either quality metric. Finally, the differences in the utility values for the
most extended pharmacy hours were significant in the pairwise comparisons between the
Convenience Class and the other two classes.
Though the four-class solution was not selected due to its higher CAIC and lower
maximum membership probability compared to the three-class solution, the difference
between the solutions is of interest. The four-class solution resulted in similar probabilities
of membership in a Relationship Class (26.4%), Service Class (3.9%), or Quality-Focused
Class (69.7%); the difference between the three and four group solutions was that the
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Quality Class seen in the three-class solution was separated in the four-class solution into a
Drug-Drug Interaction (DDI) -Specific Quality Class (37.0%) and an Overall Quality Class
(32.7%). In the Drug-Drug Interaction (DDI) -Specific Quality Class, the attribute
importance value for the DDI quality measure was much higher (53.9) than that for the
Overall quality measure (16.0). The strength of these preferences was reversed (26.7 vs.
51.0) in the Overall Quality Class. While this was a weaker class solution than that with
three classes, it still suggests that underlying preference heterogeneity may exist within the
Quality Class.
Among the demographic and health characteristics gathered, only knowing one’s
pharmacist’s name was significantly associated with class membership (Table 42), with
those assigned to the Relationship Class were more likely to know their pharmacist’s name
(42.9) than those in the Convenience (29.0) or Quality (32.67) Classes (p = 0.026). The
ability to detect additional, significant demographic differences between segments was
likely limited by the small size of the Convenience Class. Though not significant, members
of the Relationship Class tended to be more urban (31.58% vs. 25.8% and 22.0% in the
Convenience and Quality Classes, respectively) (p = 0.051) and less confident in their
ability to manage their health conditions (prevalence of low health confidence: 20% vs.
12.9% and 13.4%) (p = 0.074) than those in other segments. Additionally, women
comprised 59.0% of those in the Quality Class but only 48.4% and 49.8% in the
Convenience and Relationship Classes, respectively (p = 0.054).
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Table 43. Main Latent Class Analysis Results, Utilities, by Segment
Rescaled Utilities (Standard Error)
Segment 1
Segment 2
Segment 3
Attribute

Hours of Operation

Friendliness/Courtesy
Communication
Pharmacist Knows Me
Overall Quality

DDI Quality

Levels
8am-6pm Weekdays; 10am-3pm
Saturday; Closed Sunday
9am-9pm Weekdays;
9am-7pm Saturday;
10am-6pm Sunday
8am-10pm 7 days/week
Sometimes
Always
Sometimes
Always
No
Yes


Relationship Class

Convenience Class

Quality Class

-47.75 (10.68)

-206.85 (40.99)

-15.65 (4.15)

43.25 (10.69)

34.79 (11.63)

-2.42 (4.31)

4.50 (10.74)
-39.27(6.58)
39.27 (6.58)
-35.85 (6.56)
35.85 (6.56)
-49.14 (6.57)
49.14 (6.57)
-101.36 (14.48)

172.06 (36.14)
0.40 (8.07)
-0.40 (8.07)
-11.60 (7.34)
11.60 (7.34)
-13.71 (6.91)
13.71 (6.91)
-54.50 (24.21)

18.06 (4.15)
-15.18 (2.49)
15.18 (2.49)
-11.09 (2.70)
11.09 (2.70)
-11.63 (2.53)
11.63 (2.53)
-113.00 (5.83)



20.37 (10.74)

-14.70 (13.30)

17.37 (4.80)






80.99 (14.53)
-41.69 (14.34)
5.24 (11.04)
36.44 (14.14)

69.20 (28.82)
-19.04 (16.05)
-7.90 (12.07)
26.94 (16.84)

95.63 (4.69)
-150.93 (5.13)
20.00 (4.81)
130.93 (5.13)
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Table 44. Latent Class Analysis Results, Attribute Importance Values, by Segment

Segment 1

Segment 2

Segment 3

Relationship Class

Convenience Class

Quality Class

Attribute

Rank

Mean

Rank

Mean

Rank

Mean

Hours of Operation

2

15.17

1

63.15

3

5.62

Friendliness/Courtesy

4

13.09

6

0.13

4

5.06

Communication

6

11.95

5

3.87

6

3.70

Pharmacist Knows Me

3

16.38

4

4.57

5

3.88

Overall Quality

1

30.39

2

20.62

2

34.77

DDI Quality

5

13.02

3

7.66

1

46.98

Figure 4. Latent Class Analysis Results, Attribute Importance Scores, by Segment
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Figure 5. Latent Class Analysis Results, Attribute Importance Scores, by Segment
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Table 45. Sociodemographic and Health Characteristics, by Segment

Size
Sociodemographic and Health Characteristics
Male Sex
Age
18-34 years
35-44 years
45-54 years
55-64 years
≥ 65 years
Race
Non-Hispanic, White
Non-Hispanic, Black
Hispanic
Other
Household Annual Income
<$25,000
$25,000-$49,999
$50,000-$74,999
$75,000-$99,999
≥$100,0009
Highest Level of Education
Less Than High School/GED
High School Degree
At Least Some College
Bachelor’s Degree
At Least Some Graduate School

Number (%), by Segment
Relationship
Convenience
Class
Class
Quality Class
210 (28.3)
31 (4.2)
500 (67.5)
104 (50.2)

16 (51.6)

205 (41.2)

48 (23.1)
52 (25.0)
41 (19.7)
44 (21.2)
23 (11.1)

10 (32.3)
4 (12.9)
2 (6.5)
9 (29.0)
6 (19.4)

119 (23.9)
108 (21.7)
94 (18.9)
116 (23.3)
61 (12.3)

166 (80.2)
14 (6.8)
11 (5.3)
16 (7.7)

27 (87.1)
3 (9.7)
1 (3.2)
0 (0)

415 (84.0)
37 (7.5)
22 (4.5)
20 (4.1)

39 (18.9)
43 (20.9)
49(23.8)
36 (17.5)
39 (18.9)

4 (12.9)
6 (19.4)
7 (22.6)
9 (29.0)
6 (16.1)

55 (11.0)
127 (25.5)
114 (22.9)
87 (17.5)
115 (23.1)

4 (1.9)
47 (22.6)
69 (33.2)
50 (24.0)
38 (18.3)

1 (3.2)
5 (16.1)
13 (41.9)
8 (25.8)
4 (12.9)

4 (0.8)
88 (17.7)
156 (31.5)
161 (32.5)
87 (17.5)

38 (18.3)
135 (64.9)
35 (16.8)

6 (19.4)
23 (74.2)
2 (6.5)

117 (23.7)
305 (61.7)
72 (14.6)

Marital Status
Never Married
Married
Separated/Divorced/Widowed
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Table 45. Sociodemographic and Health Characteristics, by Segment, continued
Number (%), by Segment
Relationship
Convenience
Class
Class
Quality Class
US Census Region of Residence
Northeast
Midwest
South
West
Urbanicity
Urban
Suburban
Small Town
Rural
Health Literacy
Adequate

66 (31.7)
48 (23.1)
66 (31.7)
28 (13.5)

7 (22.6)
11 (35.5)
8 (25.8)
5 (16.1)

144 (29.0)
127 (25.6)
176 (35.4)
50 (10.1)

66 (31.6)
79 (37.8)
26 (12.4)
38 (18.2)

8 (25.8)
14 (45.2)
4 (12.9)
5 (16.1)

110 (22.1)
255 (51.2)
49 (9.8)
84 (16.9)

193 (92.3)

30 (96.8)

470 (94.4)

31 (14.8)
66 (31.6)
76 (36.4)
29 (13.9)
7 (3.4)
2.7 (2.3)

5 (16.1)
11 (35.5)
11 (35.5)
3 (9.7)
1 (3.2)
2.5 (2.1)

84 (16.9)
208 (41.8)
143 (28.7)
52 (10.4)
11 (2.2)
2.8 (3.7)

2.2 (3.5)

1.7 (2.9)

2.0 (3.6)

102 (49.3)
29 (14.0)
29(14.0)
38 (18.4)
9 (4.4)

22 (71.0)
2 (6.5)
3 (9.7)
2 (6.5)
2 (6.5)

255 (51.2)
50 (10.0)
74 (14.9)
86 (17.3)
33 (6.6)

90 (42.9)

9 (29.0)

164 (32.8)

8.3 (2.3)
168 (80.0)

8.8 (2.2)
27 (87.1)

8.6 (1.9)
433 (86.6)

Self-Perceived Health Status
Excellent
Very Good
Good
Fair
Poor
Number of Chronic Medications, Self
Number of Chronic Medications, Care
Recipients
Type of Pharmacy
Chain
Independent
Grocery
Mass Merchandiser
Mail Order
I Know My Pharmacist’s Name
Yesa
Health Confidence
Mean (SD)
High (≥7)
a

p < 0.05
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Chapter 5: Discussion
5.1 Survey Responses and National Representativeness
The Qualtrics Panel Study Population
The demographics and health characteristics of the sample yielded by the Qualtrics
survey panel for this study are relevant to an ongoing discussion about the use of easily and
inexpensively accessible online study panels for research purposes. Opt-out study panels
generated through random sampling may provide nationally representative samples but, at
a cost of up to ten times that of opt-in panels, are often cost prohibitive for academic
researchers. Comparisons between the participants in this survey and the US population as
a whole may provide insights that inform the use of opt-in panels for healthcare research.
Compared to the US population, the respondents of this survey were more
commonly female, middle-aged, and residents of the Northeast. Participants also reported,
on average, higher levels of education and annual household income than the US
population as a whole. Furthermore, the prevalence of inadequate health literacy in the
study population, 6.1%, was considerably lower than the pooled estimate of a 26%
prevalence of limited health literacy in the US.263 Older age, black race, and lower levels of
education are strongly associated with low health literacy, suggesting that the
demographics of the study population likely played a significant role in the low level of
inadequate health literacy observed in this survey. 263 However, the distribution of selfreported health status264 and the proportions of respondents patronizing chain and
independent pharmacies265 were similar to reports from nationally representative samples.
Finally, the proportion of participants who reported any use of a chronic medication
(85.1%) exceeded that reported in a study of nationally representative data from the
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National Health and Nutrition Examination Study (NHANES) (59%)250 and in an analysis of
population-based drug prescription records in Minnesota (68%).266 This difference is likely
a function of the screening question used in this study, “Have you filled a prescription at a
pharmacy, other than a mail-order pharmacy, within the last 12 months,” which likely
screened out many of the lowest drug utilizers. The prevalence of polypharmacy, as
defined by the use of at least 5 prescription drugs, in this study (19.3%) was consistent
with that in the NHANES (15%)250 and Minnesota studies (21.2%). 266
The generalizability and external validity of results obtained by opt-in and
crowdsourced panels, particularly relative to nationally representative panels, have been
explored by researchers in numerous social science fields. A group of researchers
compared the average treatment effects of 20 social science experiments that were
conducted twice, once among a nationally representative GfK sample and again with
Amazon’s MTurk participants.267 They reported that the treatment effects in the two
populations showed “considerable similarity.”267 Participants of MTurk or other opt-in
panels have also responded similarly to those recruited through nationally representative
samples or in-person convenience samples in other sociology,268,269 psychology270–272, and
political science273 studies. However, several studies of internet behavior274 and political
preferences275,276 have reported divergence between MTurk and census-representative
web panel participants.
Studies comparing the health beliefs, behaviors, and preferences reported by opt-in
panel samples to those of nationally representative samples are much more limited. While
this study does not compare the preferences of multiple samples, it does report the health
characteristics, including chronic medication use, pharmacy patronage, and health literacy
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and confidence, of an opt-in Qualtrics panel. The distribution of most health characteristics
surveyed closely mirrored patterns obtained in nationally representative studies, though
the low prevalence of health literacy among panel participants was notable. Together, these
findings suggest that the Qualtrics panel may be a relatively inexpensive method for
recruiting a study panel with nationally representative patterns of self-reported health,
pharmacy patronage, and medication use. However, research into the complex causes and
effects of health literacy277 may require a different source of study participants or the use
of more restrictive inclusion criteria and quotas. Future research comparing the
community pharmacy preferences of this or other opt-in survey panel participants (e.g.
MTurk) to nationally representative samples could further inform the generalizability and
validity of using these samples for pharmacy research.
The Quality of Survey Responses
The quality of the survey responses, as assessed by average time per task, the
proportion of participants failing the dominant scenario, and the number of respondents
always selecting the left or right alternatives, was acceptable and consistent with
previously reported findings. Two studies assessing choice behavior in discrete choice
experiments reported that 0.0%-13.3% of participants in a series of experiments always
selected a right or left alternative, consistent with the 0.2%-1.3% reported in this
study.199,201 Additionally, the median response time per choice task was consistent with
those reported in the literature.278–280 The proportion of patients failing the dominant
scenario, 5.6%, was consistent with the 5%-10%154,281–284 commonly reported in
healthcare-related discrete choice experiments. The current ISPOR guidelines for conjoint
analysis applications in health do not recommend a specific mode of administration for
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DCEs,166but the use of computers for DCE administration has increased substantially over
the last 20 years.213 The high quality of survey responses gathered in this study provides
evidence supporting the acceptability of online survey administration for DCEs.
5.2 Demographics and Service Utilization by Current Pharmacy Patronage
The demographic and health characteristics of respondents varied between patrons
of different pharmacy settings and differed somewhat from past studies on pharmacy
patronage. The majority of patients under the age of 45 years patronized chain pharmacies,
but these patients were also overrepresented in the group of patients reporting use of
independent pharmacies. In contrast, Franic et al. reported in 2008 that the average age of
patrons of independent and chain pharmacy settings was nine to twelve years higher than
that of grocery and discount store patrons.12 The increased use of mail order pharmacies
with age reported in this study is, however, consistent with past reports of high utilization
of mail order pharmacies among those over 65 years of age,104 often due to insurance plan
requirements or price incentives. 104,106 Also consistent with previously published
literature was this study’s finding that the likelihood of mail-order pharmacy use increased
with the number of prescription drugs taken.106
It is not immediately evident why chain and independent pharmacy use was higher
among the younger participants in this study than has been reported in past studies. While
independent and chain pharmacy patrons in this study prioritized pharmacist-patient
relationships and extended hours, respectively, younger respondents did not consistently
ascribe stronger preferences to these attributes than their older counterparts. Few studies
have specifically examined the pharmacy preferences of the millennial generation. A recent
Accenture study on millennial shoppers found that, contrary to popular perceptions that
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millennials prefer online shopping, 91% prefer brick-and-mortar shopping for drugstores,
a higher proportion than for consumer electronics (68%), discount stores (83%), and
department stores (84%).285 Millennials commonly distrust big business and favor niche
and local retailers,286,287 perhaps contributing to their patronage of independent
pharmacies relative to their non-millennial counterparts. At the same time, the
convenience of non-pharmacy purchases at chain pharmacies and rewards programs have
been cited as drivers for millennial patronage.288Given that the vast majority of younger
participants in this study reported use of chronic medications, future research is warranted
to more comprehensively explore the motivations that are driving millennial shoppers to
chain and independent pharmacies.
Patient pharmacy experiences and service utilization also different by pharmacy
setting. Independent pharmacy patrons were nearly twice as likely as those who patronize
other types of pharmacies to report that they knew their pharmacist’s name. Similarly, in
the 2008 Franic study of determinant attributes during pharmacy selection, patients at
independent pharmacies were more likely to know their pharmacists’ names than patients
at grocery, chain, and discount store pharmacies.12 These results suggest that patientpharmacist relationships may be more common in independent pharmacy settings, a
finding echoed in industry surveys and reports. A 2015 J.D. Power survey reported that
patient satisfaction with and loyalty to their pharmacy was strongly related to speaking
with a pharmacist, and the pharmacies with the highest overall satisfaction ratings were
locally owned chains, including Good Neighbor Pharmacy, Health Mart, and The Medicine
Shoppe Pharmacy.289 Articles by Consumer Reports and Pharmacy Times have also
stressed the strength of pharmacist-patient relationships at independent pharmacies.290,291
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The proportions of patients using a number of pharmacy services, including
appointment-based medication synchronization (ABMS), adherence packaging, and home
delivery were also higher among patrons of independent pharmacies than other types of
brick and mortar pharmacies. Both ABMS292,293 and adherence packaging294 are associated
with increased medication adherence, as is having a pharmacist who “knows you pretty
well.”295 While numerous studies have examined the effect of mail order pharmacy use on
medication adherence,296,297 few studies have specifically compared medication adherence
across brick-and-mortar pharmacy types. Future research is needed to explore the impact
of pharmacy patronage and the utilization of different combinations of pharmacy services
on adherence. Such research is particularly pertinent given the growth of PBM-defined
pharmacy networks and concerns about the systematic exclusion of independent
pharmacies from these networks.
Other pharmacy services, included automatic refill programs, technology-based
reminders, and smartphone apps were more commonly utilized by patrons of chain
pharmacies than those patronizing other types of pharmacies. These differences were
likely driven by the overrepresentation of millennials among chain pharmacy patrons.
While not statistically significant, millennials were more likely than their older
counterparts to report use of technology-based reminders (42% vs. 36%) and smartphone
apps (14% vs. 9%). did not exceed that of older patrons. In fact, the use of smart phone
apps was higher (13.6%) among older respondents than millennials (9.5%), though this
difference was not statistically significant. In the discrete choice experiment, millennials,
who have been termed the “convenience generation,”298 commonly patronized chain
pharmacies but did not exhibit strong preferences for extended pharmacy hours, a proxy
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for convenience. This finding suggests that younger patients may feel that technologybased programs do more to increase pharmacy-related convenience more than extended
hours.
Finally, the similar levels of automatic refill utilization among patrons of grocery,
chain, and mail order pharmacies was notable given differences in pharmacy practices
surrounding automatic refills. Mail order pharmacies, either in accordance with internal
policies or the policies of plan sponsors, often provide opt-out framing for automatic refill
systems, requiring patients to actively decide against the service. In contrast, opt-in
systems are generally used to enroll patients in automatic refill programs at brick-andmortar pharmacies. Given the documented impact of opt-out defaults on enrollment
behavior,299,300 this finding may warrant additional research surrounding the current
choice architecture frameworks for pharmacy services at different pharmacy types and
their impact on service utilization and adherence.

5.3 Patient Preferences for Quality-Related Attributes
The participants in this discrete choice experiment exhibited strong preferences for
quality-related attributes during pharmacy selection. This finding was somewhat contrary
to expectations based on published pharmacy quality-centered focus groups and the
feedback received in the pilot testing of this DCE. Specifically, participants in focus groups
conducted by Shiyanbola et al. generally did not define pharmacy quality in terms of
outcomes14 and were reluctant to use quality information to switch pharmacies.15
Similarly, in pilot testing, participants repeatedly stressed that their expectation of a
pharmacy was to receive the correct medication in a prompt and convenient manner.
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Several factors may have contributed to the high attribute importance values of the quality
metrics used in this study: the scenario in which participants were asked to make their
decisions, the use of a quality metric that may have been more closely aligned with
participant expectations for community pharmacists, and the framing of the drug-drug
interaction quality metric. These factors are discussed in more detail below.

The Scenario Presented to DCE Participants
In this discrete choice experiment, participants were asked to consider the scenario
in which they had moved to a new town and needed to select a new pharmacy. This
scenario was used to control for the =status quo bias previously observed during pharmacy
selection.15,170 The absence of attributes related to subjective personal experiences or the
recommendations of friends and family may have increased the strength of patient
preferences for the objective quality attributes.

Consistency Between Patient Preferences and Expectations for Community Pharmacies
As discussed in the literature review above, several theories posited in marketing
literature emphasize the complex interplay between preferences, expectations, and
satisfaction.110–112 Consistent with these theories, the patient preferences expressed in this
discrete choice experiment are likely closely associated with their expectations for
community pharmacists. Past studies have demonstrated that patient expectations for
community pharmacies are primarily product-focused and centered on dispensing roles.
Patients are far more familiar with the dispensing role of pharmacists than more clinical
roles13 and generally do not expect that pharmacists counsel them on their medications136
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or be involved in medication management.28 Furthermore, when dispensing prescriptions,
pharmacists are expected to protect patient safety by ensuring that medications are
accurately filled. When asked about whether he or she would use quality information to
select a pharmacy, one focus group participant noted, “if it’s something kind of serious like
they’ve been dispensing the wrong drugs or something, then I would definitely go to a
different one.”15 Another participant echoed that sentiment, saying, “if they are giving the
wrong prescriptions, I don’t want to take that chance with me.”15 In another series of focus
groups, participants said they wanted pharmacists to “serve me right” and “check to see if
there’s any drug interactions with other things I’m taking.”28 Taken together, these
findings suggest that the pharmacist’s role is primarily seen as one that promotes the safety
of medication therapy rather than its effectiveness.
Many of the PQA quality metrics studied in past focus groups,14,15 including those
focused on medication use, dosing, and adherence, reflect pharmacists’ involvement in
improving the therapeutic effectiveness of patients’ medication regimens. However, the
role presented to patients through the specific quality metric used in this study – that
pharmacists screen for drug-drug interactions – predominately reflects pharmacist
involvement in the safe delivery of medication therapy. The strong preferences for quality
metrics seen in this DCE may therefore reflect congruence between the DDI-specific quality
metric and patient expectations that pharmacists ensure the safety, but not the
effectiveness, of their medications.
The interpretation that the strong observed patient preferences for high quality
pharmacies reflect limited expectations for pharmacist roles tampers the potentially overoptimistic interpretation of this study’s results as validation that patients recognize the
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positive contributions of pharmacists to pharmacotherapy management. That is, it is
unlikely that patients who selected the higher quality pharmacies in this DCE made their
selections based on a perception that higher-quality pharmacies are associated with
improved pharmacotherapy management and health outcomes. Rather, patients likely
perceived higher quality pharmacies to be those that improve patient safety. Educational
efforts that inform patients about the full scope of pharmacist expertise and scope of
practice should continue, perhaps drawing upon patient expectations that pharmacists
promote patient safety by presenting evidence of the association between pharmacist
participation on the healthcare team and reductions in long-term harms associated with
chronic conditions.301,302

Risk Aversion and The Loss Framing of the DDI Quality Metric
The strong patient preferences for the DDI quality metric in this study may also
reflect the wording of this attribute and the aversions to risk and loss that have been well
documented in behavioral economics and social psychology.303 Specifically, loss aversion is
defined as an emotional response or decision heuristic that occurs when the decisionmaker is more sensitive to a loss than to the equivalent gain.303 Consequently, decisionmakers are as much as two times more likely to select an alternative that will avoid a loss
than will create a gain.304 Sensitivity to loss may be a consequence of systematically
underestimating one’s ability to rationalize loss while overestimating the future time spent
dwelling on that loss.303
The DDI quality metric used in this study was phrased using a loss framework, “The
pharmacy ensured that there were no patients who were dispensed two medications that
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could cause harm when taken together.”15 Specifically, this wording frames the metric as a
loss (i.e., patients at low quality pharmacies may experience harm) rather than as a gain (i.e.
patients at high quality pharmacies may experience improved health). A review of loss
framing versus gain framing in healthcare decision-making reported 3likely because loss
framing triggers the large behavioral response associated with loss aversion.304
Furthermore, loss-framed metrics on mock report cards were more important to patients
in a study on health plan selection than gain-framed metrics.305 Reframing the DDI metric
in a more gain-framed manner (e.g., “the pharmacy ensured that patients on multiple
medications only took those drugs that are safe and effective when taken together”) may
have decreased the perceived importance of the measure.
The risk aversion explanation for the strength of observed participant preferences
for the DDI quality metric in this DCE may offer insight into how to effectively promote
patient use of quality information during healthcare decision-making by altering the
presentation of quality data. Loss-framed quality metrics may resonate more strongly with
patients and therefore be more likely to be prioritized during provider and facility selection.
Future studies can, and should, explore the impact of loss and gain framing on patient
preferences for pharmacy and healthcare quality information to gain a better
understanding of how changes in the presentation of quality information may promote its
use among patients during real-world decision-making.

5.4 Patient Preferences for Non-Quality Attributes
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Although several past studies reported that patients see value in friendly,
relationship-oriented pharmacies and pharmacists,12,13,28 the utility values for attributes
related to functional quality in this study were low relative to those of the technical quality
metrics. Several factors may have contributed to this finding. First, as previously discussed,
patient preferences for the technical quality metrics were high in this study. Given that
preferences for attributes in discrete choice experiments are, by definition, relative to one
another, strong preferences for some attributes necessarily require that preferences for
other attributes be relatively weak. Thus, obtaining relatively weak preferences for
functional quality-related attributes does not necessarily mean that participants have
absolutely weak preferences for pharmacist friendliness and communication. If the
relatively low utilities for these functional quality-related attributes do indeed reflect low
absolute preferences, this finding may reflect the role of functional quality as a “deal
breaker” rather than a “deal maker” and/or limited patient expectations for pharmacists
outside of safe dispensing.
The Kano Model of Customer Satisfaction posits that the most basic of customer
needs and expectations for a service may be regarded as prerequisites such that if met,
they are taken for granted, but if not met, will be deal-breakers for a customer.306 For
example, when asked about grocery store preferences, one focus group participant
remarked, “it works in reverse. I won’t come to a store for good assistants, but poor
service/bad assistants will mean that I won’t go there.”102 The relatively weak utilities for
the attributes related to functional quality in this study may reflect patient perceptions that
pharmacy customer service is a deal-breaker rather than a deal-maker. In focus groups
conducted by Shiyanbola, Mott, and Croes, a participant stated, “It [choice of pharmacy] has
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a lot to do with that [pharmacy staff], because the first one that I was going to, to get my
prescriptions, it was because of convenience. But then the staff wasn’t as friendly and they
didn’t ask you questions, and then somebody recommended someplace else but it was
inconvenient. But it turned out to be worth the inconvenience.”28 In a broader study of
customer switching, service encounter failures, including encounters with uncaring,
impolite, or unresponsive employees, were second only to core service failures – mistakes,
billing errors, and severe catastrophes – as the reason for service switching.307 Taken
together, these findings suggest that pharmacy resources dedicated to customer service
may, for many pharmacies, be most efficiently allocated to avoiding service mistakes rather
than providing service far above patient expectations.
Finally, the relatively weak preferences for relationship- and communicationoriented attributes seen in this DCE may reflect limited patient expectations for
pharmacists outside of safe dispensing. As previously discussed, patient expectations for
pharmacists are predominately dispensing-based,13,28 and few patients expect that
pharmacists show an interest in working with patients to meet their healthcare needs135 or
provide counseling on a medication’s indication.136 Patients who do not expect pharmacists
to be friendly, communicate well, or show a willingness to get to know them would be
unlikely to have strong preferences for pharmacies scoring well on these attributes in the
DCE, resulting in the low attribute importance values found in this study.
The alignment of patient expectations for healthcare providers and their relative
preferences for those providers’ technical or interpersonal skills has been previously
documented. In a study of patient preferences for physicians, the relative importance that
patients placed on interpersonal communication-related factors and clinical competence-
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related attributes was different for obstetrician-gynecologists (OBGYNs) and family
physicians than for surgeons.86 Study participants reported that expertise was equally as
important as or more important than interpersonal communication skills and bedside
manner for surgeons,86 a finding echoed in two other studies of patient preferences for
surgeons.87,88 In contrast, communication factors, including ‘listens to me,’ ‘explains things
clearly,’ ‘respectful,’ ‘easy to talk to,’ and ‘caring,’ were rated more highly than expertise
when patients were considering OBGYN and family physicians.86
In conclusion, the low preferences for non-quality attributes in this study may
provide further evidence that patients perceive the role of a pharmacist as primarily
focused on accurately performing technical, episodic care (i.e. dispensing) rather than the
type of ongoing, relationship-centered care they expect of primary care physicians.
However, ongoing, patient-centered alliances between patients and pharmacists have
consistently been associated with improved adherence308 and self-efficacy.309,310 Continued
efforts may therefore be required to promote the role of the pharmacist as a long-term
partner in the management of chronic conditions.
5.5 Demographic Differences in Community Pharmacy Preferences
Several demographic differences in community pharmacy preferences were revealed in
this discrete choice experiment. First, the utility values for five stars on both the overall quality
and drug-drug interaction-specific quality metrics were higher among women than men. The
existing literature on gender differences in the relative importance of technical and function
quality in healthcare is limited. One study on consumer trust in physician quality information
reported that men had higher levels of trust in expert sources of information about healthcare
providers than their female counterparts.73 Another reported that few women prioritize
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quality metrics when selecting a hospital for labor and delivery.311 The higher importance
ascribed to quality metrics among the women in this study may reflect their higher degree
of risk aversion.312 Notably, however, the overall attribute importance value for the quality
metrics were not significantly different between men and women. Additionally, the utility
ascribed to a three-star rating was higher among men, though this difference was not
statistically significant. These findings suggest that both men and women prioritized
quality during pharmacy selection but that men were more likely than women to perceive
three stars as adequate. Future research that gathers qualitative information on gender
differences in the interpretation of the quality metrics and assesses patient preferences for
gain-framed quality metrics would provide additional insights on the gender differences
observed in this experiment.
The utility values obtained in this discrete choice experiment did not vary by age.
This finding was unexpected given consistent reports that younger patients better
understand quality data.58,63,64 Past literature also suggests that older patients ascribe
more value to the communication skills of physicians86 and less value to the convenience of
grocery stores than their younger counterparts.101 The lack of age differences in the utility
values obtained in this study may reflect the competing effects of age and education on
patient preferences for healthcare providers. Higher education is associated with improved
comprehension of quality information,70 increased trust in institutional sources of
information,73 and decreased importance ascribed to communication-related attributes
when selecting a physician.86 The older participants (≥65 years) in this study were highly
educated; a significantly higher proportion of older adults had at least some graduate
education (26.7%) than those aged 55-64 years (14.8%), 45-54 years (11.0%), 35-44 years
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(22.7%), and 18-34 years (15.8%). They were also less likely (18.9%) than those aged 5564 (24.9%) and 45-54 (24.1%) to report a high school education or less. These differences
in educational attainment may have confounded the effect of age on quality metric
comprehension and preferences during healthcare provider selection.
Patient preferences for pharmacy attributes differed by urbanicity. Specifically, the
utilities of the friendliness/courtesy and patient-pharmacist relationship attributes were
highest among small town and rural respondents, consistent with past reports patients
living in rural areas maintain high levels of pharmacy loyalty because of established
personal relationships with their pharmacists.15 These findings add to the discussion of
dual relationships with patients and overlapping roles for clinicians as community
members as notable aspects of healthcare provision in rural settings.313–315
The utility values for friendliness/courtesy, pharmacist effort to establish a
relationship, and communication were higher among survey respondents who had an
existing relationship with a pharmacist, as indicated by responding “yes” to the statement
“I know my pharmacist’s name,” than those who did not. The directionality of this
association cannot be determined from the data. That is, patients who prioritize
communication and relationships may be more likely to know their pharmacist’s name
because they either choose a relationship-oriented pharmacy or initiate a relationship with
the pharmacist. Conversely, patients who know their pharmacist’s name may be satisfied
with this relationship or feel that it adds to the quality of their care and therefore more
strongly prefer relationship-oriented attributes when choosing future pharmacies than
those who have not experienced a personal pharmacist-patient relationship. The latter
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explanation would suggest that, by making an effort to get to know their patients,
pharmacists can effectively market the value of ongoing pharmacist-patient relationships.

5.6 Community Pharmacy Market Segmentation
The results of the latent class analysis suggested that patient preferences for
community pharmacy attributes were heterogeneous and that this heterogeneity was best
represented with a three-class model. Approximately two-thirds of patients belonged to
the largest segment, the “Quality Class.” Members of the quality class displayed strong
preferences for quality metrics, with mean attribute importance values (AIV) for the drugdrug interaction (DDI)-specific quality metric and the overall quality metric of 45.5 and
33.3, respectively. In that class, no other attribute had a mean attribute importance value
over five. The second largest segment, to which 28.3% of patients belonged, was labeled
the “Relationship Class.” As in Quality Class, the attributes with the highest utility values in
the Relationship Class were the quality metrics. However, the attribute importance values
of the friendliness/courtesy, communication, and patient-pharmacist relationship
attributes (9.0-11.5) were approximately twice as large in the Relationship Class than they
were in the other classes (3.8-6.2). Finally, members of the Convenience Class, who
comprised only 4.2% of all respondents, strongly preferred pharmacies with extended
hours of operation.
There were few statistically significant differences in demographic and health
characteristics between the segments, though the lack of statistical significance may reflect
the small size of the convenience class. Notably, a significantly higher proportion of
patients in the Relationship Class reported that they know their pharmacist’s name
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(42.3%) than members of the convenience (29.0%) and quality classes (32.3%). As
discussed above, this may suggest that patients with established patient-pharmacist
relationships ascribe more value to relationship-oriented attributes because of positive
experiences with personalized pharmacy care. The age distributions of class members also
differed by segment. Members of the Convenience Class were predominantly members of
the youngest (18-24 years, 32.3%) and oldest (≥ 55 years, 48.4%) age groups surveyed.
Members of the middle age groups (25-54 years) were underrepresented in the
Convenience Class despite the growing time demands on middle-aged adults “sandwiched”
between caring for both their children and their aging parents.316
The overrepresentation of the oldest survey participants in the Convenience Class
was unexpected given the drop in labor force participation with age.317 However, several
retired, older adults in the pilot testing for this experiment had referenced prioritizing
extended pharmacy hours not for everyday accessibility but “in case” something urgent
comes up. The degree to which older adult membership in the convenience class reflects
concerns about accessibility in urgent situations could be explored in future research. If
this concern is widespread, pharmacies with more limited hours may find that offering
after hours and emergency services for loyal customers, as do many independent
pharmacies, may prove valuable for recruiting and retaining baby boomers.

5.7 Limitations and Future Research
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5.7.1 Limitations – Methodological Considerations
The attribute selection process is a critical component of any discrete choice
analysis, and despite attempts to methodically and transparently select the most
appropriate attributes for this DCE, certain limitations were introduced by the process.
First, cost and location were held constant across all pharmacy alternatives. The rationale
behind this decision is discussed in detail in the methods section and included a desire to
avoid introducing dominating attributes and a recognition that similar medication costs
and locations across multiple pharmacies are indeed realistic for a substantial portion of
the US population. However, preferred pharmacy networks introduce differential pricing
dependent upon pharmacy selection for many insured adults, particularly those with one of
the 85% of Medicare Part D plans with preferred pharmacy networks in 2017.318 Because
cost was held constant in this study, its results cannot be generalized to populations with
insurance plans that introduce substantial price incentives for patronage at an in-network
pharmacy.
The omission of potentially important attributes presents an additional
methodological limitation. This limitation is intrinsic to the use of DCEs to elicit participant
preferences, as the number of attributes is necessarily limited by the need to minimize the
cognitive burden for participants. A number of efforts were made to minimize omitted
variable bias in this study, including the inclusion of attributes that would be relevant to
the majority of patients,164 the inclusion of participants who failed the dominant
scenario,214 and the use of unlabeled alternatives. 214 Still, some participants may have felt
that the included attributes did not adequately reflect those that would be influential
during real-life decision-making. For example, several rural participants in focus groups
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noted that their pharmacy selection processes were largely dependent upon personal or
community relationships with local pharmacy owners.15 Additionally, feedback received
during the attribute selection process for this DCE suggested that the presence of a
pharmacy drive-through and the availability of specialized services like compounding and
home delivery drive pharmacy patronage decisions in select patients. Future studies
conducted in targeted patient populations could include different pharmacy attributes that
are salient to specific populations, though such an approach would considerably limit
comparability between studies.
The instructions for this discrete choice experiment outlined a specific scenario for
study participants, namely, that they were to consider the scenario in which they had
recently moved to a new town and needed to find a new pharmacy. This scenario, which
occurs for the estimated 11.5% of the US population that moves each year,319 was used to
make clear to participants that a status quo option of remaining at their current pharmacy
would not be an option in the experiment. The omission of a status quo option allowed this
experiment to assess patient preferences in the absence of status quo bias and pharmacy
loyalty, known to be dominating factors in pharmacy selection.15,170 However, this omission
also constrains the generalizability of this study to those patients who are choosing to
select a new pharmacy. If pharmacy-related quality metrics were to become publicly
available, the likelihood that patients would change pharmacies to one more consistent
with their stated preferences is not known but is likely small given the documented impact
of status quo bias.
The demographic and health characteristics collected at the end of this discrete
choice experiment were selected based on published literature but were not exhaustive.
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Participant characteristics that were not collected may have impacted preferences during
community pharmacy selection in meaningful ways. For example, while limited
information on caregiving was collected, the specific nature of the caregiving relationship
was not obtained, and the preferences of caregivers of children, able-bodied spouses, and
ailing spouses or parents may systematically differ. Employment status, mental health, and
the use of high-risk or narrow-therapeutic index medications may also influence
preferences. However, the number of questionnaire items, which exceeded that of most
health-care related DCEs, was necessarily limited by the cognitive burden of the preceding
DCE and concerns about participant attrition as that burden was increased.
Conditional logit (CL), the most commonly used model in the analysis of healthcarerelated DCEs,213 was used in the analysis of the first study aim. CL does not and cannot
account for systematic preference heterogeneity between respondents, introducing the
potential for biased estimates. Recognizing the limitation imposed by the assumption of CL
that preferences are homogenous, a latent class analysis - which models preference
heterogeneity across a discrete number of groups – was conducted alongside the CL.
Additionally, the Hierarchical Bayes model used Study Aim 2 accounts for preference
variation by estimating individual-level utility values. The results of all three models were
presented here, consistent with the way in which many published studies that estimate
both CL and latent class models report the results of both.209,320,321
Finally, this study design employed a main-effects model only. This design is the
most commonly used design in healthcare-related DCEs213 and the use of a main-effects
model minimizes the number of choice tasks per person required for an efficient design.
However, the main effects model makes the assumption that interactions are statistically
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significantly different from zero.180 In this study, pilot testing was used to identify
attributes that were seen as highly correlated, and redundant attributes were removed.
The final attribute list included two quality metrics, an overall and a specific measure.
Though participants in the pilot test and published focus groups14,71 and surveys67 tended
to view overall and specific scores as distinct, with different types of measures appealing to
different subpopulations, the possibility of bias introduced by interattribute correlation
cannot be excluded.

5.7.2 Limitations – The External Validity of Discrete Choice Experiments
Stated preference techniques, including discrete choice experiments, have a number
of inherent limitations in their ability to accurately predict real life decision-making, and
analyses of the external validity of healthcare-related discrete choice experiments are
notably limited.322 However, stated preference techniques provide an opportunity to assess
participant preferences for attributes or attribute levels that do not currently exist,
allowing decision-makers to gain insights into the possible impact of introducing a new
attribute – here, publicly available pharmacy-level quality metrics – into the marketplace.
Should pharmacy-level quality metrics become publicly available, additional research
should explore the convergence between the results of this and future pharmacy qualityrelated discrete choice experiments with real life patient decisions in the community
pharmacy market.
The external validity of this DCE may be limited by the easy accessibility of the
quality information in the experiment. Studies on patient awareness of healthcare quality
metrics report very low levels of awareness of publicly available hospital quality
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metrics,50,51 particularly those available through governmental outlets. 54 If pharmacy
quality metrics were publicly available, patient awareness of those metrics is likely to be
similarly low, thus limiting the degree to which the metrics would be used during
pharmacy selection. Furthermore, this experiment presented the quality information as
“expert-assessed,” reflecting that the metrics presented were those that have been
developed by the non-governmental, multi-stakeholder Pharmacy Quality Alliance. If the
PQA metrics were presented through a .gov website, the metrics may be perceived as less
trustworthy by patients, who have previously reported moderate to low degrees of trust in
CAHPS, HEDIS, and Medicare performance data. 74,75 The effect of presenting pharmacy
quality information through a government-related channel on patient preferences for the
quality metrics is not known but could be explored in future research.
Finally, limits on this study’s generalizability are relevant to a discussion of its
external validity. The population of respondents yielded from the Qualtrics study panel
was not nationally representative and therefore are not generalizable to the entire US
population . The preferences calculated and discussed in this study may best reflect the
preferences of middle aged Americans with above-average levels of education and income.
Future research should explore the community pharmacy preferences of populations
underrepresented in this study population, particularly older adults and those with low
levels of education and health literacy.

5.7.3 Future Research
As this was the first quantitative study on patient preferences for community
pharmacy attributes, its results raise numerous questions and hypotheses to be explored in
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future research. First, the study results generated a hypothesis that patient preferences for
the drug-drug interaction metric reflect an underlying risk aversion common among both
patients and clinicians. Future research is needed to explore the validity of this hypothesis
and may include additional discrete choice experiments testing the impact of loss- and
gain-framing on patient preferences for high-quality pharmacies. This hypothesis could
also be extended to research on quality metrics in other aspects of healthcare, including
hospitals and physicians. Hospitalcompare.gov currently presents predominantly gainframed quality metrics, most often in terms of the proportions of patients who receive
appropriate care. The impact of loss-framing on increased patient utilization of these
metrics remains to be studied and would add to the body literature on the optimal
presentation of quality information. The vast majority of studies on the impact of
presentation on patient comprehension and use of quality data focus on the presentation of
the data itself, including the amount and format of data presentation. Few, if any, studies
have investigated the effect of the wording of the quality measure itself on perceived
importance and relevance of the measure.
Secondly, as discussed above, older adults, particularly those above 75 years of age,
were underrepresented in this study population. The number of older adults and the
proportion of the population over 65 years is expected to rise considerably in the next 30
years.323 Polypharmacy is increasingly common in older adults248 and has documented
associations with numerous adverse health outcomes.324 Community pharmacists are in a
position to identify and limit polypharmacy and its adverse effects;325 thus, the ways to best
nudge older adults towards high quality pharmacies that are proactively involved with
pharmacotherapy management warrant further exploration.

164

Finally, as noted above, the external validity of healthcare-related discrete choice
experiments has not been extensively studied.322 The pharmacy choices made in this DCE
cannot currently be compared to those made in real life because pharmacy quality metrics
are not yet publicly available. Furthermore, “soft” attributes like pharmacist
communication and friendliness would be difficult to quantify across a large array of
pharmacies, complicating an analysis of real-life patient decision-making. However, the
preferences calculated from this DCE could be compared to those estimated from
alternative preference elicitation methods. For example, the utilities generated from a DCE
can be compared to those generated from a best-worst scaling exercise. These types of
empirical comparisons have been encouraged for healthcare-related choice experiments,
particularly in light of conflicting findings reported by studies comparing the two.326–328

5.8 Conclusion
In conclusion, this study explored patient preferences for six community pharmacy
attributes: two quality metrics, hours of operation, pharmacist friendliness, pharmacist
communication, and pharmacist effort to establish a pharmacist-patient relationship. The
participants in this discrete choice experiment exhibited strong preferences for pharmacies
with high star ratings on a specific quality metric, “Pharmacy ensured there were no
patients who were dispensed two medications that can cause harm when taken together.”
This finding may reflect patient expectations of community pharmacists, namely that
pharmacists ensure that patients are not harmed by the medications filled at their
pharmacies. Latent class analysis revealed underlying preference heterogeneity and
identified three classes, including a Quality Class, a Relationship Class, and a Convenience
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Class. The role of community pharmacists has expanded considerably in past decades and
will likely continue to change with the changing healthcare environment and efforts to gain
provider status. Future research on patient expectations of and preferences for community
pharmacies will be needed to assess the degree to which patients buy-in to expanding
pharmacist roles and the most effective ways to encourage patients to actively engage with
their pharmacists to improve health outcomes.
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